<SEC-DOCUMENT>0001213900-26-007207.txt : 20260123
<SEC-HEADER>0001213900-26-007207.hdr.sgml : 20260123
<ACCEPTANCE-DATETIME>20260123161003
ACCESSION NUMBER:		0001213900-26-007207
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20260123
FILED AS OF DATE:		20260123
DATE AS OF CHANGE:		20260123

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			VCI Global Ltd
		CENTRAL INDEX KEY:			0001930510
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-FACILITIES SUPPORT MANAGEMENT SERVICES [8744]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				000000000
		STATE OF INCORPORATION:			N8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41678
		FILM NUMBER:		26556525

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		B03-C-8 MENARA 3A, KL ECO CITY, NO. 3
		STREET 2:		JALAN BANGSAR
		CITY:			KUALA LUMPUR
		PROVINCE COUNTRY:   	N8
		BUSINESS PHONE:		603 2201 5249

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		B03-C-8 MENARA 3A, KL ECO CITY, NO. 3
		STREET 2:		JALAN BANGSAR
		CITY:			KUALA LUMPUR
		PROVINCE COUNTRY:   	N8
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0273586-6k_vciglobal.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
6-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPORT
OF FOREIGN PRIVATE ISSUER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO SECTION 13a-16 OR 15d-16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF
THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the month of January 2026</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Commission
File Number: 001-41678</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VCI
Global Limited </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Translation
of registrant&rsquo;s name into English)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Suite
33.03 of Level 33, Menara Exchange 106, Lingkaran TRX, Tun Razak Exchange,<BR>
55188 Kuala Lumpur, Malaysia</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
20-F &#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Registered
Direct Offering</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 20, 2026, VCI Global Limited (the &ldquo;Company&rdquo;)
entered into a securities purchase agreement (the &ldquo;Purchase Agreement&rdquo;) with a single institutional investor (the &ldquo;Purchaser&rdquo;),
pursuant to which the Purchaser agreed, subject to the satisfaction of certain conditions contained in the Purchase Agreement, to purchase
$15 million of the Company&rsquo;s securities consisting of the Company&rsquo;s ordinary shares, no par value (the &ldquo;Shares&rdquo;),
pre-funded warrants (&ldquo;Pre-Funded Warrants&rdquo;) to purchase ordinary shares, common A warrants (&ldquo;Common A Warrants&rdquo;)
to purchase ordinary shares and common B warrants (&ldquo;Common B Warrants&rdquo;&rdquo;, and together with the Common A Warrants, the
&ldquo;Common Warrants&rdquo;) in three tranches of $5 million each in three separate closings. The initial closing, being referred to
herein as the &ldquo;Initial Closing&rdquo; and the second and third closings are referred to herein as the First Tranche Closing and
Second Tranche Closing, respectively. The issuance of the Shares, the Pre-Funded Warrants, the Common Warrants and the ordinary shares
underlying the Pre-Funded Warrants and the Common Warrants (the &ldquo;Offering&rdquo;) is pursuant the Purchase Agreement and the Company&rsquo;s
Prospectus Supplement (the &ldquo;Prospectus Supplement&rdquo;) dated January 21, 2026 and filed with the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) on January 21, 2026 pursuant to Rule 424(b)(5). The Common A Warrants have a 5-year term and an initial exercise
price of $0.8020 per share, which is subject to adjustment as set forth in the Purchase Agreement and described in the Prospectus Supplement.
The Common B Warrants have a 180-day term and an initial exercise price of $0.8020 per share, which is subject to adjustment as set forth
in the Purchase Agreement and described in the Prospectus Supplement. The Common A Warrants also have cashless exercise and forced exercise
provisions that are set forth in the Purchase Agreement and described in the Prospectus Supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Initial Closing occurred on January 21, 2026 and the Company issued
3,179,716 Shares, Pre-Funded Warrants to Purchase up to 5,393,672 ordinary shares, Common A Warrants to purchase up to 8,573,388 ordinary
shares and Common B Warrants to purchase up to 8,573,388 ordinary shares for gross proceeds of approximately $5 million. Each of the First
Tranche Closing and Second Tranche Closing may occur if the Company satisfies certain conditions contained in the Purchase Agreement and
described in the Prospectus Supplement, which include, but are not limited to certain conditions relating to the trading price and trading
volume of the Company&rsquo;s ordinary shares immediately prior to such closing date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
Purchase Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification
obligations of the Company, including for liabilities arising under the Securities Act of 1933, as amended, other obligations of the
parties and termination provisions. The representations, warranties and covenants contained in the Purchase Agreement were made only
for the purpose of such agreement and as of specific dates, were solely for the benefit of the parties to the Purchase Agreement and
may be subject to limitations agreed upon by the contracting parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into a placement agency agreement (the &ldquo;Placement Agency Agreement&rdquo;) with E.F. Hutton &amp; Co. (the &ldquo;Placement
Agent&rdquo;) on January 16, 2026, pursuant to which the Placement Agent agreed to serve as the exclusive placement agent for the Company,
on a reasonable best efforts basis, in connection with the Offering. The Company has agreed to pay the Placement Agent an aggregate cash
fee equal to 7.0% of the gross proceeds received in the Offering and for certain expenses incurred by the Placement Agent in connection
with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Electronic copies of the Prospectus Supplement and the related shelf
registration statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1930510/000121390024044823/ea0206442-f3_vciglobal.htm">Form
F-3</A> (File No. 333-279521), filed with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) on May 17, 2024, and declared
effective by the Commission on May 28, 2024 (the &ldquo;Registration Statement&rdquo;) may be obtained, when available, on the SEC&rsquo;s
website at http://www.sec.gov or by contacting E.F. Hutton&amp; Co. at 745 Fifth Avenue, 34th Floor &amp; PH, New York, NY 10151, by phone
at (212) 970-3700 or e-mail at info@efhutton.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing descriptions of the Purchase Agreement, Placement Agency Agreement, Common A Warrants Common B Warrants and the Pre-Funded
Warrants are only summaries and are qualified in their entirety by reference to the complete text of the form of Purchase Agreement,
Placement Agency Agreement, Common A Warrants Common B Warrants and Pre-Funded Warrants, copies of which are attached as Exhibit 10.1,
Exhibit 4.1, Exhibit 4.2 and Exhibit 4.3, respectively, to this Report on Form 6-K and are incorporated by reference herein, and such
description and exhibits are incorporated by reference into the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Copies
of the opinion of Carey Olsen (BVI) L.P. regarding the validity of the Ordinary Shares issued in the Offering, including Ordinary Shares
issuable upon exercise of the Pre-Funded Warrants and the Placement Agent Warrants, and the opinion of Sichenzia Ross Ference Carmel
LLP regarding the validity of the Pre-Funded Warrants and the Placement Agent Warrants are filed as Exhibit 5.1 and Exhibit 5.2, respectively,
to this Report on Form 6-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the press release issued by the Company on January 19, 2026 announcing the Offering is attached hereto as Exhibit 99.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Report on Form 6-K does not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these
securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification
under the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit<BR>
    Number</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ea027358601ex4-1_vciglobal.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Common A Warrants</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ea027358601ex4-2_vciglobal.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Common B Warrants</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ea027358601ex4-3_vciglobal.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Pre-Funded Warrants</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ea027358601ex5-1_vciglobal.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Carey Olsen (BVI) L.P.</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ea027358601ex5-2_vciglobal.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Sichenzia Ross Ference Carmel LLP</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ea027358601ex10-1_vciglobal.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Securities Purchase Agreement</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ea027358601ex10-2_vciglobal.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Placement Agency Agreement</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ea027358601ex5-1_vciglobal.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Carey Olsen (BVI) L.P. (set forth in Exhibit 5.1)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ea027358601ex5-2_vciglobal.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Sichenzia Ross Ference Carmel LLP (set forth in Exhibit 5.2)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ea027358601ex99-1_vciglobal.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release issued by VCI Global Limited on January 20, 2026</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    January 23, 2026</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VCI
    Global Limited</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 34%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Victor Hoo</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Victor
    Hoo</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    and Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea027358601ex4-1_vciglobal.htm
<DESCRIPTION>FORM OF COMMON A WARRANTS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 4.1</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VCI GLOBAL LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WARRANT TO PURCHASE ORDINARY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date of Issuance: January 21, 2026 (&ldquo;<B>Issuance
Date</B>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">VCI Global Limited, a company incorporated under
the BVI Business Companies Act, 2004 (as amended) of the British Virgin Islands (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that,
for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Esousa Group Holdings, LLC, the registered
holder hereof or its permitted assigns (the &ldquo;<B>Holder</B>&rdquo;), is entitled, subject to the terms set forth below, to purchase
from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant to Purchase Ordinary Shares (including
any Warrants to Purchase Ordinary Shares issued in exchange, transfer or replacement hereof, the &ldquo;<B>Warrant</B>&rdquo;), at any
time or times on or after the Issuance Date, subject to the terms set forth below, but not after 11:59 p.m., New York time, on the Expiration
Date (as defined below), 8,573,388 (subject to adjustment as provided herein) fully paid and non-assessable Ordinary Shares (as defined
below) (the &ldquo;<B>Warrant Shares</B>&rdquo;). Except as otherwise defined herein, capitalized terms in this Warrant shall have the
meanings set forth in Section 16. This Warrant is one of the Warrants to purchase Ordinary Shares (the &ldquo;<B>SPA Warrants</B>&rdquo;)
issued to Holder pursuant to that certain Securities Purchase Agreement dated January 20, 2026 by and among the Company, the Holder and
the other investors thereto (the &ldquo;<B>Securities Purchase Agreement</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1. <U>EXERCISE OF WARRANT</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Mechanics of Exercise</U>.
Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in Section 1(f)), this Warrant may
be exercised by the Holder on any day on or after the Issuance Date in whole or in part, by delivery (whether via facsimile or otherwise)
of a written notice, in the form attached hereto as <B><U>Exhibit A</U></B> (the &ldquo;<B>Exercise Notice</B>&rdquo;), of the Holder&rsquo;s
election to exercise this Warrant. Within one (1) Trading Day following an exercise of this Warrant as aforesaid, the Holder shall deliver
payment to the Company of an amount equal to the number of Warrant Shares as to which this Warrant was so exercised multiplied by the
lower of (i) the Exercise Price in effect on the date of such exercise and (ii) 50% of the lowest daily VWAP in the five (5) consecutive
Trading Days prior to the time of such exercise (in respect of such specific exercise, the &ldquo;<B>Aggregate Exercise Price</B>&rdquo;),
in each case in cash or via wire transfer of immediately available funds if the Holder did not notify the Company in such Exercise Notice
that such exercise was made pursuant to a Cashless Exercise (as defined in Section 1(d)) permitted hereunder. The Holder shall not be
required to deliver the original of this Warrant in order to effect an exercise hereunder. Execution and delivery of an Exercise Notice
with respect to less than all of the Warrant Shares shall have the same effect as cancellation of the original of this Warrant certificate
and issuance of a new Warrant certificate evidencing the right to purchase the remaining number of Warrant Shares. Execution and delivery
of an Exercise Notice for all of the then-remaining Warrant Shares shall have the same effect as cancellation of the original of this
Warrant certificate after delivery of the Warrant Shares in accordance with the terms hereof. On or before the first (1st) Trading Day
following the date on which the Company has received an Exercise Notice, the Company shall transmit by email an acknowledgment of confirmation
of receipt of such Exercise Notice, in the form attached hereto as <U>Exhibit B</U>, to the Holder and the Company&rsquo;s transfer agent
(the &ldquo;<B>Transfer Agent</B>&rdquo;). On or before the first (1st) Trading Day following the date on which the Company has received
such Exercise Notice (the &ldquo;<B>Required Delivery Date</B>&rdquo;), the Company shall, upon the request of the Holder, credit such
aggregate number of Ordinary Shares to which the Holder is entitled pursuant to such exercise to the Holder&rsquo;s or its designee&rsquo;s
balance account with The Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) through its Deposit/ Withdrawal at Custodian system. Upon
delivery of an Exercise Notice, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant
Shares with respect to which this Warrant has been exercised, irrespective of the date such Warrant Shares are credited to the Holder&rsquo;s
DTC account. If this Warrant is submitted in connection with any exercise pursuant to this Section 1(a) and the number of Warrant Shares
represented by this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired upon an exercise, then,
at the request of the Holder and upon surrender hereof by the Holder at the principal office of the Company, the Company shall as soon
as practicable and in no event later than three (3) Business Days after any exercise and at its own expense, issue and deliver to the
Holder (or its designee) a new Warrant (in accordance with Section 7(d)) representing the right to purchase the number of Warrant Shares
purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect to which this Warrant
is exercised. No fractional Ordinary Shares are to be issued upon the exercise of this Warrant, but rather the number of Ordinary Shares
to be issued shall be rounded up to the nearest whole number. The Company shall pay any and all taxes and fees which may be payable with
respect to the issuance and delivery of Warrant Shares upon exercise of this Warrant.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) &thinsp;<U>Exercise Price</U>.
For purposes of this Warrant, &ldquo;<B>Exercise Price</B>&rdquo; means $0.8020, subject to adjustment as provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Company&rsquo;s Failure
to Timely Deliver Securities</U>. If the Company fails to issue and credit the balance account of Holder or Holder&rsquo;s nominee with
DTC for such number of Warrant Shares for which this Warrant is exercised by the Holder, then, in addition to all other remedies available
to Holder, at the sole discretion of Holder, the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) pay in cash
or shares of Ordinary Shares at the discretion of the Company to Holder on each Trading Day after the Required Delivery Date that the
issuance and credit of such Warrant Shares is not timely effected an amount equal to 5% of the product of (A) the number of Ordinary Shares
Ordinary Shares not so credited to Holder or Holder&rsquo;s nominee multiplied by (B) the Closing Sale Price of the Ordinary Shares on
the Trading Day immediately preceding the Required Delivery Date; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) if on or after
the Required Delivery Date, Holder (or any other Person in respect, or on behalf, of Holder) purchases (in an open market transaction
or otherwise) Ordinary Shares (&ldquo;<B>Replacement Shares</B>&rdquo;) to deliver in satisfaction of a sale by Holder of all or any portion
of the number of Ordinary Shares, or a sale of a number of Ordinary Shares equal to all or any portion of the number of Ordinary Shares,
that Holder so anticipated receiving from the Company without any restrictive legend, then, within five (5) Trading Days after Holder&rsquo;s
request and in Holder&rsquo;s sole discretion, either (A) pay cash to Holder in an amount equal to Holder&rsquo;s total purchase price
(including brokerage commissions and other out-of-pocket expenses, if any) for the Replacement Shares (the &ldquo;<B>Buy-In Price</B>&rdquo;),
at which point the Company&rsquo;s obligation to so credit Holder&rsquo;s balance account shall terminate and such shares shall be cancelled,
or (B) promptly honor its obligation to so credit Holder&rsquo;s DTC account representing such number of Ordinary Shares that would have
been so delivered if the Company timely complied with its obligations hereunder and pay cash to Holder in an amount equal to the excess
(if any) of the Buy-In Price over the product of (1) such number of Ordinary Shares that the Company was required to deliver to Holder
by the Required Delivery Date multiplied by (2) the lowest Closing Sale Price of the Ordinary Shares on any Trading Day during the period
commencing on the date Holder purchased Replacement Shares and ending on the date of such delivery and payment under this clause (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent permitted by law, the Company&rsquo;s
obligations to issue and deliver the Ordinary Shares upon exercise of the Warrant in accordance with the terms hereof are absolute and
unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision
hereof, the recovery of any judgment against any person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation
or termination, or any breach or alleged breach by the Holder or any other person of any obligation to the Company or any violation or
alleged violation of law by the Holder or any other person, and irrespective of any other circumstance that might otherwise limit such
obligation of the Company to the Holder in connection with the issuance of the Ordinary Shares. Nothing herein shall limit the Holder&rsquo;s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver the Ordinary Shares issuable upon exercise
of this Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Cashless Exercise</U>.
Notwithstanding anything contained herein to the contrary (other than Section 1(f) below), if the Closing Sale Price of the Ordinary Shares
on the Trading Day immediately prior to the time of such exercise is lower than the Exercise Price, the Holder may at any time and in
its sole discretion (and without limiting the Holder&rsquo;s rights and remedies contained herein or in any of the other Transaction Documents
(as defined in the Securities Purchase Agreement)), exercise this Warrant in whole or in part and, in lieu of making the cash payment
otherwise contemplated to be made to the Company upon such exercise in payment of the Aggregate Exercise Price, elect instead to receive
upon such exercise the &ldquo;Net Number&rdquo; of Ordinary Shares determined according to the following formula (a &ldquo;<B>Cashless
Exercise</B>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0pt">Net Number =
(A x B) / C</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For purposes of the foregoing formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0pt">A = The total number of shares with
respect to which this Warrant is then being exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0pt">B = The Black Scholes Value (as defined
in Section 16 herein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0pt">C = The lower of the two Closing Bid
Prices of the Ordinary Shares in the two days prior to the time of such exercise (as such Closing Bid Price is defined in Section 16 herein),
but in any event not less than $0.01 (as may be adjusted for stock dividends, subdivisions, or combinations in the manner described in
Section 2(a) herein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Disputes</U>. In the
case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of Warrant Shares to be issued
pursuant to the terms hereof (including, without limitation, the Net Number), the Company shall promptly issue to the Holder the number
of Warrant Shares that are not disputed, <I><U>provided</U></I> that following such issuance to Holder such dispute shall be resolved
in accordance with Section 13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Limitations on Exercises
and Exchan</U>g<U>es</U>. Notwithstanding anything to the contrary contained in this Warrant, this Warrant shall not be exercisable or
exchangeable by the Holder hereof to the extent (but only to the extent) that the Holder or any of its affiliates would beneficially own
in excess of 9.9% of the number of Ordinary Shares outstanding after giving effect to the issuance of Ordinary Shares issuable upon exercise
of the Warrants calculated in accordance with Section 13(d) of the Exchange Act (the &ldquo;<B>Maximum Percentage</B>&rdquo;). To the
extent the above limitation applies, the determination of whether this Warrant shall be exercisable or exchangeable (vis-&agrave;-vis
other convertible, exercisable or exchangeable securities owned by the Holder or any of its affiliates) and of which such securities shall
be exercisable or exchangeable (as among all such securities owned by the Holder) shall, subject to such Maximum Percentage limitation,
be determined on the basis of the first submission to the Company for conversion, exercise or exchange (as the case may be). No prior
inability to exercise or exchange this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions
of this paragraph with respect to any subsequent determination of exercisability or exchangeability. For the purposes of this paragraph,
beneficial ownership and all determinations and calculations (including, without limitation, with respect to calculations of percentage
ownership) shall be determined in accordance with Section 13(d) of the Exchange Act (as defined in the Securities Purchase Agreement)
and the rules and regulations promulgated thereunder. The provisions of this paragraph shall be implemented in a manner otherwise than
in strict conformity with the terms of this paragraph to correct this paragraph (or any portion hereof) which may be defective or inconsistent
with the intended Maximum Percentage beneficial ownership limitation herein contained or to make changes or supplements necessary or desirable
to properly give effect to such Maximum Percentage limitation. The limitations contained in this paragraph shall apply to a successor
Holder of this Warrant. The holders of Ordinary Shares shall be third party beneficiaries of this paragraph and the Company may not waive
this paragraph without the consent of holders of a majority of its Ordinary Shares. For any reason at any time, upon the written or oral
request of the Holder, the Company shall within two (2) Business Days confirm orally and in writing to the Holder the number of Ordinary
Shares then outstanding, including by virtue of any prior conversion or exercise or exchange of convertible or exercisable or exchangeable
securities into Ordinary Shares, including, without limitation, pursuant to this Warrant or securities issued pursuant to the Securities
Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Reservation of Shares;
Insufficient Authorized Shares</U>. The Company shall initially reserve out of its authorized and unissued Ordinary Shares a number of
Ordinary Shares equal to 250% of the maximum number of Warrant Shares issuable to satisfy the Company&rsquo;s obligations to issue Ordinary
Shares hereunder, and the Company shall at all times keep reserved for issuance under this Warrant a number of Ordinary Shares equal to
250% of the maximum number of Warrant Shares issuable to satisfy the Company&rsquo;s obligation to issue shares of Ordinary Shares hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>Activity Restrictions</U>.
For so long as Holder holds this Warrant or any Warrant Shares, Holder will not: (i) engage or participate in any actions, plans or proposals
which relate to or would result in (a) acquiring additional securities of the Company, alone or together with any other Person, which
would result in beneficially owning or controlling, or being deemed to beneficially own or control, more than 4.99% of the total outstanding
Ordinary Shares or other voting securities of the Company, (b) an extraordinary corporate transaction, such as a merger, reorganization
or liquidation, involving Company, (c) a sale or transfer of a material amount of assets of the Company, (d) any change in the present
board of directors or management of the Company, including any plans or proposals to change the number or term of directors or to fill
any existing vacancies on the board, (e) any material change in the present capitalization or dividend policy of the Company, (f) any
other material change in the Company&rsquo;s business or corporate structure, including but not limited to, if the Company is a registered
closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by Section
13 of the Investment Company Act of 1940, (g) changes in the Company&rsquo;s memorandum or articles of association or instruments corresponding
thereto or other actions which may impede the acquisition of control of the Company by any Person, (h) causing a class of securities of
the Company being delisted from a national securities exchange or ceasing to be authorized to be quoted in an inter-dealer quotation system
of a registered national securities association, (i) a class of equity securities of the Company becoming eligible for termination of
registration pursuant to Section 12(g)(4) of the Securities Act (as defined in the Securities Purchase Agreement), or (j) any action,
intention, plan or arrangement similar to any of those enumerated above, or (ii) request the Company or its directors, officers, employees,
agents or representatives to amend or waive any provision of this Section 1(h); <I><U>provided</U></I>, <I><U>however</U></I>, that notwithstanding
anything to the contrary contain in clauses (i) and (ii) above, Holder may in its discretion vote any Ordinary Shares owned or controlled
by it, solicit any proxies, or seek to advise or influence any Person with respect to any voting securities of the Company. Holder may
only exercise this Warrant for a cash exercise price if the trading price at the time of exercise is greater than the then applicable
Exercise Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) <U>Forced Cash Exercise
Provision</U>. Subject to the provisions of Section 1(f) and this Section 1(i), if, after the Initial Exercise Date, (i) the VWAP for
each of 10 consecutive Trading Days (the &ldquo;<U>Measurement Period</U>,&rdquo; which 10 consecutive Trading Day period shall not have
commenced until after the Initial Exercise Date) exceeds 120% of the Exercise Price (subject to adjustment for forward and reverse stock
splits, recapitalizations, stock dividends and the like after the Initial Exercise Date), (ii) the Company is then in compliance with
all conditions for continued listing on the Trading Market (i.e., the Company has cured any previously outstanding Trading Market deficiencies
and has not received any new deficiency or delisting notices from the Trading Market), (iii) the Warrant Shares issuable upon exercise
or exchange of this Warrant (as determined based on the number of Warrant Shares issuable on the first day of the Measurement Period)
have been registered for resale on an effective resale registration statement and (iv) the Company in not then in default under any provision
of this Warrant, then the Company may, within 1 Trading Day of the end of such Measurement Period, force the Holder to exercise all or
any portion of this Warrant for which a Notice of Exercise has not yet been delivered (such right, a &ldquo;<U>Forced Cash Exercise</U>&rdquo;)
for cash as provided herein. To exercise this right, the Company must deliver to the Holder an irrevocable written notice (a &ldquo;<U>Forced
Cash Exercise Notice</U>&rdquo;), indicating therein the portion of unexercised portion of this Warrant to which such notice applies.
If the conditions set forth below for such Forced Cash Exercise are satisfied from the period from the date of the Forced Cash Exercise
Notice through and including the Forced Cash Exercise Date (as defined below), then any portion of this Warrant subject to such Forced
Cash Exercise Notice for which a Notice of Exercise shall not have been received by the Forced Cash Exercise Date will be cancelled at
6:30 p.m. (New York City time) on the Trading Day after the date the Forced Cash Exercise Notice is received by the Holder (such date
and time, the &ldquo;<U>Forced Cash Exercise Date</U>&rdquo;). Any unexercised portion of this Warrant to which the Forced Cash Exercise
Notice does not pertain will be unaffected by such Forced Cash Exercise Notice. In furtherance thereof, the Company covenants and agrees
that it will honor all Notices of Exercise with respect to Warrant Shares subject to a Forced Cash Exercise Notice that are tendered through
6:30 p.m. (New York City time) on the Forced Cash Exercise Date. The parties agree that any Notice of Exercise delivered following a Forced
Cash Exercise Notice which calls for the exercise of less than all of the Warrants shall first reduce to zero the number of Warrant Shares
subject to such Forced Cash Exercise Notice prior to reducing the remaining Warrant Shares available for purchase under this Warrant.
For example, if (A) this Warrant then permits the Holder to acquire 100 Warrant Shares, (B) a Forced Cash Exercise Notice pertains to
75 Warrant Shares, and (C) prior to 6:30 p.m. (New York City time) on the Forced Cash Exercise Date the Holder tenders a Notice of Exercise
in respect of 50 Warrant Shares, then (x) on the Forced Cash Exercise Date the right under this Warrant to acquire 25 Warrant Shares will
be automatically cancelled, (y) the Company, in the time and manner required under this Warrant, will have issued and delivered to the
Holder 50 Warrant Shares in respect of the exercises following receipt of the Forced Cash Exercise Notice, and (z) the Holder may, until
the Termination Date, exercise this Warrant for 25 Warrant Shares (subject to adjustment as herein provided and subject to subsequent
Forced Cash Exercise Notices). Subject again to the provisions of this Section 1(i), the Company may deliver subsequent Forced Cash Exercise
Notices for any portion of this Warrant for which the Holder shall not have delivered a Notice of Exercise. Notwithstanding anything to
the contrary set forth in this Warrant, the Company may not deliver a Forced Cash Exercise Notice or require the cancellation of this
Warrant (and any such Forced Cash Exercise Notice shall be void), unless, from the beginning of the Measurement Period through the Forced
Cash Exercise Date, (1) the Company shall have honored in accordance with the terms of this Warrant all Notices of Exercise delivered
by 6:30 p.m. (New York City time) on the Forced Cash Exercise Date, and (2) a registration statement shall be effective as to all Warrant
Shares and the prospectus thereunder available for use by the Company for the sale of all such Warrant Shares to the Holder, and (3) the
Ordinary Shares shall be listed or quoted for trading on the Trading Market, and (4) there is a sufficient number of authorized Ordinary
Shares for issuance of all Warrant Shares, and (5) the issuance of all Warrant Shares subject to a Forced Cash Exercise Notice shall not
cause a breach of any provision of Section 1(i) herein. The Company&rsquo;s right to force the exercise of the Warrants under this Section
1(i) shall be exercised ratably among the Holders based on each Holder&rsquo;s initial purchase of Warrants.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2. <U>ADJUSTMENT OF EXERCISE PRICE AND NUMBER
OF WARRANT SHARES</U>. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment
from time to time as set forth in this Section 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Share Dividends and
Splits</U>. Without limiting any provision of Section 4, if the Company, at any time on or after the date of the Securities Purchase Agreement,
(i) pays a stock dividend on one or more classes of its then outstanding Ordinary Shares or otherwise makes a distribution on any class
of share capital that is payable in Ordinary Shares, (ii) subdivides (by any stock split, stock dividend, recapitalization or otherwise)
one or more classes of its then outstanding Ordinary Shares into a larger number of shares or (iii) combines (by combination, reverse
stock split or otherwise) one or more classes of its then outstanding Ordinary Shares into a smaller number of shares, then in each such
case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Ordinary Shares outstanding immediately
before such event and of which the denominator shall be the number of Ordinary Shares outstanding immediately after such event. Any adjustment
made pursuant to clause (i) of this paragraph shall become effective immediately after the record date for the determination of shareholders
entitled to receive such dividend or distribution, and any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become
effective immediately after the effective date of such subdivision or combination. If any event requiring an adjustment under this paragraph
occurs during the period that an Exercise Price is calculated hereunder, then the calculation of such Exercise Price shall be adjusted
appropriately to reflect such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Ad</U>j<U>ustment Upon
Issuance of Ordinary Shares</U>. If, during the Restricted Period (as defined in the Securities Purchase Agreement), the Company effects
an Subsequent Financing (as defined in the Securities Purchase Agreement), or in accordance with this Section 2 is deemed to have effected
a Subsequent Financing, any Ordinary Shares (including the issuance or sale of Ordinary Shares owned or held by or for the account of
the Company) issued or sold or deemed to have been issued or sold) for a consideration per share (the &ldquo;<B>New Issuance Price</B>&rdquo;)
less than a price equal to the Exercise Price in effect immediately prior to such issue or sale or deemed issuance or sale (such Exercise
Price then in effect is referred to as the &ldquo;<B>Applicable Price</B>&rdquo;) (the foregoing a &ldquo;<B>Dilutive Issuance</B>&rdquo;),
then immediately after such Dilutive Issuance, the Exercise Price then in effect shall be reduced (and in no event increased) to the price
per share as determined in accordance with the following formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">EP2 = EP1 x (A + B) / (A + C)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">For purposes of the foregoing formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">A= The total number of Warrant Shares with respect to which this Warrant may be exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">B= The total number of Ordinary Shares that would be issued or issuable under the Dilutive Issuance if issued at a per share equal to EP1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">C= The total number of Ordinary Shares actually issued or issuable under the Dilutive Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.85pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.85pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">EP1= The Exercise Price in effect immediately prior to a Dilutive Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">EP2= The Exercise Price immediately
after such Dilutive Issuance; <I><U>provided</U></I>, <I><U>however</U></I>, that such price shall in no event be less than $0.1458 per
Ordinary Share (as may be adjusted for stock dividends, subdivisions, or combinations in the manner described in Section 2(a) herein,
the &ldquo;<B>Floor Price</B>&rdquo;);&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I><U>provided</U></I>, that if such
issuance or sale (or deemed issuance or sale) was without consideration, then the Company shall be deemed to have received the Floor Price
for each such share so issued or deemed to be issued. For all purposes of the foregoing (including, without limitation, determining the
adjusted Exercise Price and consideration per share under this Section 2(b)), the following shall be applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) <U>Issuance
of Options</U>. If, during the Restricted Period, the Company in any manner grants or sells any Options and the lowest price per share
for which one Ordinary Share is issuable upon the exercise of any such Option or upon conversion, exercise or exchange of any Convertible
Securities issuable upon exercise of any such Option is less than the Applicable Price, then such Ordinary Share shall be deemed to be
outstanding and to have been issued and sold by the Company at the time of the granting or sale of such Option for such price per share.
For purposes of this Section 2(b)(i), the &ldquo;lowest price per share for which one Ordinary Share is issuable upon the exercise of
any such Options or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option&rdquo;
shall be equal to (A) the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to any
one Ordinary Shares upon the granting or sale of such Option, upon exercise of such Option and upon conversion, exercise or exchange of
any Convertible Security issuable upon exercise of such Option minus (B) the sum of all amounts paid or payable to the holder of such
Option (or any other Person) upon the granting or sale of such Option, upon exercise of such Option and upon conversion, exercise or exchange
of any Convertible Security issuable upon exercise of such Option plus the value of any other consideration received or receivable by,
or benefit conferred on, the holder of such Option (or any other Person). Except as contemplated below, no further adjustment of the Exercise
Price shall be made upon the actual issuance of such Ordinary Shares or of such Convertible Securities upon the exercise of such Options
or upon the actual issuance of such Ordinary Shares upon conversion, exercise or exchange of such Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) <U>Issuance
of Convertible Securities</U>. If, during the Restricted Period, the Company in any manner issues or sells any Convertible Securities
and the lowest price per share for which one Ordinary Shares is issuable upon the conversion, exercise or exchange thereof is less than
the Applicable Price, then such Ordinary Share shall be deemed to be outstanding and to have been issued and sold by the Company at the
time of the issuance or sale of such Convertible Securities for such price per share. For the purposes of this Section 2(b)(ii), the &ldquo;lowest
price per share for which one Ordinary Share is issuable upon the conversion, exercise or exchange thereof&rdquo; shall be equal to (A)
the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to one Ordinary Share upon
the issuance or sale of the Convertible Security and upon conversion, exercise or exchange of such Convertible Security minus (B) the
sum of all amounts paid or payable to the holder of such Convertible Security (or any other Person) upon the issuance or sale of such
Convertible Security plus the value of any other consideration received or receivable by, or benefit conferred on, the holder of such
Convertible Security (or any other Person). Except as contemplated below, no further adjustment of the Exercise Price shall be made upon
the actual issuance of such Ordinary Shares upon conversion, exercise or exchange of such Convertible Securities, and if any such issue
or sale of such Convertible Securities is made upon exercise of any Options for which adjustment of this Warrant has been or is to be
made pursuant to other provisions of this Section 2(b), except as contemplated below, no further adjustment of the Exercise Price shall
be made by reason of such issue or sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii) <U>Chan</U>g<U>e
in Option Price or Rate of Conversion</U>. If, during the Restricted Period, the purchase or exercise price provided for in any Options,
the additional consideration, if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate
at which any Convertible Securities are convertible into or exercisable or exchangeable for Ordinary Shares increases or decreases at
any time, the Exercise Price in effect at the time of such increase or decrease shall be adjusted to the Exercise Price which would have
been in effect at such time had such Options or Convertible Securities provided for such increased or decreased purchase price, additional
consideration or increased or decreased conversion rate, as the case may be, at the time initially granted, issued or sold. For purposes
of this Section 2(b)(iii), if the terms of any Option or Convertible Security that was outstanding as of the date of issuance of this
Warrant are increased or decreased in the manner described in the immediately preceding sentence, then such Option or Convertible Security
and the Ordinary Shares deemed issuable upon exercise, conversion or exchange thereof shall be deemed to have been issued as of the date
of such increase or decrease. No adjustment pursuant to this Section 2(b) shall be made if such adjustment would result in an increase
of the Exercise Price then in effect.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv) <U>Calculation
of Consideration Received</U>. If, during the Restricted Period, any Option or Convertible Security is issued in connection with the issuance
or sale or deemed issuance or sale of any other securities of the Company, together comprising one integrated transaction, (A) such Option
or Convertible Security (as applicable) will be deemed to have been issued for consideration equal to the Black Scholes Value &ndash;
Consideration thereof and (B) the other securities issued or sold or deemed to have been issued or sold in such integrated transaction
shall be deemed to have been issued for consideration equal to the difference of (1) the aggregate consideration received by the Company,
minus (2) the Black Scholes Value &ndash; Consideration of each such Option or Convertible Security (as applicable). If any Ordinary Shares,
Options or Convertible Securities are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor
will be deemed to be the net amount of consideration received by the Company therefor. If any Ordinary Shares, Options or Convertible
Securities are issued or sold for a consideration other than cash, the amount of such consideration received by the Company will be the
fair value of such consideration, except where such consideration consists of publicly traded securities, in which case the amount of
consideration received by the Company for such securities will be the arithmetic average of the VWAPs of such security for each of the
five (5) Trading Days immediately preceding the date of receipt. If any Ordinary Shares, Options or Convertible Securities are issued
to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving entity, the amount of consideration
therefor will be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity as is attributable
to such Ordinary Shares, Options or Convertible Securities, as the case may be. The fair value of any consideration other than cash or
publicly traded securities will be determined jointly by the Company and the Holder. If such parties are unable to reach agreement within
ten (10) days after the occurrence of an event requiring valuation (the &ldquo;<B>Valuation Event</B>&rdquo;), the fair value of such
consideration will be determined within five (5) Trading Days after the tenth (10th) day following such Valuation Event by an independent,
reputable appraiser jointly selected by the Company and the Holder. The determination of such appraiser shall be final and binding upon
all parties absent manifest error and the fees and expenses of such appraiser shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v) <U>Record Date</U>.
If, during the Restricted Period, the Company takes a record of the holders of Ordinary Shares for the purpose of entitling them (A) to
receive a dividend or other distribution payable in Ordinary Shares, Options or in Convertible Securities or (B) to subscribe for or purchase
Ordinary Shares, Options or Convertible Securities, then such record date will be deemed to be the date of the issue or sale of the Ordinary
Shares deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of
the granting of such right of subscription or purchase (as the case may be).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vi) <U>Exempt Issuance</U>.
For the avoidance of doubt, no adjustment shall be made pursuant to this Section 2(b) for an Exempt Issuance (as defined in the Securities
Purchase Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt">(c) <U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.75pt">(d) <U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.75pt"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Other Events</U>.
In the event that the Company shall take any action to which the provisions hereof are not strictly applicable, or, if applicable, would
not operate to protect the Holder from dilution or if any event occurs of the type contemplated by the provisions of this Section 2 but
not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock
rights or other rights with equity features), then the Company&rsquo;s board of directors shall in good faith determine and implement
an appropriate adjustment in the Exercise Price and the number of Warrant Shares (if applicable) so as to protect the rights of the Holder,
<I><U>provided</U></I> that no such adjustment pursuant to this Section 2(e) will increase the Exercise Price or decrease the number of
Warrant Shares as otherwise determined pursuant to this Section 2, <I><U>provided</U> f<U>urther</U></I> that if the Holder does not accept
such adjustments as appropriately protecting its interests hereunder against such dilution, then the Company&rsquo;s board of directors
and the Holder shall agree, in good faith, upon an independent investment bank of nationally recognized standing to make such appropriate
adjustments, whose determination shall be final and binding and whose fees and expenses shall be borne by the Company.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3. <U>RIGHTS UPON DISTRIBUTION OF ASSETS</U>.
In addition to any adjustments pursuant to Section 2 above, if the Company shall declare or make any dividend or other distribution of
its assets (or rights to acquire its assets) to holders of Ordinary Shares, by way of return of capital or otherwise (including, without
limitation, any distribution of cash, stock or other securities, indebtedness, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction, other than a distribution of Ordinary Shares covered by Section
2(a)) (a &ldquo;<B>Distribution</B>&rdquo;), at any time after the issuance of this Warrant, then, in each such case, provision shall
be made so that upon exercise of this Warrant, the Holder shall be entitled to participate in such Distribution to the same extent that
the Holder would have participated therein if the Holder had held the number of Ordinary Shares acquirable upon complete exercise of this
Warrant (without regard to any limitations on exercise hereof, including without limitation, the Maximum Percentage) immediately before
the date on which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of
Ordinary Shares are to be determined for the participation in such Distribution (<I><U>provided</U></I>, <I><U>however</U></I>, to the
extent that the Holder&rsquo;s right to participate in any such Distributions would result in the Holder exceeding the Maximum Percentage,
then the Holder shall not be entitled to participate in such Distribution to such extent (or the beneficial ownership of any such Ordinary
Shares as a result of such Distribution to such extent) and such Distribution to such extent shall be held in abeyance for the benefit
of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Maximum Percentage).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4. &thinsp;<U>PURCHASE RIGHTS; FUNDAMENTAL TRANSACTIONS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Purchase R</U>ig<U>hts</U>.
In addition to any adjustments pursuant to Section 2 above, if at any time the Company grants, issues or sells any Options, Convertible
Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of Ordinary
Shares (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase
Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Ordinary Shares acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Maximum
Percentage) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no
such record is taken, the date as of which the record holders of Ordinary Shares are to be determined for the grant, issue or sale of
such Purchase Rights (<I><U>provided</U></I>, <I><U>however</U></I>, to the extent that the Holder&rsquo;s right to participate in any
such Purchase Right would result in the Holder exceeding the Maximum Percentage, then the Holder shall not be entitled to participate
in such Purchase Right to such extent (or beneficial ownership of such Ordinary Shares as a result of such Purchase Right to such extent)
and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not
result in the Holder exceeding the Maximum Percentage).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Fundamental Transactions</U>.
The Company shall not enter into or be party to a Fundamental Transaction unless the Successor Entity assumes in writing all of the obligations
of the Company under this Warrant and the other Transaction Documents related to this Warrant in accordance with the provisions of this
Section 4(b) pursuant to written agreements in form and substance reasonably satisfactory to the Holder, including agreements confirming
the obligations of the Successor Entity as set forth in this paragraph (b) and (c) and elsewhere in this Warrant and an obligation to
deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant, including, without limitation, which is exercisable for a corresponding number of shares
of equivalent to the Ordinary Shares acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the
exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares (but taking into account the relative value of the Ordinary Shares pursuant to such Fundamental Transaction and the value
of such shares, such adjustments to the number of shares and such exercise price being for the purpose of protecting the economic value
of this Warrant immediately prior to the consummation of such Fundamental Transaction). Notwithstanding the foregoing, at the election
of the Holder upon exercise of this Warrant following a Fundamental Transaction, the Successor Entity shall deliver to the Holder, in
lieu of the Ordinary Shares (or other securities, cash, assets or other property (except such items still issuable under Sections 3 and
4(a) above, which shall continue to be receivable thereafter)) issuable upon the exercise of this Warrant prior to the applicable Fundamental
Transaction, such ordinary shares (or its equivalent) of the Successor Entity (including its Parent Entity), or other securities, cash,
assets or other property, which the Holder would have been entitled to receive upon the happening of the applicable Fundamental Transaction
had this Warrant been exercised immediately prior to the applicable Fundamental Transaction; <I><U>provided</U></I>, <I><U>however</U></I>,
that such amount of reserved Ordinary Shares shall be limited by the Maximum Percentage of Ordinary Shares as set forth in Section 1(f).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Black Scholes Value
&ndash; FT</U>. Notwithstanding the foregoing and the provisions of Section 4(b) above, at the request of the Holder delivered at any
time commencing on the earliest to occur of (i) the public disclosure of any Fundamental Transaction, (ii) the consummation of any Fundamental
Transaction that was disclosed after the date of the Securities Purchase Agreement and (iii) the Holder first becoming aware of any Fundamental
Transaction through the date that is ninety (90) days after the public disclosure of the consummation of such Fundamental Transaction,
the Company or the Successor Entity, at the election of the Holder, shall purchase this Warrant from the Holder on the date of the consummation
of such Fundamental Transaction by paying to the Holder cash in an amount equal to the Black Scholes Value &ndash; FT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>A</U>pp<U>lication</U>.
The provisions of this Section 4 shall apply similarly and equally to successive Fundamental Transactions and shall be applied as if this
Warrant (and any such subsequent warrants issued hereunder) were fully exercisable and without regard to any limitations on the exercise
of this Warrant (<I><U>provided</U></I> that the Holder shall continue to be entitled to the benefit of the Maximum Percentage, applied
however with respect to shares registered under the Exchange Act and thereafter receivable upon exercise of this Warrant (or any such
other warrant)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">5. <U>NONCIRCUMVENTION</U>. The Company hereby
covenants and agrees that the Company will not, by amendment of its certificate of incorporation, bylaws or through any reorganization,
transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith carry out
all the provisions of this Warrant and take all action as may be required to protect the rights of the Holder. Without limiting the generality
of the foregoing, the Company (i) shall not increase the par value of any Ordinary Shares receivable upon the exercise of this Warrant
above the Exercise Price then in effect, (ii) shall take all such actions as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and non-assessable Ordinary Shares upon the exercise of this Warrant, and (iii) shall, so long
as any of the SPA Warrants are outstanding, take all action necessary to reserve and keep available out of its authorized and unissued
Ordinary Shares, solely for the purpose of effecting the exercise of the SPA Warrants, the maximum number of Ordinary Shares as shall
from time to time be necessary to effect the exercise of the SPA Warrants then outstanding; <I><U>provided</U></I>, <I><U>however</U></I>,
that such amount of reserved Ordinary Shares shall be limited by the Maximum Percentage of Ordinary Shares as set forth in Section 1(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">6. <U>WARRANT HOLDER NOT DEEMED A SHAREHOLDER</U>.
Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder of this Warrant, shall not be entitled
to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in
this Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of this Warrant, any of the rights of a shareholder
of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification
of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise,
prior to the issuance to the Holder of the Warrant Shares which it is then entitled to receive upon the due exercise of this Warrant.
In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities
(upon exercise of this Warrant or otherwise) or as a shareholder of the Company, whether such liabilities are asserted by the Company
or by creditors of the Company. Notwithstanding this Section 6, the Company shall provide the Holder with copies of the same notices and
other information given to the shareholders of the Company generally, contemporaneously with the giving thereof to the shareholders.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">7. &thinsp;<U>REISSUANCE OF WARRANTS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Transfer of Warrant</U>.
If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the Company will forthwith issue
and deliver upon the order of the Holder a new Warrant (in accordance with Section 7(d)), registered as the Holder may request, representing
the right to purchase the number of Warrant Shares being transferred by the Holder and, if less than the total number of Warrant Shares
then underlying this Warrant is being transferred, a new Warrant (in accordance with Section 7(d)) to the Holder representing the right
to purchase the number of Warrant Shares not being transferred. If, at the time of the surrender of this Warrant in connection with any
transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement
under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale
restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such
transfer, that the Holder or transferee of this Warrant, as the case may be, provide to the Company an opinion of counsel selected by
the Holder and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company,
to the effect that such transfer does not require registration of such transferred securities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Lost, Stolen or Mutilated
Warrant</U>. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation
of this Warrant (as to which a written certification and the indemnification contemplated below shall suffice as such evidence), and,
in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary and reasonable
form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute and deliver to the Holder
a new Warrant (in accordance with Section 7(d)) representing the right to purchase the Warrant Shares then underlying this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Exchan</U>g<U>eable
for Multiple Warrants</U>. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company,
for a new Warrant or Warrants (in accordance with Section 7(d)) representing in the aggregate the right to purchase the number of Warrant
Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of such Warrant Shares
as is designated by the Holder at the time of such surrender; <I><U>provided</U></I>, <I><U>however</U></I>, no warrants for fractional
Ordinary Shares shall be given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Issuance of New Warrants</U>.
Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant (i) shall be of like tenor
with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to purchase the Warrant Shares then underlying
this Warrant (or in the case of a new Warrant being issued pursuant to Section 7(a) or Section 7(c), the Warrant Shares designated by
the Holder which, when added to the number of Ordinary Shares underlying the other new Warrants issued in connection with such issuance,
does not exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an issuance date, as indicated on the face
of such new Warrant which is the same as the Issuance Date, and (iv) shall have the same rights and conditions as this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">8. <U>NOTICES</U>. Whenever notice is required
to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance with Section 5.4 of the Securities
Purchase Agreement. The Company shall provide the Holder with prompt written notice of all actions taken pursuant to this Warrant, including
in reasonable detail a description of such action and the reason therefor. Without limiting the generality of the foregoing, the Company
will give written notice to the Holder (i) as soon as practicable upon each adjustment of the Exercise Price and the number of Warrant
Shares, setting forth in reasonable detail, and certifying, the calculation of such adjustment(s) and (ii) at least fifteen (15) days
prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon the Ordinary
Shares, (B) with respect to any grants, issuances or sales of any Options, Convertible Securities or rights to purchase stock, warrants,
securities, indebtedness, or other property pro rata to holders of Ordinary Shares or (C) for determining rights to vote with respect
to any Fundamental Transaction, dissolution or liquidation, provided in each case that such information (to the extent it constitutes,
or contains, material, non-public information regarding the Company shall be made known to the public prior to or in conjunction with
such notice being provided to the Holder and (iii) at least ten (10) Trading Days prior to the consummation of any Fundamental Transaction.
It is expressly understood and agreed that the time of execution specified by the Holder in each Exercise Notice shall be definitive and
may not be disputed or challenged by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">9. <U>AMENDMENT AND WAIVER</U>. Except as otherwise
provided herein, the provisions of this Warrant (other than Section 1(f)) may be amended and the Company may take any action herein prohibited,
or omit to perform any act herein required to be performed by it, only if the Company has obtained the written consent of the Holder.
The Holder shall be entitled, at its option, to the benefit of any amendment of any other similar warrant issued under the Securities
Purchase Agreement. No waiver shall be effective unless it is in writing and signed by an authorized representative of the waiving party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">10. <U>SEVERABILITY</U>. If any provision of this
Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction, the provision
that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that it would be
valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining provisions
of this Warrant so long as this Warrant as so modified continues to express, without material change, the original intentions of the parties
as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially
impair the respective expectations or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise
be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable
provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable
provision(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>11. </B><U>GOVERNING LAW</U>. This Warrant
shall be governed by and construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation
and performance of this Warrant shall be governed by, the internal laws of the State of New York, without giving effect to any choice
of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of New York. The Company hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not
to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such
suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein
shall be deemed or operate to preclude the Holder from bringing suit or taking other legal action against the Company in any other jurisdiction
to collect on the Company&rsquo;s obligations to the Holder or to enforce a judgment or other court ruling in favor of the Holder. <B>THE
COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE
HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">12. <U>CONSTRUCTION; HEADINGS</U>. This Warrant
shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against any Person as the drafter hereof.
The headings of this Warrant are for convenience of reference and shall not form part of, or affect the interpretation of, this Warrant.
Terms used in this Warrant but defined in the other Transaction Documents shall have the meanings ascribed to such terms on the Closing
Date (as defined in the Securities Purchase Agreement) in such other Transaction Documents unless otherwise consented to in writing by
the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">13. <U>DISPUTE RESOLUTION</U>. In the case of
a dispute as to the determination of the Exercise Price, the Closing Sale Price, the Closing Bid Price, the Bid Price or fair market value
or the arithmetic calculation of the Warrant Shares (as the case may be), the Company or the Holder (as the case may be) shall submit
the disputed determinations or arithmetic calculations (as the case may be) via email (i) within two (2) Business Days after receipt of
the applicable notice giving rise to such dispute to the Company or the Holder (as the case may be) or (ii) if no notice gave rise to
such dispute, at any time after the Holder or the Company (as the case may be) learned of the circumstances giving rise to such dispute.
If the Holder and the Company are unable to agree upon such determination or calculation (as the case may be) of the Exercise Price, the
Closing Sale Price, the Closing Bid Price, the Bid Price or fair market value or the number of Warrant Shares (as the case may be) within
three (3) Business Days of such disputed determination or arithmetic calculation being submitted to the Company or the Holder (as the
case may be), then the Company shall, within two (2) Business Days submit via email (a) the disputed arithmetic calculation of the Warrant
Shares, the disputed determination of the Exercise Price, the Closing Sale Price, the Closing Bid Price, the Bid Price or fair market
value (as the case may be) to an independent, reputable investment bank selected by the Holder, with the consent of the Company (which
may not be unreasonably withheld, conditioned or delayed), or (b) if acceptable to the Holder, the disputed arithmetic calculation of
the Warrant Shares to the Company&rsquo;s independent, outside accountant. The Company shall cause at its expense the investment bank
or the accountant (as the case may be) to perform the determinations or calculations (as the case may be) and notify the Company and the
Holder of the results no later than ten (10) Business Days from the time it receives such disputed determinations or calculations (as
the case may be). Such investment bank&rsquo;s or accountant&rsquo;s determination or calculation (as the case may be) shall be binding
upon all parties absent demonstrable error. The fees and expenses of such investment bank or accountant shall be borne by the parties
in the same proportion as the respective amounts by which the investment bank&rsquo;s or accountant&rsquo;s determination differs from
such party&rsquo;s calculation.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">14. <U>REMEDIES, CHARACTERIZATION, OTHER OBLIGATIONS,
BREACHES AND INJUNCTIVE RELIEF</U>. The remedies provided in this Warrant shall be cumulative and in addition to all other remedies available
under this Warrant and the other Transaction Documents, at law or in equity (including a decree of specific performance and/or other injunctive
relief), and nothing herein shall limit the right of the Holder to pursue actual damages for any failure by the Company to comply with
the terms of this Warrant. The Company covenants to the Holder that there shall be no characterization concerning this instrument other
than as expressly provided herein. Amounts set forth or provided for herein with respect to payments, exercises and the like (and the
computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly provided herein, be subject
to any other obligation of the Company (or the performance thereof). The Company acknowledges that a breach by it of its obligations hereunder
will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees
that, in the event of any such breach or threatened breach, the holder of this Warrant shall be entitled, in addition to all other available
remedies, to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security
being required. The Company shall provide all information and documentation to the Holder that is requested by the Holder to enable the
Holder to confirm the Company&rsquo;s compliance with the terms and conditions of this Warrant (including, without limitation, compliance
with Section 2 hereof). The issuance of shares as contemplated hereby upon the exercise of this Warrant shall be made without charge to
the Holder or such shares for any issuance tax or other costs in respect thereof, <I><U>provided</U></I> that the Company shall not be
required to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery of any certificate in a
name other than the Holder or its agent on its behalf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">15. <U>TRANSFER</U>. This Warrant may be offered
for sale, sold, transferred or assigned without the consent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">16. <U>CERTAIN DEFINITIONS</U>. For purposes of
this Warrant, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) &ldquo;<B>Bid Price</B>&rdquo;
means, for any security as of the particular time of determination, the bid price of such security on the principal securities exchange
or trading market where such security is listed or traded as reported by Bloomberg as of such time of determination, or if the foregoing
does not apply, the bid price of such security in the over-the-counter market on the electronic bulletin board for such security as reported
by Bloomberg as of such time of determination, or, if no bid price is reported for such security by Bloomberg as of such time of determination,
the average of the bid prices of all of the market makers for such security as reported in the &ldquo;pink sheets&rdquo; by OTC Markets
Group Inc. (formerly Pink Sheets LLC) as of such time of determination. If the Bid Price cannot be calculated for a security as of the
particular time of determination on any of the foregoing bases, the Bid Price of such security as of such time of determination shall
be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon
the fair market value of such security, then such dispute shall be resolved in accordance with the procedures in Section 13. All such
determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during
such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) &ldquo;<B>Black Scholes
Value</B>&rdquo; means the Black Scholes value of an option for one Ordinary Share at the date of the applicable Cashless Exercise, as
such Black Scholes value is determined, calculated using the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function
on Bloomberg utilizing (i) an underlying price per share equal to the Exercise Price, as adjusted, (ii) a risk-free interest rate corresponding
to the U.S. Treasury rate, (iii) a strike price equal to the Exercise Price in effect at the time of the applicable Cashless Exercise,
(iv) an expected volatility equal to 175%, and (v) a deemed remaining term of the Warrant of five (5) years (regardless of the actual
remaining term of the Warrant).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) &ldquo;<B>Black Scholes
Value &ndash; Consideration</B>&rdquo; means the value of the applicable Option or Convertible Security (as the case may be) as of the
date of issuance thereof calculated using the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg
utilizing (i) an underlying price per share equal to the Closing Sale Price of the Ordinary Shares on the Trading Day immediately preceding
the public announcement of the execution of definitive documents with respect to the issuance of such Option or Convertible Security (as
the case may be), (ii) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of such
Option or Convertible Security (as the case may be) as of the date of issuance of such Option or Convertible Security (as the case may
be) and (iii) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg
(determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the date of issuance of such Option
or Convertible Security (as the case may be).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) &ldquo;<B>Black Scholes
Value &ndash; FT</B>&rdquo; means the value of the unexercised portion of this Warrant remaining on the date of the Holder&rsquo;s request
pursuant to Section 4(c), which value is calculated using the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function
on Bloomberg utilizing (i) an underlying price per share equal to the greater of (A) the highest Closing Sale Price of the Ordinary Shares
during the period beginning on the Trading Day immediately preceding the earliest to occur of (1) the public disclosure of the applicable
Fundamental Transaction, (2) the consummation of the applicable Fundamental Transaction and (3) the date on which the Holder first became
aware of the applicable Fundamental Transaction and ending on the Trading Day of the Holder&rsquo;s request pursuant to Section 4(c) and
(B) the sum of the price per share being offered in cash in the applicable Fundamental Transaction (if any) plus the value of the non-cash
consideration being offered in the applicable Fundamental Transaction (if any), (ii) a strike price equal to the Exercise Price in effect
on the date of the Holder&rsquo;s request pursuant to Section 4(c), (iii) a risk-free interest rate corresponding to the U.S. Treasury
rate for a period equal to the greater of (A) the remaining term of this Warrant as of the date of the Holder&rsquo;s request pursuant
to Section 4(c) and (B) the remaining term of this Warrant as of the date of consummation of the applicable Fundamental Transaction or
as of the date of the Holder&rsquo;s request pursuant to Section 4(c) if such request is prior to the date of the consummation of the
applicable Fundamental Transaction and (iv) an expected volatility equal to the greater of 175% and the 100 day volatility obtained from
the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the earliest
to occur of (A) the public disclosure of the applicable Fundamental Transaction, (B) the consummation of the applicable Fundamental Transaction
and (C) the date on which the Holder first became aware of the applicable Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) &ldquo;<B>Bloomberg</B>&rdquo;
means Bloomberg, L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) &ldquo;<B>Business Day</B>&rdquo;
means any day other than Saturday, Sunday or other day on which commercial banks in New York, New York are authorized or required by law
to remain closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) &ldquo;<B>Closing Bid
Price</B>&rdquo; and &ldquo;<B>Closing Sale Price</B>&rdquo; means, for any security as of any date, the last closing bid price and the
last closing trade price, respectively, for such security on the principal securities exchange or trading market where such security is
listed or traded as reported by Bloomberg, or if the foregoing do not apply, the average of the bid prices, or the ask prices, respectively,
of all of the market makers for such security as reported in the &ldquo;pink sheets&rdquo; by OTC Markets Group Inc. (formerly Pink Sheets
LLC). If the Closing Bid Price or the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing
bases, the Closing Bid Price or the Closing Sale Price (as the case may be) of such security on such date shall be the fair market value
as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of
such security, then such dispute shall be resolved in accordance with the procedures in Section 13. All such determinations shall be appropriately
adjusted for any stock dividend, stock split, stock combination or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) &ldquo;<B>Convertible
Securities</B>&rdquo; means any share capital or other security of the Company that is at any time and under any circumstances directly
or indirectly convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any share
capital or other security of the Company (including, without limitation, Ordinary Shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) &ldquo;<B>Eligible Market</B>&rdquo;
means the New York Stock Exchange, the NYSE Amex, the Nasdaq Global Select Market, the Nasdaq Global Market or the Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) &ldquo;<B>Expiration Date</B>&rdquo;
means the date that is January 21, 2031 or, if such date falls on a day other than a Business Day or on which trading does not take place
on the principal securities exchange or trading market where the Ordinary Shares are listed (a &ldquo;<B>Holiday</B>&rdquo;), the next
date that is not a Holiday.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) &ldquo;<B>Fundamental
Transaction</B>&rdquo; means that (i) the Company shall, directly or indirectly, in one or more related transactions, (1) consolidate
or merge with or into (whether or not the Company is the surviving entity) any other Person unless the shareholders of the Company immediately
prior to such consolidation or merger continue to hold more than 50% of the outstanding shares of Voting Stock after such consolidation
or merger, or (2) sell, lease, license, assign, transfer, convey or otherwise dispose of all or substantially all of its properties or
assets to any other Person, in connection with which the Company is dissolved, or (3) allow any other Person to make a purchase, tender
or exchange offer that is accepted by the holders of more than 50% of the outstanding shares of Voting Stock of the Company (not including
any shares of Voting Stock of the Company held by the Person or Persons making or party to, or associated or affiliated with the Persons
making or party to, such purchase, tender or exchange offer), or (4) consummate a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with any other Person
whereby such other Person acquires more than 50% of the outstanding shares of Voting Stock of the Company (not including any shares of
Voting Stock of the Company held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons
making or party to, such stock or share purchase agreement or other business combination), or (ii) any &ldquo;person&rdquo; or &ldquo;group&rdquo;
(as these terms are used for purposes of Sections 13(d) and 14(d) of the Exchange Act and the rules and regulations promulgated thereunder)
is or shall become the &ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of 50%
of the aggregate ordinary voting power represented by issued and outstanding Voting Stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) &thinsp;&rdquo;<B>Options</B>&rdquo;
means any rights, warrants or options to subscribe for or purchase Ordinary Shares or Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) &ldquo;<B>Ordinary Shares</B>&rdquo;
means the ordinary shares, no par value per share, of the Company and any other shares issued or issuable with respect thereto (whether
by way of a share dividend or share split or in exchange for or upon conversion of such shares or otherwise in connection with a combination
of shares, distribution, recapitalization, merger, consolidation, other corporate reorganization or other similar event with respect to
the Ordinary Shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) &ldquo;<B>Parent Entity</B>&rdquo;
of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or equivalent equity security
is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent Entity with
the largest public market capitalization as of the date of consummation of the Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o) &ldquo;<B>Person</B>&rdquo;
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity or a government or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p) &ldquo;<B>Successor Entity</B>&rdquo;
means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting from or surviving any Fundamental Transaction
or the Person (or, if so elected by the Holder, the Parent Entity) with which such Fundamental Transaction shall have been entered into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q) &ldquo;<B>Trading Day</B>&rdquo;
means, as applicable, (x) with respect to all price determinations relating to the Ordinary Shares, any day on which the Ordinary Shares
are traded on the principal securities exchange or securities market on which the Ordinary Shares are then traded, <I><U>provided</U></I>
that &ldquo;Trading Day&rdquo; shall not include any day on which the Ordinary Shares are scheduled to trade on such exchange or market
for less than 4.5 hours or any day that Ordinary Shares are suspended from trading during the final hour of trading on such exchange or
market (or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during
the hour ending at 4:00:00 p.m., New York time) unless such day is otherwise designated as a Trading Day in writing by the Holder or (y)
with respect to all determinations other than price determinations relating to the Ordinary Shares, any day on which The New York Stock
Exchange (or any successor thereto) is open for trading of securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r) &ldquo;<B>Voting Stock</B>&rdquo;
of a Person means capital stock of such Person of the class or classes pursuant to which the holders thereof have the general voting power
to elect, or the general power to appoint, at least a majority of the board of directors, managers or trustees of such Person (irrespective
of whether or not at the time capital stock of any other class or classes shall have or might have voting power by reason of the happening
of any contingency).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s) &ldquo;<B>VWAP</B>&rdquo;
means, for any security as of any date, the dollar volume-weighted average price for such security on the principal securities exchange
or securities market on which such security is then traded during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00
p.m., New York time, as reported by Bloomberg through its &ldquo;Volume at Price&rdquo; function or, if the foregoing does not apply,
the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security
during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg, or, if
no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the three highest closing
bid prices and the three lowest closing ask prices of all of the market makers for such security as reported in the &ldquo;pink sheets&rdquo;
by OTC Markets Group Inc. (formerly Pink Sheets LLC). If VWAP cannot be calculated for such security on such date on any of the foregoing
bases, the VWAP of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If
the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved in accordance
with the procedures in Section 13. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock
combination or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>signature page follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>IN WITNESS WHEREOF</B>, the Company has caused this Warrant to Purchase
Ordinary Shares to be duly executed as of the Issuance Date set out above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><B>VCI GLOBAL LIMITED</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 35%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXERCISE NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE
THIS WARRANT TO PURCHASE ORDINARY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VCI GLOBAL LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned holder hereby exercises the right
to purchase <U>________</U> Ordinary Shares (&ldquo;<B>Warrant Shares</B>&rdquo;) of VCI Global Limited, a company incorporated under
the BVI Business Companies Act, 2004 (as amended) of the British Virgin Islands (the &ldquo;<B>Company</B>&rdquo;), evidenced by Warrant
to Purchase Ordinary Shares No. ___ (the &ldquo;<B>Warrant</B>&rdquo;). Capitalized terms used herein and not otherwise defined shall
have the respective meanings set forth in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1. &thinsp;&thinsp;&thinsp;Form of Exercise Price.
The Holder intends that payment of the Exercise Price shall be made as:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 33%">_____________</TD>
    <TD STYLE="text-align: justify; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 65%">a &ldquo;<U>Cash Exercise</U>&rdquo; with respect to _____________ Warrant Shares; and/or</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">_____________</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">a &ldquo;<U>Cashless Exercise</U>&rdquo; with respect to _____________ Warrant Shares.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event that the Holder has elected a Cashless
Exercise with respect to some or all of the Warrant Shares, the Holder represents and warrants that ________ Ordinary Shares are to be
delivered pursuant to such Cashless Exercise, as further specified in Annex A to this Exercise Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2&thinsp;.&thinsp;&thinsp;<U>Pa</U>y<U>ment of
Exercise Price</U>. In the event that the Holder has elected a Cash Exercise with respect to some or all of the Warrant Shares, the Holder
shall pay the Aggregate Exercise Price in the sum of $________ to the Company in accordance with the terms of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3. &thinsp;&thinsp;&thinsp;<U>Deliver</U>y <U>of
Warrant Shares and Net Number of Ordinary Shares</U>. The Company shall deliver to Holder, or its designee or agent as specified below,
<U>________</U> Ordinary Shares in respect of the exercise contemplated hereby. Delivery shall be made to Holder, or for its benefit,
to the following address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%">Date:&thinsp;______ ,______</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name of Registered Holder</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>Account Number: (if electronic book entry transfer) Transaction Code Number:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Transaction Code Number: (if electronic book entry transfer)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>ANNEX A TO EXERCISE NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CASHLESS EXERCISE EXCHANGE CALCULATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO BE FILLED IN BY THE REGISTERED HOLDER TO
EXCHANGE THE WARRANT TO PURCHASE ORDINARY SHARES IN A CASHLESS EXERCISE PURSUANT TO SECTION 1(d) OF THE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.85pt; text-align: justify; text-indent: -62.2pt">Capitalized
terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.85pt; text-align: justify; text-indent: -62.2pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.85pt; text-align: justify">&#9744; Net Number = (A x B)/C =
Ordinary Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.85pt">For purposes of the foregoing formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.85pt">A = the total number of shares with respect to which the
Warrant is then being exercised =.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.85pt">B = Black Scholes Value (as defined in Section 16 of the
Warrant) =.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 67.85pt; text-align: justify">C = The lower of the two Closing Bid
Prices of the Ordinary Shares in the two days prior the time of such exercise (as such Closing Bid Price is defined in Section 16 of the
Warrant) =.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%">Date:&thinsp; _____, _____</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name of Registered Holder</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name: </TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ACKNOWLEDGMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company hereby acknowledges this Exercise
Notice and hereby directs to issue the above indicated number of Ordinary Shares in accordance with the Transfer Agent Instructions dated
, 20 , from the Company and acknowledged and agreed to by&#8239; .</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-indent: 83.35pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><B>VCI GLOBAL LIMITED</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 5%">By:</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid; width: 35%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ea027358601ex4-2_vciglobal.htm
<DESCRIPTION>FORM OF COMMON B WARRANTS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VCI GLOBAL LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WARRANT TO PURCHASE ORDINARY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date of Issuance: January 21, 2026 (&ldquo;<B>Issuance
Date</B>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">VCI Global Limited, a company incorporated under
the BVI Business Companies Act, 2004 (as amended) of the British Virgin Islands (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that,
for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Esousa Group Holdings, LLC, the registered
holder hereof or its permitted assigns (the &ldquo;<B>Holder</B>&rdquo;), is entitled, subject to the terms set forth below, to purchase
from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant to Purchase Ordinary Shares (including
any Warrants to Purchase Ordinary Shares issued in exchange, transfer or replacement hereof, the &ldquo;<B>Warrant</B>&rdquo;), at any
time or times on or after the Issuance Date, subject to the terms set forth below, but not after 11:59 p.m., New York time, on the Expiration
Date (as defined below), 8,573,388 (subject to adjustment as provided herein) fully paid and non-assessable Ordinary Shares (as defined
below) (the &ldquo;<B>Warrant Shares</B>&rdquo;). Except as otherwise defined herein, capitalized terms in this Warrant shall have the
meanings set forth in Section 16. This Warrant is one of the Warrants to purchase Ordinary Shares (the &ldquo;<B>SPA Warrants</B>&rdquo;)
issued to Holder pursuant to that certain Securities Purchase Agreement dated January 20, 2026 by and among the Company, the Holder and
the other investors thereto (the &ldquo;<B>Securities Purchase Agreement</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1. <U>EXERCISE OF WARRANT</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Mechanics of Exercise</U>.
Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in Section 1(f)), this Warrant may
be exercised by the Holder on any day on or after the Issuance Date in whole or in part, by delivery (whether via facsimile or otherwise)
of a written notice, in the form attached hereto as <B><U>Exhibit A</U></B> (the &ldquo;<B>Exercise Notice</B>&rdquo;), of the Holder&rsquo;s
election to exercise this Warrant. Within one (1) Trading Day following an exercise of this Warrant as aforesaid, the Holder shall deliver
payment to the Company of an amount equal to the number of Warrant Shares as to which this Warrant was so exercised multiplied by the
lower of (i) the Exercise Price in effect on the date of such exercise and (ii) 50% of the lowest daily VWAP in the five (5) consecutive
Trading Days prior to the time of such exercise (in respect of such specific exercise, the &ldquo;<B>Aggregate Exercise Price</B>&rdquo;),
in each case in cash or via wire transfer of immediately available funds. The Holder shall not be required to deliver the original of
this Warrant in order to effect an exercise hereunder. Execution and delivery of an Exercise Notice with respect to less than all of the
Warrant Shares shall have the same effect as cancellation of the original of this Warrant certificate and issuance of a new Warrant certificate
evidencing the right to purchase the remaining number of Warrant Shares. Execution and delivery of an Exercise Notice for all of the then-remaining
Warrant Shares shall have the same effect as cancellation of the original of this Warrant certificate after delivery of the Warrant Shares
in accordance with the terms hereof. On or before the first (1st) Trading Day following the date on which the Company has received an
Exercise Notice, the Company shall transmit by email an acknowledgment of confirmation of receipt of such Exercise Notice, in the form
attached hereto as <U>Exhibit B</U>, to the Holder and the Company&rsquo;s transfer agent (the &ldquo;<B>Transfer Agent</B>&rdquo;). On
or before the first (1st) Trading Day following the date on which the Company has received such Exercise Notice (the &ldquo;<B>Required
Delivery Date</B>&rdquo;), the Company shall, upon the request of the Holder, credit such aggregate number of Ordinary Shares to which
the Holder is entitled pursuant to such exercise to the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
Company (&ldquo;<B>DTC</B>&rdquo;) through its Deposit/ Withdrawal at Custodian system. Upon delivery of an Exercise Notice, the Holder
shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant
has been exercised, irrespective of the date such Warrant Shares are credited to the Holder&rsquo;s DTC account. If this Warrant is submitted
in connection with any exercise pursuant to this Section 1(a) and the number of Warrant Shares represented by this Warrant submitted for
exercise is greater than the number of Warrant Shares being acquired upon an exercise, then, at the request of the Holder and upon surrender
hereof by the Holder at the principal office of the Company, the Company shall as soon as practicable and in no event later than three
(3) Business Days after any exercise and at its own expense, issue and deliver to the Holder (or its designee) a new Warrant (in accordance
with Section 7(d)) representing the right to purchase the number of Warrant Shares purchasable immediately prior to such exercise under
this Warrant, less the number of Warrant Shares with respect to which this Warrant is exercised. No fractional Ordinary Shares are to
be issued upon the exercise of this Warrant, but rather the number of Ordinary Shares to be issued shall be rounded up to the nearest
whole number. The Company shall pay any and all taxes and fees which may be payable with respect to the issuance and delivery of Warrant
Shares upon exercise of this Warrant.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) &thinsp;<U>Exercise Price</U>.
For purposes of this Warrant, &ldquo;<B>Exercise Price</B>&rdquo; means $0.8020, subject to adjustment as provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Company&rsquo;s Failure
to Timely Deliver Securities</U>. If the Company fails to issue and credit the balance account of Holder or Holder&rsquo;s nominee with
DTC for such number of Warrant Shares for which this Warrant is exercised by the Holder, then, in addition to all other remedies available
to Holder, at the sole discretion of Holder, the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) pay in cash
or shares of Ordinary Shares at the discretion of the Company to Holder on each Trading Day after the Required Delivery Date that the
issuance and credit of such Warrant Shares is not timely effected an amount equal to 5% of the product of (A) the number of Ordinary Shares
Ordinary Shares not so credited to Holder or Holder&rsquo;s nominee multiplied by (B) the Closing Sale Price of the Ordinary Shares on
the Trading Day immediately preceding the Required Delivery Date; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) if on or after
the Required Delivery Date, Holder (or any other Person in respect, or on behalf, of Holder) purchases (in an open market transaction
or otherwise) Ordinary Shares (&ldquo;<B>Replacement Shares</B>&rdquo;) to deliver in satisfaction of a sale by Holder of all or any portion
of the number of Ordinary Shares, or a sale of a number of Ordinary Shares equal to all or any portion of the number of Ordinary Shares,
that Holder so anticipated receiving from the Company without any restrictive legend, then, within five (5) Trading Days after Holder&rsquo;s
request and in Holder&rsquo;s sole discretion, either (A) pay cash to Holder in an amount equal to Holder&rsquo;s total purchase price
(including brokerage commissions and other out-of-pocket expenses, if any) for the Replacement Shares (the &ldquo;<B>Buy-In Price</B>&rdquo;),
at which point the Company&rsquo;s obligation to so credit Holder&rsquo;s balance account shall terminate and such shares shall be cancelled,
or (B) promptly honor its obligation to so credit Holder&rsquo;s DTC account representing such number of Ordinary Shares that would have
been so delivered if the Company timely complied with its obligations hereunder and pay cash to Holder in an amount equal to the excess
(if any) of the Buy-In Price over the product of (1) such number of Ordinary Shares that the Company was required to deliver to Holder
by the Required Delivery Date multiplied by (2) the lowest Closing Sale Price of the Ordinary Shares on any Trading Day during the period
commencing on the date Holder purchased Replacement Shares and ending on the date of such delivery and payment under this clause (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent permitted by law, the Company&rsquo;s
obligations to issue and deliver the Ordinary Shares upon exercise of the Warrant in accordance with the terms hereof are absolute and
unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision
hereof, the recovery of any judgment against any person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation
or termination, or any breach or alleged breach by the Holder or any other person of any obligation to the Company or any violation or
alleged violation of law by the Holder or any other person, and irrespective of any other circumstance that might otherwise limit such
obligation of the Company to the Holder in connection with the issuance of the Ordinary Shares. Nothing herein shall limit the Holder&rsquo;s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver the Ordinary Shares issuable upon exercise
of this Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Disputes</U>. In the
case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of Warrant Shares to be issued
pursuant to the terms hereof (including, without limitation, the Net Number), the Company shall promptly issue to the Holder the number
of Warrant Shares that are not disputed, <I><U>provided</U></I> that following such issuance to Holder such dispute shall be resolved
in accordance with Section 13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Limitations on Exercises
and Exchan</U>g<U>es</U>. Notwithstanding anything to the contrary contained in this Warrant, this Warrant shall not be exercisable or
exchangeable by the Holder hereof to the extent (but only to the extent) that the Holder or any of its affiliates would beneficially own
in excess of 9.9% of the number of Ordinary Shares outstanding after giving effect to the issuance of Ordinary Shares issuable upon exercise
of the Warrants calculated in accordance with Section 13(d) of the Exchange Act (the &ldquo;<B>Maximum Percentage</B>&rdquo;). To the
extent the above limitation applies, the determination of whether this Warrant shall be exercisable or exchangeable (vis-&agrave;-vis
other convertible, exercisable or exchangeable securities owned by the Holder or any of its affiliates) and of which such securities shall
be exercisable or exchangeable (as among all such securities owned by the Holder) shall, subject to such Maximum Percentage limitation,
be determined on the basis of the first submission to the Company for conversion, exercise or exchange (as the case may be). No prior
inability to exercise or exchange this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions
of this paragraph with respect to any subsequent determination of exercisability or exchangeability. For the purposes of this paragraph,
beneficial ownership and all determinations and calculations (including, without limitation, with respect to calculations of percentage
ownership) shall be determined in accordance with Section 13(d) of the Exchange Act (as defined in the Securities Purchase Agreement)
and the rules and regulations promulgated thereunder. The provisions of this paragraph shall be implemented in a manner otherwise than
in strict conformity with the terms of this paragraph to correct this paragraph (or any portion hereof) which may be defective or inconsistent
with the intended Maximum Percentage beneficial ownership limitation herein contained or to make changes or supplements necessary or desirable
to properly give effect to such Maximum Percentage limitation. The limitations contained in this paragraph shall apply to a successor
Holder of this Warrant. The holders of Ordinary Shares shall be third party beneficiaries of this paragraph and the Company may not waive
this paragraph without the consent of holders of a majority of its Ordinary Shares. For any reason at any time, upon the written or oral
request of the Holder, the Company shall within two (2) Business Days confirm orally and in writing to the Holder the number of Ordinary
Shares then outstanding, including by virtue of any prior conversion or exercise or exchange of convertible or exercisable or exchangeable
securities into Ordinary Shares, including, without limitation, pursuant to this Warrant or securities issued pursuant to the Securities
Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Reservation of Shares;
Insufficient Authorized Shares</U>. The Company shall initially reserve out of its authorized and unissued Ordinary Shares a number of
Ordinary Shares equal to 250% of the maximum number of Warrant Shares issuable to satisfy the Company&rsquo;s obligations to issue Ordinary
Shares hereunder, and the Company shall at all times keep reserved for issuance under this Warrant a number of Ordinary Shares equal to
250% of the maximum number of Warrant Shares issuable to satisfy the Company&rsquo;s obligation to issue shares of Ordinary Shares hereunder.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>Activity Restrictions</U>.
For so long as Holder holds this Warrant or any Warrant Shares, Holder will not: (i) engage or participate in any actions, plans or proposals
which relate to or would result in (a) acquiring additional securities of the Company, alone or together with any other Person, which
would result in beneficially owning or controlling, or being deemed to beneficially own or control, more than 4.99% of the total outstanding
Ordinary Shares or other voting securities of the Company, (b) an extraordinary corporate transaction, such as a merger, reorganization
or liquidation, involving Company, (c) a sale or transfer of a material amount of assets of the Company, (d) any change in the present
board of directors or management of the Company, including any plans or proposals to change the number or term of directors or to fill
any existing vacancies on the board, (e) any material change in the present capitalization or dividend policy of the Company, (f) any
other material change in the Company&rsquo;s business or corporate structure, including but not limited to, if the Company is a registered
closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by Section
13 of the Investment Company Act of 1940, (g) changes in the Company&rsquo;s memorandum or articles of association or instruments corresponding
thereto or other actions which may impede the acquisition of control of the Company by any Person, (h) causing a class of securities of
the Company being delisted from a national securities exchange or ceasing to be authorized to be quoted in an inter-dealer quotation system
of a registered national securities association, (i) a class of equity securities of the Company becoming eligible for termination of
registration pursuant to Section 12(g)(4) of the Securities Act (as defined in the Securities Purchase Agreement), or (j) any action,
intention, plan or arrangement similar to any of those enumerated above, or (ii) request the Company or its directors, officers, employees,
agents or representatives to amend or waive any provision of this Section 1(h); <I><U>provided</U></I>, <I><U>however</U></I>, that notwithstanding
anything to the contrary contain in clauses (i) and (ii) above, Holder may in its discretion vote any Ordinary Shares owned or controlled
by it, solicit any proxies, or seek to advise or influence any Person with respect to any voting securities of the Company. Holder may
only exercise this Warrant for a cash exercise price if the trading price at the time of exercise is greater than the then applicable
Exercise Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) <U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2. <U>ADJUSTMENT OF EXERCISE PRICE AND NUMBER
OF WARRANT SHARES</U>. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment
from time to time as set forth in this Section 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Share Dividends and
Splits</U>. Without limiting any provision of Section 4, if the Company, at any time on or after the date of the Securities Purchase Agreement,
(i) pays a stock dividend on one or more classes of its then outstanding Ordinary Shares or otherwise makes a distribution on any class
of share capital that is payable in Ordinary Shares, (ii) subdivides (by any stock split, stock dividend, recapitalization or otherwise)
one or more classes of its then outstanding Ordinary Shares into a larger number of shares or (iii) combines (by combination, reverse
stock split or otherwise) one or more classes of its then outstanding Ordinary Shares into a smaller number of shares, then in each such
case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Ordinary Shares outstanding immediately
before such event and of which the denominator shall be the number of Ordinary Shares outstanding immediately after such event. Any adjustment
made pursuant to clause (i) of this paragraph shall become effective immediately after the record date for the determination of shareholders
entitled to receive such dividend or distribution, and any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become
effective immediately after the effective date of such subdivision or combination. If any event requiring an adjustment under this paragraph
occurs during the period that an Exercise Price is calculated hereunder, then the calculation of such Exercise Price shall be adjusted
appropriately to reflect such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Ad</U>j<U>ustment Upon
Issuance of Ordinary Shares</U>. If, during the Restricted Period (as defined in the Securities Purchase Agreement), the Company effects
an Subsequent Financing (as defined in the Securities Purchase Agreement), or in accordance with this Section 2 is deemed to have effected
a Subsequent Financing, any Ordinary Shares (including the issuance or sale of Ordinary Shares owned or held by or for the account of
the Company) issued or sold or deemed to have been issued or sold) for a consideration per share (the &ldquo;<B>New Issuance Price</B>&rdquo;)
less than a price equal to the Exercise Price in effect immediately prior to such issue or sale or deemed issuance or sale (such Exercise
Price then in effect is referred to as the &ldquo;<B>Applicable Price</B>&rdquo;) (the foregoing a &ldquo;<B>Dilutive Issuance</B>&rdquo;),
then immediately after such Dilutive Issuance, the Exercise Price then in effect shall be reduced (and in no event increased) to the price
per share as determined in accordance with the following formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">EP2 = EP1 x (A + B) / (A + C)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">For purposes of the foregoing formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">A=&thinsp;&thinsp;&thinsp;&thinsp;
The total number of Warrant Shares with respect to which this Warrant may be exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">B=&thinsp;&thinsp;&thinsp;&thinsp;
The total number of Ordinary Shares that would be issued or issuable under the Dilutive Issuance if issued at a per share equal to EP1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">C=&thinsp;&thinsp;&thinsp;&thinsp;
The total number of Ordinary Shares actually issued or issuable under the Dilutive Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">EP1= The Exercise Price in effect
immediately prior to a Dilutive Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">EP2= The Exercise Price immediately
after such Dilutive Issuance; <I><U>provided</U></I>, <I><U>however</U></I>, that such price shall in no event be less than $0.1458 per
Ordinary Share (as may be adjusted for stock dividends, subdivisions, or combinations in the manner described in Section 2(a) herein,
the &ldquo;<B>Floor Price</B>&rdquo;);&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I><U>provided</U></I>, that if such
issuance or sale (or deemed issuance or sale) was without consideration, then the Company shall be deemed to have received the Floor Price
for each such share so issued or deemed to be issued. For all purposes of the foregoing (including, without limitation, determining the
adjusted Exercise Price and consideration per share under this Section 2(b)), the following shall be applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) <U>Issuance
of Options</U>. If, during the Restricted Period, the Company in any manner grants or sells any Options and the lowest price per share
for which one Ordinary Share is issuable upon the exercise of any such Option or upon conversion, exercise or exchange of any Convertible
Securities issuable upon exercise of any such Option is less than the Applicable Price, then such Ordinary Share shall be deemed to be
outstanding and to have been issued and sold by the Company at the time of the granting or sale of such Option for such price per share.
For purposes of this Section 2(b)(i), the &ldquo;lowest price per share for which one Ordinary Share is issuable upon the exercise of
any such Options or upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option&rdquo;
shall be equal to (A) the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to any
one Ordinary Shares upon the granting or sale of such Option, upon exercise of such Option and upon conversion, exercise or exchange of
any Convertible Security issuable upon exercise of such Option minus (B) the sum of all amounts paid or payable to the holder of such
Option (or any other Person) upon the granting or sale of such Option, upon exercise of such Option and upon conversion, exercise or exchange
of any Convertible Security issuable upon exercise of such Option plus the value of any other consideration received or receivable by,
or benefit conferred on, the holder of such Option (or any other Person). Except as contemplated below, no further adjustment of the Exercise
Price shall be made upon the actual issuance of such Ordinary Shares or of such Convertible Securities upon the exercise of such Options
or upon the actual issuance of such Ordinary Shares upon conversion, exercise or exchange of such Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) <U>Issuance
of Convertible Securities</U>. If, during the Restricted Period, the Company in any manner issues or sells any Convertible Securities
and the lowest price per share for which one Ordinary Shares is issuable upon the conversion, exercise or exchange thereof is less than
the Applicable Price, then such Ordinary Share shall be deemed to be outstanding and to have been issued and sold by the Company at the
time of the issuance or sale of such Convertible Securities for such price per share. For the purposes of this Section 2(b)(ii), the &ldquo;lowest
price per share for which one Ordinary Share is issuable upon the conversion, exercise or exchange thereof&rdquo; shall be equal to (A)
the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to one Ordinary Share upon
the issuance or sale of the Convertible Security and upon conversion, exercise or exchange of such Convertible Security minus (B) the
sum of all amounts paid or payable to the holder of such Convertible Security (or any other Person) upon the issuance or sale of such
Convertible Security plus the value of any other consideration received or receivable by, or benefit conferred on, the holder of such
Convertible Security (or any other Person). Except as contemplated below, no further adjustment of the Exercise Price shall be made upon
the actual issuance of such Ordinary Shares upon conversion, exercise or exchange of such Convertible Securities, and if any such issue
or sale of such Convertible Securities is made upon exercise of any Options for which adjustment of this Warrant has been or is to be
made pursuant to other provisions of this Section 2(b), except as contemplated below, no further adjustment of the Exercise Price shall
be made by reason of such issue or sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii) <U>Chan</U>g<U>e
in Option Price or Rate of Conversion</U>. If, during the Restricted Period, the purchase or exercise price provided for in any Options,
the additional consideration, if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate
at which any Convertible Securities are convertible into or exercisable or exchangeable for Ordinary Shares increases or decreases at
any time, the Exercise Price in effect at the time of such increase or decrease shall be adjusted to the Exercise Price which would have
been in effect at such time had such Options or Convertible Securities provided for such increased or decreased purchase price, additional
consideration or increased or decreased conversion rate, as the case may be, at the time initially granted, issued or sold. For purposes
of this Section 2(b)(iii), if the terms of any Option or Convertible Security that was outstanding as of the date of issuance of this
Warrant are increased or decreased in the manner described in the immediately preceding sentence, then such Option or Convertible Security
and the Ordinary Shares deemed issuable upon exercise, conversion or exchange thereof shall be deemed to have been issued as of the date
of such increase or decrease. No adjustment pursuant to this Section 2(b) shall be made if such adjustment would result in an increase
of the Exercise Price then in effect.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv) <U>Calculation
of Consideration Received</U>. If, during the Restricted Period, any Option or Convertible Security is issued in connection with the issuance
or sale or deemed issuance or sale of any other securities of the Company, together comprising one integrated transaction, (A) such Option
or Convertible Security (as applicable) will be deemed to have been issued for consideration equal to the Black Scholes Value &ndash;
Consideration thereof and (B) the other securities issued or sold or deemed to have been issued or sold in such integrated transaction
shall be deemed to have been issued for consideration equal to the difference of (1) the aggregate consideration received by the Company,
minus (2) the Black Scholes Value &ndash; Consideration of each such Option or Convertible Security (as applicable). If any Ordinary Shares,
Options or Convertible Securities are issued or sold or deemed to have been issued or sold for cash, the consideration received therefor
will be deemed to be the net amount of consideration received by the Company therefor. If any Ordinary Shares, Options or Convertible
Securities are issued or sold for a consideration other than cash, the amount of such consideration received by the Company will be the
fair value of such consideration, except where such consideration consists of publicly traded securities, in which case the amount of
consideration received by the Company for such securities will be the arithmetic average of the VWAPs of such security for each of the
five (5) Trading Days immediately preceding the date of receipt. If any Ordinary Shares, Options or Convertible Securities are issued
to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving entity, the amount of consideration
therefor will be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity as is attributable
to such Ordinary Shares, Options or Convertible Securities, as the case may be. The fair value of any consideration other than cash or
publicly traded securities will be determined jointly by the Company and the Holder. If such parties are unable to reach agreement within
ten (10) days after the occurrence of an event requiring valuation (the &ldquo;<B>Valuation Event</B>&rdquo;), the fair value of such
consideration will be determined within five (5) Trading Days after the tenth (10th) day following such Valuation Event by an independent,
reputable appraiser jointly selected by the Company and the Holder. The determination of such appraiser shall be final and binding upon
all parties absent manifest error and the fees and expenses of such appraiser shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v) <U>Record Date</U>.
If, during the Restricted Period, the Company takes a record of the holders of Ordinary Shares for the purpose of entitling them (A) to
receive a dividend or other distribution payable in Ordinary Shares, Options or in Convertible Securities or (B) to subscribe for or purchase
Ordinary Shares, Options or Convertible Securities, then such record date will be deemed to be the date of the issue or sale of the Ordinary
Shares deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of
the granting of such right of subscription or purchase (as the case may be).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vi) <U>Exempt Issuance</U>.
For the avoidance of doubt, no adjustment shall be made pursuant to this Section 2(b) for an Exempt Issuance (as defined in the Securities
Purchase Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt">(c) &thinsp;&thinsp;&thinsp; <U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.75pt">(d) &thinsp;&thinsp;&thinsp;<U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.75pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) &thinsp; <U>Other Events</U>.
In the event that the Company shall take any action to which the provisions hereof are not strictly applicable, or, if applicable, would
not operate to protect the Holder from dilution or if any event occurs of the type contemplated by the provisions of this Section 2 but
not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock
rights or other rights with equity features), then the Company&rsquo;s board of directors shall in good faith determine and implement
an appropriate adjustment in the Exercise Price and the number of Warrant Shares (if applicable) so as to protect the rights of the Holder,
<I><U>provided</U></I> that no such adjustment pursuant to this Section 2(e) will increase the Exercise Price or decrease the number of
Warrant Shares as otherwise determined pursuant to this Section 2, <I><U>provided</U> f<U>urther</U></I> that if the Holder does not accept
such adjustments as appropriately protecting its interests hereunder against such dilution, then the Company&rsquo;s board of directors
and the Holder shall agree, in good faith, upon an independent investment bank of nationally recognized standing to make such appropriate
adjustments, whose determination shall be final and binding and whose fees and expenses shall be borne by the Company.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3. <U>RIGHTS UPON DISTRIBUTION OF ASSETS</U>.
In addition to any adjustments pursuant to Section 2 above, if the Company shall declare or make any dividend or other distribution of
its assets (or rights to acquire its assets) to holders of Ordinary Shares, by way of return of capital or otherwise (including, without
limitation, any distribution of cash, stock or other securities, indebtedness, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction, other than a distribution of Ordinary Shares covered by Section
2(a)) (a &ldquo;<B>Distribution</B>&rdquo;), at any time after the issuance of this Warrant, then, in each such case, provision shall
be made so that upon exercise of this Warrant, the Holder shall be entitled to participate in such Distribution to the same extent that
the Holder would have participated therein if the Holder had held the number of Ordinary Shares acquirable upon complete exercise of this
Warrant (without regard to any limitations on exercise hereof, including without limitation, the Maximum Percentage) immediately before
the date on which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of
Ordinary Shares are to be determined for the participation in such Distribution (<I><U>provided</U></I>, <I><U>however</U></I>, to the
extent that the Holder&rsquo;s right to participate in any such Distributions would result in the Holder exceeding the Maximum Percentage,
then the Holder shall not be entitled to participate in such Distribution to such extent (or the beneficial ownership of any such Ordinary
Shares as a result of such Distribution to such extent) and such Distribution to such extent shall be held in abeyance for the benefit
of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Maximum Percentage).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4. &thinsp;<U>PURCHASE RIGHTS; FUNDAMENTAL TRANSACTIONS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Purchase R</U>ig<U>hts</U>.
In addition to any adjustments pursuant to Section 2 above, if at any time the Company grants, issues or sells any Options, Convertible
Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of Ordinary
Shares (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase
Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Ordinary Shares acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Maximum
Percentage) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no
such record is taken, the date as of which the record holders of Ordinary Shares are to be determined for the grant, issue or sale of
such Purchase Rights (<I><U>provided</U></I>, <I><U>however</U></I>, to the extent that the Holder&rsquo;s right to participate in any
such Purchase Right would result in the Holder exceeding the Maximum Percentage, then the Holder shall not be entitled to participate
in such Purchase Right to such extent (or beneficial ownership of such Ordinary Shares as a result of such Purchase Right to such extent)
and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not
result in the Holder exceeding the Maximum Percentage).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Fundamental Transactions</U>.
The Company shall not enter into or be party to a Fundamental Transaction unless the Successor Entity assumes in writing all of the obligations
of the Company under this Warrant and the other Transaction Documents related to this Warrant in accordance with the provisions of this
Section 4(b) pursuant to written agreements in form and substance reasonably satisfactory to the Holder, including agreements confirming
the obligations of the Successor Entity as set forth in this paragraph (b) and (c) and elsewhere in this Warrant and an obligation to
deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant, including, without limitation, which is exercisable for a corresponding number of shares
of equivalent to the Ordinary Shares acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the
exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares (but taking into account the relative value of the Ordinary Shares pursuant to such Fundamental Transaction and the value
of such shares, such adjustments to the number of shares and such exercise price being for the purpose of protecting the economic value
of this Warrant immediately prior to the consummation of such Fundamental Transaction). Notwithstanding the foregoing, at the election
of the Holder upon exercise of this Warrant following a Fundamental Transaction, the Successor Entity shall deliver to the Holder, in
lieu of the Ordinary Shares (or other securities, cash, assets or other property (except such items still issuable under Sections 3 and
4(a) above, which shall continue to be receivable thereafter)) issuable upon the exercise of this Warrant prior to the applicable Fundamental
Transaction, such ordinary shares (or its equivalent) of the Successor Entity (including its Parent Entity), or other securities, cash,
assets or other property, which the Holder would have been entitled to receive upon the happening of the applicable Fundamental Transaction
had this Warrant been exercised immediately prior to the applicable Fundamental Transaction; <I><U>provided</U></I>, <I><U>however</U></I>,
that such amount of reserved Ordinary Shares shall be limited by the Maximum Percentage of Ordinary Shares as set forth in Section 1(f).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Black Scholes Value
&ndash; FT</U>. Notwithstanding the foregoing and the provisions of Section 4(b) above, at the request of the Holder delivered at any
time commencing on the earliest to occur of (i) the public disclosure of any Fundamental Transaction, (ii) the consummation of any Fundamental
Transaction that was disclosed after the date of the Securities Purchase Agreement and (iii) the Holder first becoming aware of any Fundamental
Transaction through the date that is ninety (90) days after the public disclosure of the consummation of such Fundamental Transaction,
the Company or the Successor Entity, at the election of the Holder, shall purchase this Warrant from the Holder on the date of the consummation
of such Fundamental Transaction by paying to the Holder cash in an amount equal to the Black Scholes Value &ndash; FT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>A</U>pp<U>lication</U>.
The provisions of this Section 4 shall apply similarly and equally to successive Fundamental Transactions and shall be applied as if this
Warrant (and any such subsequent warrants issued hereunder) were fully exercisable and without regard to any limitations on the exercise
of this Warrant (<I><U>provided</U></I> that the Holder shall continue to be entitled to the benefit of the Maximum Percentage, applied
however with respect to shares registered under the Exchange Act and thereafter receivable upon exercise of this Warrant (or any such
other warrant)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">5. <U>NONCIRCUMVENTION</U>. The Company hereby
covenants and agrees that the Company will not, by amendment of its certificate of incorporation, bylaws or through any reorganization,
transfer of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith carry out
all the provisions of this Warrant and take all action as may be required to protect the rights of the Holder. Without limiting the generality
of the foregoing, the Company (i) shall not increase the par value of any Ordinary Shares receivable upon the exercise of this Warrant
above the Exercise Price then in effect, (ii) shall take all such actions as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and non-assessable Ordinary Shares upon the exercise of this Warrant, and (iii) shall, so long
as any of the SPA Warrants are outstanding, take all action necessary to reserve and keep available out of its authorized and unissued
Ordinary Shares, solely for the purpose of effecting the exercise of the SPA Warrants, the maximum number of Ordinary Shares as shall
from time to time be necessary to effect the exercise of the SPA Warrants then outstanding; <I><U>provided</U></I>, <I><U>however</U></I>,
that such amount of reserved Ordinary Shares shall be limited by the Maximum Percentage of Ordinary Shares as set forth in Section 1(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">6. <U>WARRANT HOLDER NOT DEEMED A SHAREHOLDER</U>.
Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder of this Warrant, shall not be entitled
to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in
this Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of this Warrant, any of the rights of a shareholder
of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification
of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise,
prior to the issuance to the Holder of the Warrant Shares which it is then entitled to receive upon the due exercise of this Warrant.
In addition, nothing contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities
(upon exercise of this Warrant or otherwise) or as a shareholder of the Company, whether such liabilities are asserted by the Company
or by creditors of the Company. Notwithstanding this Section 6, the Company shall provide the Holder with copies of the same notices and
other information given to the shareholders of the Company generally, contemporaneously with the giving thereof to the shareholders.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">7. &thinsp;<U>REISSUANCE OF WARRANTS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Transfer of Warrant</U>.
If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the Company will forthwith issue
and deliver upon the order of the Holder a new Warrant (in accordance with Section 7(d)), registered as the Holder may request, representing
the right to purchase the number of Warrant Shares being transferred by the Holder and, if less than the total number of Warrant Shares
then underlying this Warrant is being transferred, a new Warrant (in accordance with Section 7(d)) to the Holder representing the right
to purchase the number of Warrant Shares not being transferred. If, at the time of the surrender of this Warrant in connection with any
transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration statement
under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale
restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such
transfer, that the Holder or transferee of this Warrant, as the case may be, provide to the Company an opinion of counsel selected by
the Holder and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company,
to the effect that such transfer does not require registration of such transferred securities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Lost, Stolen or Mutilated
Warrant</U>. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation
of this Warrant (as to which a written certification and the indemnification contemplated below shall suffice as such evidence), and,
in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary and reasonable
form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute and deliver to the Holder
a new Warrant (in accordance with Section 7(d)) representing the right to purchase the Warrant Shares then underlying this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Exchan</U>g<U>eable
for Multiple Warrants</U>. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company,
for a new Warrant or Warrants (in accordance with Section 7(d)) representing in the aggregate the right to purchase the number of Warrant
Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of such Warrant Shares
as is designated by the Holder at the time of such surrender; <I><U>provided</U></I>, <I><U>however</U></I>, no warrants for fractional
Ordinary Shares shall be given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Issuance of New Warrants</U>.
Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant (i) shall be of like tenor
with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to purchase the Warrant Shares then underlying
this Warrant (or in the case of a new Warrant being issued pursuant to Section 7(a) or Section 7(c), the Warrant Shares designated by
the Holder which, when added to the number of Ordinary Shares underlying the other new Warrants issued in connection with such issuance,
does not exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an issuance date, as indicated on the face
of such new Warrant which is the same as the Issuance Date, and (iv) shall have the same rights and conditions as this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">8. <U>NOTICES</U>. Whenever notice is required
to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance with Section 5.4 of the Securities
Purchase Agreement. The Company shall provide the Holder with prompt written notice of all actions taken pursuant to this Warrant, including
in reasonable detail a description of such action and the reason therefor. Without limiting the generality of the foregoing, the Company
will give written notice to the Holder (i) as soon as practicable upon each adjustment of the Exercise Price and the number of Warrant
Shares, setting forth in reasonable detail, and certifying, the calculation of such adjustment(s) and (ii) at least fifteen (15) days
prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon the Ordinary
Shares, (B) with respect to any grants, issuances or sales of any Options, Convertible Securities or rights to purchase stock, warrants,
securities, indebtedness, or other property pro rata to holders of Ordinary Shares or (C) for determining rights to vote with respect
to any Fundamental Transaction, dissolution or liquidation, provided in each case that such information (to the extent it constitutes,
or contains, material, non-public information regarding the Company shall be made known to the public prior to or in conjunction with
such notice being provided to the Holder and (iii) at least ten (10) Trading Days prior to the consummation of any Fundamental Transaction.
It is expressly understood and agreed that the time of execution specified by the Holder in each Exercise Notice shall be definitive and
may not be disputed or challenged by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">9. <U>AMENDMENT AND WAIVER</U>. Except as otherwise
provided herein, the provisions of this Warrant (other than Section 1(f)) may be amended and the Company may take any action herein prohibited,
or omit to perform any act herein required to be performed by it, only if the Company has obtained the written consent of the Holder.
The Holder shall be entitled, at its option, to the benefit of any amendment of any other similar warrant issued under the Securities
Purchase Agreement. No waiver shall be effective unless it is in writing and signed by an authorized representative of the waiving party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">10. <U>SEVERABILITY</U>. If any provision of this
Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction, the provision
that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that it would be
valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining provisions
of this Warrant so long as this Warrant as so modified continues to express, without material change, the original intentions of the parties
as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially
impair the respective expectations or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise
be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable
provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable
provision(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>11. </B><U>GOVERNING LAW</U>. This Warrant
shall be governed by and construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation
and performance of this Warrant shall be governed by, the internal laws of the State of New York, without giving effect to any choice
of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of New York. The Company hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not
to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such
suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein
shall be deemed or operate to preclude the Holder from bringing suit or taking other legal action against the Company in any other jurisdiction
to collect on the Company&rsquo;s obligations to the Holder or to enforce a judgment or other court ruling in favor of the Holder. <B>THE
COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE
HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">12. <U>CONSTRUCTION; HEADINGS</U>. This Warrant
shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against any Person as the drafter hereof.
The headings of this Warrant are for convenience of reference and shall not form part of, or affect the interpretation of, this Warrant.
Terms used in this Warrant but defined in the other Transaction Documents shall have the meanings ascribed to such terms on the Closing
Date (as defined in the Securities Purchase Agreement) in such other Transaction Documents unless otherwise consented to in writing by
the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">13. <U>DISPUTE RESOLUTION</U>. In the case of
a dispute as to the determination of the Exercise Price, the Closing Sale Price, the Closing Bid Price, the Bid Price or fair market value
or the arithmetic calculation of the Warrant Shares (as the case may be), the Company or the Holder (as the case may be) shall submit
the disputed determinations or arithmetic calculations (as the case may be) via email (i) within two (2) Business Days after receipt of
the applicable notice giving rise to such dispute to the Company or the Holder (as the case may be) or (ii) if no notice gave rise to
such dispute, at any time after the Holder or the Company (as the case may be) learned of the circumstances giving rise to such dispute.
If the Holder and the Company are unable to agree upon such determination or calculation (as the case may be) of the Exercise Price, the
Closing Sale Price, the Closing Bid Price, the Bid Price or fair market value or the number of Warrant Shares (as the case may be) within
three (3) Business Days of such disputed determination or arithmetic calculation being submitted to the Company or the Holder (as the
case may be), then the Company shall, within two (2) Business Days submit via email (a) the disputed arithmetic calculation of the Warrant
Shares, the disputed determination of the Exercise Price, the Closing Sale Price, the Closing Bid Price, the Bid Price or fair market
value (as the case may be) to an independent, reputable investment bank selected by the Holder, with the consent of the Company (which
may not be unreasonably withheld, conditioned or delayed), or (b) if acceptable to the Holder, the disputed arithmetic calculation of
the Warrant Shares to the Company&rsquo;s independent, outside accountant. The Company shall cause at its expense the investment bank
or the accountant (as the case may be) to perform the determinations or calculations (as the case may be) and notify the Company and the
Holder of the results no later than ten (10) Business Days from the time it receives such disputed determinations or calculations (as
the case may be). Such investment bank&rsquo;s or accountant&rsquo;s determination or calculation (as the case may be) shall be binding
upon all parties absent demonstrable error. The fees and expenses of such investment bank or accountant shall be borne by the parties
in the same proportion as the respective amounts by which the investment bank&rsquo;s or accountant&rsquo;s determination differs from
such party&rsquo;s calculation.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">14. <U>REMEDIES, CHARACTERIZATION, OTHER OBLIGATIONS,
BREACHES AND INJUNCTIVE RELIEF</U>. The remedies provided in this Warrant shall be cumulative and in addition to all other remedies available
under this Warrant and the other Transaction Documents, at law or in equity (including a decree of specific performance and/or other injunctive
relief), and nothing herein shall limit the right of the Holder to pursue actual damages for any failure by the Company to comply with
the terms of this Warrant. The Company covenants to the Holder that there shall be no characterization concerning this instrument other
than as expressly provided herein. Amounts set forth or provided for herein with respect to payments, exercises and the like (and the
computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly provided herein, be subject
to any other obligation of the Company (or the performance thereof). The Company acknowledges that a breach by it of its obligations hereunder
will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company therefore agrees
that, in the event of any such breach or threatened breach, the holder of this Warrant shall be entitled, in addition to all other available
remedies, to an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security
being required. The Company shall provide all information and documentation to the Holder that is requested by the Holder to enable the
Holder to confirm the Company&rsquo;s compliance with the terms and conditions of this Warrant (including, without limitation, compliance
with Section 2 hereof). The issuance of shares as contemplated hereby upon the exercise of this Warrant shall be made without charge to
the Holder or such shares for any issuance tax or other costs in respect thereof, <I><U>provided</U></I> that the Company shall not be
required to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery of any certificate in a
name other than the Holder or its agent on its behalf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">15. <U>TRANSFER</U>. This Warrant may be offered
for sale, sold, transferred or assigned without the consent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">16. <U>CERTAIN DEFINITIONS</U>. For purposes of
this Warrant, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) &ldquo;<B>Bid Price</B>&rdquo;
means, for any security as of the particular time of determination, the bid price of such security on the principal securities exchange
or trading market where such security is listed or traded as reported by Bloomberg as of such time of determination, or if the foregoing
does not apply, the bid price of such security in the over-the-counter market on the electronic bulletin board for such security as reported
by Bloomberg as of such time of determination, or, if no bid price is reported for such security by Bloomberg as of such time of determination,
the average of the bid prices of all of the market makers for such security as reported in the &ldquo;pink sheets&rdquo; by OTC Markets
Group Inc. (formerly Pink Sheets LLC) as of such time of determination. If the Bid Price cannot be calculated for a security as of the
particular time of determination on any of the foregoing bases, the Bid Price of such security as of such time of determination shall
be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon
the fair market value of such security, then such dispute shall be resolved in accordance with the procedures in Section 13. All such
determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during
such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) Reserved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) &ldquo;<B>Black Scholes
Value &ndash; Consideration</B>&rdquo; means the value of the applicable Option or Convertible Security (as the case may be) as of the
date of issuance thereof calculated using the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg
utilizing (i) an underlying price per share equal to the Closing Sale Price of the Ordinary Shares on the Trading Day immediately preceding
the public announcement of the execution of definitive documents with respect to the issuance of such Option or Convertible Security (as
the case may be), (ii) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of such
Option or Convertible Security (as the case may be) as of the date of issuance of such Option or Convertible Security (as the case may
be) and (iii) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg
(determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the date of issuance of such Option
or Convertible Security (as the case may be).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) &ldquo;<B>Black Scholes
Value &ndash; FT</B>&rdquo; means the value of the unexercised portion of this Warrant remaining on the date of the Holder&rsquo;s request
pursuant to Section 4(c), which value is calculated using the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function
on Bloomberg utilizing (i) an underlying price per share equal to the greater of (A) the highest Closing Sale Price of the Ordinary Shares
during the period beginning on the Trading Day immediately preceding the earliest to occur of (1) the public disclosure of the applicable
Fundamental Transaction, (2) the consummation of the applicable Fundamental Transaction and (3) the date on which the Holder first became
aware of the applicable Fundamental Transaction and ending on the Trading Day of the Holder&rsquo;s request pursuant to Section 4(c) and
(B) the sum of the price per share being offered in cash in the applicable Fundamental Transaction (if any) plus the value of the non-cash
consideration being offered in the applicable Fundamental Transaction (if any), (ii) a strike price equal to the Exercise Price in effect
on the date of the Holder&rsquo;s request pursuant to Section 4(c), (iii) a risk-free interest rate corresponding to the U.S. Treasury
rate for a period equal to the greater of (A) the remaining term of this Warrant as of the date of the Holder&rsquo;s request pursuant
to Section 4(c) and (B) the remaining term of this Warrant as of the date of consummation of the applicable Fundamental Transaction or
as of the date of the Holder&rsquo;s request pursuant to Section 4(c) if such request is prior to the date of the consummation of the
applicable Fundamental Transaction and (iv) an expected volatility equal to the greater of 175% and the 100 day volatility obtained from
the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the earliest
to occur of (A) the public disclosure of the applicable Fundamental Transaction, (B) the consummation of the applicable Fundamental Transaction
and (C) the date on which the Holder first became aware of the applicable Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) &ldquo;<B>Bloomberg</B>&rdquo;
means Bloomberg, L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) &ldquo;<B>Business Day</B>&rdquo;
means any day other than Saturday, Sunday or other day on which commercial banks in New York, New York are authorized or required by law
to remain closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) &ldquo;<B>Closing Bid
Price</B>&rdquo; and &ldquo;<B>Closing Sale Price</B>&rdquo; means, for any security as of any date, the last closing bid price and the
last closing trade price, respectively, for such security on the principal securities exchange or trading market where such security is
listed or traded as reported by Bloomberg, or if the foregoing do not apply, the average of the bid prices, or the ask prices, respectively,
of all of the market makers for such security as reported in the &ldquo;pink sheets&rdquo; by OTC Markets Group Inc. (formerly Pink Sheets
LLC). If the Closing Bid Price or the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing
bases, the Closing Bid Price or the Closing Sale Price (as the case may be) of such security on such date shall be the fair market value
as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of
such security, then such dispute shall be resolved in accordance with the procedures in Section 13. All such determinations shall be appropriately
adjusted for any stock dividend, stock split, stock combination or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) &ldquo;<B>Convertible
Securities</B>&rdquo; means any share capital or other security of the Company that is at any time and under any circumstances directly
or indirectly convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any share
capital or other security of the Company (including, without limitation, Ordinary Shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) &ldquo;<B>Eligible Market</B>&rdquo;
means the New York Stock Exchange, the NYSE Amex, the Nasdaq Global Select Market, the Nasdaq Global Market or the Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) &ldquo;<B>Expiration Date</B>&rdquo;
means the date that is July 20, 2026 or, if such date falls on a day other than a Business Day or on which trading does not take place
on the principal securities exchange or trading market where the Ordinary Shares are listed (a &ldquo;<B>Holiday</B>&rdquo;), the next
date that is not a Holiday.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) &ldquo;<B>Fundamental
Transaction</B>&rdquo; means that (i) the Company shall, directly or indirectly, in one or more related transactions, (1) consolidate
or merge with or into (whether or not the Company is the surviving entity) any other Person unless the shareholders of the Company immediately
prior to such consolidation or merger continue to hold more than 50% of the outstanding shares of Voting Stock after such consolidation
or merger, or (2) sell, lease, license, assign, transfer, convey or otherwise dispose of all or substantially all of its properties or
assets to any other Person, in connection with which the Company is dissolved, or (3) allow any other Person to make a purchase, tender
or exchange offer that is accepted by the holders of more than 50% of the outstanding shares of Voting Stock of the Company (not including
any shares of Voting Stock of the Company held by the Person or Persons making or party to, or associated or affiliated with the Persons
making or party to, such purchase, tender or exchange offer), or (4) consummate a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with any other Person
whereby such other Person acquires more than 50% of the outstanding shares of Voting Stock of the Company (not including any shares of
Voting Stock of the Company held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons
making or party to, such stock or share purchase agreement or other business combination), or (ii) any &ldquo;person&rdquo; or &ldquo;group&rdquo;
(as these terms are used for purposes of Sections 13(d) and 14(d) of the Exchange Act and the rules and regulations promulgated thereunder)
is or shall become the &ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of 50%
of the aggregate ordinary voting power represented by issued and outstanding Voting Stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) &thinsp;&rdquo;<B>Options</B>&rdquo;
means any rights, warrants or options to subscribe for or purchase Ordinary Shares or Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) &ldquo;<B>Ordinary Shares</B>&rdquo;
means the ordinary shares, no par value per share, of the Company and any other shares issued or issuable with respect thereto (whether
by way of a share dividend or share split or in exchange for or upon conversion of such shares or otherwise in connection with a combination
of shares, distribution, recapitalization, merger, consolidation, other corporate reorganization or other similar event with respect to
the Ordinary Shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) &ldquo;<B>Parent Entity</B>&rdquo;
of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or equivalent equity security
is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent Entity with
the largest public market capitalization as of the date of consummation of the Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o) &ldquo;<B>Person</B>&rdquo;
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity or a government or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p) &ldquo;<B>Successor Entity</B>&rdquo;
means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting from or surviving any Fundamental Transaction
or the Person (or, if so elected by the Holder, the Parent Entity) with which such Fundamental Transaction shall have been entered into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q) &ldquo;<B>Trading Day</B>&rdquo;
means, as applicable, (x) with respect to all price determinations relating to the Ordinary Shares, any day on which the Ordinary Shares
are traded on the principal securities exchange or securities market on which the Ordinary Shares are then traded, <I><U>provided</U></I>
that &ldquo;Trading Day&rdquo; shall not include any day on which the Ordinary Shares are scheduled to trade on such exchange or market
for less than 4.5 hours or any day that Ordinary Shares are suspended from trading during the final hour of trading on such exchange or
market (or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during
the hour ending at 4:00:00 p.m., New York time) unless such day is otherwise designated as a Trading Day in writing by the Holder or (y)
with respect to all determinations other than price determinations relating to the Ordinary Shares, any day on which The New York Stock
Exchange (or any successor thereto) is open for trading of securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r) &ldquo;<B>Voting Stock</B>&rdquo;
of a Person means capital stock of such Person of the class or classes pursuant to which the holders thereof have the general voting power
to elect, or the general power to appoint, at least a majority of the board of directors, managers or trustees of such Person (irrespective
of whether or not at the time capital stock of any other class or classes shall have or might have voting power by reason of the happening
of any contingency).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s) &ldquo;<B>VWAP</B>&rdquo;
means, for any security as of any date, the dollar volume-weighted average price for such security on the principal securities exchange
or securities market on which such security is then traded during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00
p.m., New York time, as reported by Bloomberg through its &ldquo;Volume at Price&rdquo; function or, if the foregoing does not apply,
the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security
during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg, or, if
no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the three highest closing
bid prices and the three lowest closing ask prices of all of the market makers for such security as reported in the &ldquo;pink sheets&rdquo;
by OTC Markets Group Inc. (formerly Pink Sheets LLC). If VWAP cannot be calculated for such security on such date on any of the foregoing
bases, the VWAP of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If
the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved in accordance
with the procedures in Section 13. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock
combination or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>signature page follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>IN WITNESS WHEREOF</B>, the Company has caused this Warrant to Purchase
Ordinary Shares to be duly executed as of the Issuance Date set out above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><B>VCI GLOBAL LIMITED</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name: </TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXERCISE NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE
THIS WARRANT TO PURCHASE ORDINARY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VCI GLOBAL LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned holder hereby exercises the right
to purchase <U>________</U> Ordinary Shares (&ldquo;<B>Warrant Shares</B>&rdquo;) of VCI Global Limited, a company incorporated under
the BVI Business Companies Act, 2004 (as amended) of the British Virgin Islands (the &ldquo;<B>Company</B>&rdquo;), evidenced by Warrant
to Purchase Ordinary Shares No. ___ (the &ldquo;<B>Warrant</B>&rdquo;). Capitalized terms used herein and not otherwise defined shall
have the respective meanings set forth in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1. &thinsp;&thinsp;&thinsp;<U>Form of Exercise Price</U>. The Holder
intends that payment of the Exercise Price shall be made as a &ldquo;<U>Cash Exercise</U>&rdquo; with respect to _____________ Warrant
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2&thinsp;.&thinsp;&thinsp;<U>Pa</U>y<U>ment of
Exercise Price</U>. In the event that the Holder has elected a Cash Exercise with respect to some or all of the Warrant Shares, the Holder
shall pay the Aggregate Exercise Price in the sum of $<U>________</U> to the Company in accordance with the terms of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3. &thinsp;&thinsp;&thinsp;<U>Deliver</U>y <U>of
Warrant Shares and Net Number of Ordinary Shares</U>. The Company shall deliver to Holder, or its designee or agent as specified below,
<U>________</U> Ordinary Shares in respect of the exercise contemplated hereby. Delivery shall be made to Holder, or for its benefit,
to the following address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>Date:&thinsp;______ ,______</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>_______________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name of Registered Holder</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name: </TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%">Account Number: (if electronic book entry transfer) Transaction Code Number:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Transaction Code Number: (if electronic book entry transfer)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ACKNOWLEDGMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company hereby acknowledges this Exercise
Notice and hereby directs to issue the above indicated number of Ordinary Shares in accordance with the Transfer Agent Instructions dated
, 20 , from the Company and acknowledged and agreed to by&#8239; .</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.65pt; text-indent: 83.35pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><B>VCI GLOBAL LIMITED</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 5%">By:</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid; width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>ea027358601ex4-3_vciglobal.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANTS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VCI GLOBAL LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%">Warrant Shares: 5,393,672</TD>
    <TD STYLE="width: 60%">Initial Exercise Date: January 21, 2026</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Issue Date: January 21, 2026</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS PRE-FUNDED ORDINARY SHARE
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Esousa Group Holdings, LLC or its assigns (the
&ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and until this Warrant is exercised in
full (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from VCI Global Limited, a company
incorporated under the BVI Business Companies Act, 2004 (as amended) of the British Virgin Islands VCI Global Limited, a company incorporated
under the BVI Business Companies Act, 2004 (as amended) of the British Virgin Islands (the &ldquo;<U>Company</U>&rdquo;), up to 5,393,672
Ordinary Shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;). The purchase price of one share of Ordinary
Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated January 20, 2026, among the Company and the purchasers signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Exercise of
Warrant</U>. Subject to Section 2(e) herein, exercise of the purchase rights represented by this Warrant may be made, in whole or in part,
at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly
executed facsimile copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the
&ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising
the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver
the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s
check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable
Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee
or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the
Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three
(3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting
in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver
any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance
of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the
Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount
stated on the face hereof.</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Exercise Price</U>.
The exercise price per Ordinary Share under this Warrant shall be <B>$0.0001</B>, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Cashless Exercise</U>.
This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder
shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="ex4-3_001.jpg" ALT=""></B></FONT>, where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">(A)</TD>
    <TD STYLE="width: 0.25in"> =</TD>
    <TD STYLE="text-align: justify">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the highest Bid Price of the Ordinary Shares on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;Bloomberg&rdquo;) within two (2) hours of the time of the Holder&rsquo;s delivery of the Notice of Exercise pursuant to Section 2(a) hereof if such Notice of Exercise is delivered during &ldquo;regular trading hours,&rdquo; or with two (2) hours after the close of &ldquo;regular trading hours,&rdquo; on a Trading Day or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is delivered pursuant to Section 2(a) hereof after two (2) hours following the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">(B)</TD>
    <TD STYLE="width: 0.25in"> =</TD>
    <TD STYLE="text-align: justify">the Exercise Price of this Warrant, as adjusted hereunder; and</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">(X)</TD>
    <TD STYLE="width: 0.25in"> = </TD>
    <TD STYLE="text-align: justify">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant
Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this
Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Ordinary Shares are then listed
or quoted on a Trading Market, the daily volume weighted average price of the Ordinary Shares for such date (or the nearest preceding
date) on the Trading Market on which the Ordinary Shares is then listed or quoted as reported by Bloomberg (based on a Trading Day from
9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Ordinary Shares for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Ordinary
Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Ordinary Shares are then reported in The Pink
Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per Ordinary
Share so reported, or (d) in all other cases, the fair market value of a share of Ordinary Share as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;Bid Price&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Ordinary Shares are then listed
or quoted on a Trading Market, the bid price of the Ordinary Shares for the time in question (or the nearest preceding date) on the Trading
Market on which the Ordinary Shares are then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the
Ordinary Shares for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Ordinary Shares are not then
listed or quoted for trading on OTCQB or OTCQX and if prices for Ordinary Shares are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Ordinary Shares so
reported, or (d) in all other cases, the fair market value of an Ordinary Share as determined by an independent appraiser selected in
good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the
fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">d) <U>Mechanics of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Delivery of
Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent
to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system
and either (A) there is an effective registration statement registering the issuance of the Warrant Shares to or resale of the Warrant
Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant
to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s
share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to
such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) one (1) Trading
Day after the delivery to the Company of the Notice of Exercise, and (ii) the number of Trading Days comprising the Standard Settlement
Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of
the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares,
provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of
(i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice
of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant
Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant
Shares subject to such exercise (based on the VWAP of the Ordinary Shares on the date of the applicable Notice of Exercise), $10 per Trading
Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such
Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a
transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein,
&ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s
primary Trading Market with respect to the Ordinary Shares as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date (other than any such failure that is solely due to
any action or inaction by the Holder with respect to such exercise), and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, Ordinary Shares to deliver in satisfaction
of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including
brokerage commissions, if any) for the Ordinary Shares so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant
Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the
sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of
the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed
rescinded) or deliver to the Holder the number of Ordinary Shares that would have been issued had the Company timely complied with its
exercise and delivery obligations hereunder. For example, if the Holder purchases Ordinary Shares having a total purchase price of $11,000
to cover a Buy-In with respect to an attempted exercise of Ordinary Shares with an aggregate sale price giving rise to such purchase obligation
of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder
shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the
Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available
to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect
to the Company&rsquo;s failure to timely deliver Ordinary Shares upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">v. <U>No Fractional
Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As
to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election,
either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or
round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its register of members in any manner which prevents the timely exercise of this Warrant, pursuant
to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">e) <U>Holder&rsquo;s Exercise Limitations</U>.
The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant,
pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable
Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting as a group together with the
Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess
of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of Ordinary Shares beneficially
owned by the Holder and its Affiliates and Attribution Parties shall include the number of Ordinary Shares issuable upon exercise of this
Warrant with respect to which such determination is being made, but shall exclude the number of Ordinary Shares which would be issuable
upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or
Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company
(including, without limitation, any other Ordinary Share Equivalents) subject to a limitation on conversion or exercise analogous to the
limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the
preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the
Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing
to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any
schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission
of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable,
in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy
of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with
Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining
the number of outstanding Ordinary Shares, a Holder may rely on the number of outstanding Ordinary Shares as reflected in (A) the Company&rsquo;s
most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company
or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of Ordinary Shares outstanding. Upon
the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number
of Ordinary Shares then outstanding. In any case, the number of outstanding Ordinary Shares shall be determined after giving effect to
the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties
since the date as of which such number of outstanding Ordinary Shares was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 9.9% of the number of Ordinary Shares outstanding immediately after giving effect to the issuance of Ordinary Shares issuable
upon exercise of this Warrant. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict
conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent
with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Stock Dividends
and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution
or distributions on Ordinary Shares or any other equity or equity equivalent securities payable in Ordinary Shares (which, for avoidance
of doubt, shall not include any Ordinary Shares issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding Ordinary
Shares into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding Ordinary Shares into a smaller
number of shares, or (iv) issues by reclassification of shares of the Ordinary Shares any shares or other equity interests of the Company,
then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Ordinary Shares (excluding
treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of Ordinary Shares
outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted
such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall
become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or distribution
and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Intentionally
Omitted</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Ordinary Share Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of Ordinary Shares (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable
to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Ordinary
Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation,
the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase
Rights, or, if no such record is taken, the date as of which the record holders of Ordinary Shares are to be determined for the grant,
issue or sale of such Purchase Rights (provided, however, to the extent that the Holder&rsquo;s right to participate in any such Purchase
Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in
such Purchase Right to such extent (or beneficial ownership of such Ordinary Shares as a result of such Purchase Right to such extent)
and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not
result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Pro Rata Distributions</U>.
During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets
(or rights to acquire its assets) to holders of Ordinary Shares , by way of return of capital or otherwise (including, without limitation,
any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement,
scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant,
then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have
participated therein if the Holder had held the number of Ordinary Shares acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of Ordinary
Shares are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, to the extent that the Holder&rsquo;s
right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder
shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any Ordinary Shares as a result
of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until
such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Fundamental
Transaction.</U> If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in
one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the
Company or another Person) is completed pursuant to which holders of Ordinary Shares are permitted to sell, tender or exchange their
shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Ordinary Shares
or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related
transactions effects any reclassification, reorganization or recapitalization of the Ordinary Shares or any compulsory share exchange
pursuant to which the Ordinary Shares are effectively converted into or exchanged for other securities, cash or property, or (v) the
Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another
Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding Ordinary Shares or 50% or more
of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent
exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such
exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation
in Section 2(e) on the exercise of this Warrant), the number of Ordinary Shares of the successor or acquiring corporation or of the Company,
if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as
a result of such Fundamental Transaction by a holder of the number of Ordinary Shares for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one Ordinary Share in such Fundamental Transaction, and the Company
shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different
components of the Alternate Consideration. If holders of Ordinary Shares are given any choice as to the securities, cash or property
to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives
upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a
Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any
time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public
announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash
equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the consummation
of such Fundamental Transaction; provided, however, that, if the Fundamental Transaction is not within the Company&rsquo;s control, including
not approved by the Company&rsquo;s Board of Directors, Holder shall only be entitled to receive from the Company or any Successor Entity
the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant,
that is being offered and paid to the holders of Ordinary Shares of the Company in connection with the Fundamental Transaction, whether
that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Ordinary Shares are given the
choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided, further, that
if holders of Ordinary Shares of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders
of Ordinary Shares will be deemed to have received common stock of the Successor Entity (which Entity may be the Company following such
Fundamental Transaction) in such Fundamental Transaction. &ldquo;Black Scholes Value&rdquo; means the value of this Warrant based on
the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of consummation
of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S.
Treasury rate for a period equal to the time between the date of the public announcement of the applicable Fundamental Transaction and
the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function
on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement
of the applicable Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater of (i) the
sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such
Fundamental Transaction and (ii) the highest VWAP during the period beginning on the Trading Day immediately preceding the announcement
of the applicable Fundamental Transaction (or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the
Trading Day of the Holder&rsquo;s request pursuant to this Section 3(e) and (D) a remaining option time equal to the time between the
date of the public announcement of the applicable Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The
payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within
the later of (i) five Business Days of the Holder&rsquo;s election and (ii) the date of consummation of the Fundamental Transaction.
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;Successor
Entity&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance
with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and
approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver
to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar
in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity
(or its parent entity) equivalent to the Ordinary Shares acquirable and receivable upon exercise of this Warrant (without regard to any
limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise
price hereunder to such shares of capital stock (but taking into account the relative value of the Ordinary Shares pursuant to such Fundamental
Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the
purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and
which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this
Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and
may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other
Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein. For the avoidance of doubt,
the Holder shall be entitled to the benefits of the provisions of this Section 3(e) regardless of (i) whether the Company has sufficient
authorized Ordinary Shares for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the Initial
Exercise Date.&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number
of Ordinary Shares (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Notice to
Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.75in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.75in">ii. <U>Notice to
Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Ordinary
Shares, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Ordinary Shares, (C) the Company
shall authorize the granting to all holders of the Ordinary Shares rights or warrants to subscribe for or purchase any Ordinary Shares
(or other equity interests) of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection
with any reclassification of the Ordinary Shares, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party,
any sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Ordinary Shares are converted
into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its
last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 10 calendar days prior to
the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the
purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders
of the Ordinary Shares of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or
(y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or
close, and the date as of which it is expected that holders of the Ordinary Shares of record shall be entitled to exchange their Ordinary
Shares for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the
corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with
the Commission pursuant to a Report on Form 6-K. The Holder shall remain entitled to exercise this Warrant during the period commencing
on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant, subject to the prior written consent of the holders of a majority of the then outstanding Warrants (based on the number
of Warrant Shares then underlying such Warrants), reduce the then current Exercise Price to any amount and for any period of time deemed
appropriate by the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including, without limitation, any registration
rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated
agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its
agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if
required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>New Warrants</U>.
This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together
with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent
or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company
shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with
such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and shall be identical with this Warrant
except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant Register</U>.
The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant Register</U>&rdquo;),
in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the
absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual
notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No Rights
as Shareholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends or
other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth
in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to Section
2(c) or to receive cash payments pursuant to Section 2(d)(i), Section 2(d)(iv) and Section 3(e) herein, in no event shall the Company
be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Loss, Theft,
Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to
it of the loss, theft, destruction or mutilation of this Warrant or any share certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or share certificate, if mutilated, the Company will make
and deliver a new Warrant or share certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or share certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Trading Day, then such action may be taken or such right may be exercised on the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Ordinary Shares a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Ordinary Shares may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Ordinary Shares or as a shareholder of the Company, whether such liability is asserted by the Company or by creditors of
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and holders of a majority
of the then outstanding Warrants (based on the number of Warrant Shares then underlying such Warrants), provided that if any amendment,
modification or waiver disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately
impacted Holder (or group of Holders) shall also be required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="text-transform: uppercase"><B>VCI GLOBAL LIMITED</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">By:</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 37%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name: Victor</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title: Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To: [_______________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The undersigned hereby elects
to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders
herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment shall take the form
of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
in lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>
[if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please issue said Warrant
Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: ________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: __________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: _____________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ________________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><I>(To assign the foregoing Warrant, execute this
form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 70%">Name:</TD>
    <TD STYLE="text-align: justify; width: 30%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Address:</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone Number:</P></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Email Address:</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Dated: _______________ __, ______</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Holder&rsquo;s Signature:</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Holder&rsquo;s Address:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>ea027358601ex5-1_vciglobal.htm
<DESCRIPTION>OPINION OF CAREY OLSEN (BVI) L.P
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21
January 2026</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">VCI
Global Limited</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">B03-C-8
Menara 3A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">KL
Eco City, No. 3 Jalan Bangsar</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">59200
Kuala Lumpur</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Dear
Sir / Madam</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:
VCI Global Limited (the &ldquo;Company&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">We
are lawyers qualified to practise in the British Virgin Islands and have acted as British Virgin Islands legal counsel to the Company.
We have been asked to issue this legal opinion in connection with a prospectus supplement dated 21 January 2026 (the &ldquo;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prospectus
Supplement</B><FONT STYLE="font-weight: normal">&rdquo; and together with the base prospectus included in the Registration Statement
(as defined below), the &ldquo;</FONT><B>Prospectus</B><FONT STYLE="font-weight: normal">&rdquo;) forming part of the registration statement
on Form F-3 (file number 333-279521) filed with the U.S. Securities and Exchange Commission (the &ldquo;</FONT><B>Commission</B><FONT STYLE="font-weight: normal">&rdquo;)
(the &ldquo;</FONT><B>Registration Statement</B><FONT STYLE="font-weight: normal">&rdquo;), under the Securities Act of 1933, as amended
(the &ldquo;</FONT><B>Securities Act</B><FONT STYLE="font-weight: normal">&rdquo;).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">The Prospectus Supplement relates
to the offering by the Company of: (i) 3,179,716 ordinary shares, no par value (the &ldquo;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ordinary
Shares</B><FONT STYLE="font-weight: normal">&rdquo;); (ii) pre-funded warrant shares to purchase up to 5,393,672 Ordinary Shares (the
&ldquo;</FONT><B>Pre-Funded Warrants Shares</B><FONT STYLE="font-weight: normal">&rdquo;); (iii) Common A Warrants to purchase up to
8,573,388 Ordinary Shares; (iv) Common B Warrants to purchase up to 8,573,388 (together the &ldquo;</FONT><B>Common Warrants</B><FONT STYLE="font-weight: normal">&rdquo;);
and together with the Ordinary Shares, Pre-Funded Warrant Shares, the &ldquo;</FONT><B>Securities</B><FONT STYLE="font-weight: normal">&rdquo;).
The Ordinary Shares, the Pre-Funded Warrants and the Common Warrants are being sold to an investor named in, and pursuant to, a securities
purchase agreement among the Company and such investor (the &ldquo;</FONT><B>Securities Purchase Agreement</B><FONT STYLE="font-weight: normal">&rdquo;).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">We
hereby consent to the filing of this opinion letter as an exhibit to the Registration Statement and to the references to our firm under
the heading &ldquo;Legal Matters&rdquo; in the Prospectus. In providing our consent, we do not thereby admit that we are in the category
of persons whose consent is required under Section 7 of the Securities Act or the Rules and Regulations of the Commission thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex5-1_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCOPE
                                            OF OPINION</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">This
Opinion is given only on the laws of the British Virgin Islands in force at the date hereof and is based solely on matters of fact known
to us at the date hereof. We have not investigated the laws or regulations of any jurisdiction other than the British Virgin Islands
(collectively, &ldquo;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Foreign Laws</B><FONT STYLE="font-weight: normal">&rdquo;).
We express no opinion as to matters of fact or, unless expressly stated otherwise, the veracity of any representations or warranties
given in or in connection with any of the documents set out in Schedule 1.</FONT></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify; width: 0in"></TD><TD STYLE="width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DOCUMENTS
                                            REVIEWED AND ENQUIRIES MADE</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">In
giving this Opinion, we have undertaken the Searches and reviewed originals, copies, drafts, conformed copies, certified copies or notarised
copies of the documents set out in Schedule 1.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify; width: 0in"></TD><TD STYLE="width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSUMPTIONS
                                            AND QUALIFICATIONS</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">This
Opinion is given on the basis that the assumptions set out in Schedule 2 (which we have not independently investigated or verified) are
true, complete and accurate in all respects. In addition, this Opinion is subject to the qualifications set out in Schedule 3.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify; width: 0in"></TD><TD STYLE="width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OPINIONS</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Having
regard to such legal considerations as we deem relevant, we are of the opinion that:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify; width: 0in"></TD><TD STYLE="width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
                                            incorporation, existence and status</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
Company has been duly incorporated as a BVI business company, limited by shares, under the BVI Business Companies Act 2004 (as amended)
(the &ldquo;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Act</B><FONT STYLE="font-weight: normal">&rdquo;),
is validly existing and was in good standing with the Registrar of Corporate Affairs in the British Virgin Islands at the date of the
Certificate of Good Standing (the &ldquo;</FONT><B>Registrar</B><FONT STYLE="font-weight: normal">&rdquo;).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;/ 11</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power
                                            and authority</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
Company has full power (including both capacity and authority) under its Memorandum and Articles to enter into, deliver and perform its
obligations under the Documents and to offer the Securities under the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            conflict</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
execution and delivery of the Documents by the Company and the performance of its obligations thereunder do not contravene:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            law to which the Company is currently subject in the British Virgin Islands; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            provision of the Memorandum and Articles.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
                                            solely on the Memorandum and Articles, the Company is authorised to issue an unlimited number
                                            of Ordinary Shares, no par value per share.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Securities, to be issued and sold by the Company pursuant to the terms of the Securities
                                            Purchase Agreements, have been duly authorised for issuance and when: (a) the board of directors
                                            of the Company has taken all necessary corporate action to approve the issue thereof, the
                                            terms of the offering thereof and related matters; (b) the issue of such Securities have
                                            been recorded in the Company&rsquo;s register of members; and (c) the subscription price
                                            of such Securities have been fully paid in cash or other consideration approved by the board
                                            of directors of the Company, the Ordinary Shares, the Pre-Funded Warrant Shares and the Common
                                            Warrants will be duly authorised, validly issued, fully-paid and non-assessable, and free
                                            of any pre-emptive or similar rights. As a matter of British Virgin Islands law, a share
                                            is only issued when it has been entered in the register of members.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Board Resolutions authorise and approve the issue of the Securities for the purposes of paragraph
                                            (d) above.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            description of the Ordinary Shares in the Registration Statement and <FONT STYLE="font-weight: normal">Prospectus
                                            is correct in all material aspects.</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Official
                                            Consents</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">No
authorisation, approval, consent, registration, licence or exemption is required from any court or governmental, regulatory, judicial
or public body or authority in the British Virgin Islands Is required in connection with:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            execution and delivery by the Company of the Documents; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;/ 11</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            performance of the Company&rsquo;s obligations under the Documents.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.6</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Choice
                                            of Law</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
express choice of law of the jurisdiction specified in the Documents (the &ldquo;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Governing
Law</B><FONT STYLE="font-weight: normal">&rdquo;) is a valid choice of law and will be recognised and upheld by the courts of the British
Virgin Islands.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.7</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Submission
                                            to Jurisdiction</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
submission to the jurisdiction of the courts contained in the Documents is a valid one and will be recognised by the courts of the British
Virgin Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.8</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
                                            Validity</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
execution and delivery of the Securities Purchase Agreement and the performance by the Company of its obligations thereunder have been
authorised by the Company and, the Securities Purchase Agreement have been duly executed on behalf of the Company constitutes the legal,
valid and binding obligations of the Company enforceable in accordance with its terms.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: justify; width: 0in"></TD><TD STYLE="width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RELIANCE</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Except
                                            as specifically referred to in this Opinion we have not examined, and give no opinion on,
                                            any contracts, instruments or other documents (whether or not referred to in, or contemplated
                                            by, the Documents). We do not give any opinion on the commercial merits of any transaction
                                            contemplated or entered into under or pursuant to the Documents.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">This
                                            Opinion (and any obligations arising out of or in connection with it) is given on the basis
                                            that it shall be governed by and construed in accordance with the laws of the British Virgin
                                            Islands. By relying on the opinions set out in this Opinion the addressee(s) hereby irrevocably
                                            agree(s) that the courts of the British Virgin Islands are to have exclusive jurisdiction
                                            to settle any disputes which may arise in connection with this Opinion.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">We
                                            assume no responsibility to advise any person entitled to rely on this Opinion, or to undertake
                                            any investigations, as to any change in British Virgin Islands law (or its application) or
                                            factual matters arising after the date of this Opinion, which might affect the opinions set
                                            out herein.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;/ 11</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">This
                                            opinion deals only with the specified legal issues expressly addressed herein, and you should
                                            not infer any opinion that is not explicitly stated herein from any matter addressed in this
                                            opinion.</FONT></TD>
</TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">This
                                            opinion is issued solely in connection with the Registration Statement and Prospectus and
                                            the offering of the Securities by the Company and is not to be relied upon in respect of
                                            any other matter.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Yours
faithfully</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%">/s/ Carey
Olsen</TD>
  <TD STYLE="padding-bottom: 1.5pt; width: 60%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Carey
Olsen</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: -0.5pt"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;/ 11</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
1</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DOCUMENTS
REVIEWED AND ENQUIRIES MADE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">For
the purpose of this Opinion, we have reviewed originals, copies, drafts or conformed copies of the following documents:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CORPORATE
                                            DOCUMENTS</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            certificate of incorporation of the Company obtained by us pursuant to the Company Searches.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            memorandum and articles of association of the Company (the &ldquo;<B>Memorandum and Articles</B>&rdquo;)
                                            obtained by us pursuant to the Company Searches.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            certificate of good standing relating to the Company issued by the Registrar, dated 19 January
                                            2026 (the &ldquo;<B>Certificate of Good Standing</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            registered agent&rsquo;s certificate dated 20 January 2026 (the &ldquo;<B>Certificate</B>&rdquo;)
                                            issued by the Registered Agent.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            board resolutions of the Company duly executed and dated 29 December 2025 (the &ldquo;<B>Board
                                            Resolutions</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEARCHES
                                            AND ENQUIRIES</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
information revealed by our search of the Company&rsquo;s public records on file and available for public inspection from the Registrar
at the time of our search on 21 January 2026 (the &ldquo;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
Searches</B><FONT STYLE="font-weight: normal">&rdquo;), including all relevant forms and charges (if any) created by the Company and
filed with the Registrar pursuant to section 163 of the BVI Business Companies Act (the &ldquo;</FONT><B>Act</B><FONT STYLE="font-weight: normal">&rdquo;).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DOCUMENTS</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            copy of the Prospectus Supplement, the Prospectus and the Registration Statement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Duly
                                            executed copy of the Securities Purchase Agreement dated 20 January 2026.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
documents listed in paragraph C of this Schedule are together, the &ldquo;<B>Documents</B>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCOPE</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
documents listed in this Schedule are the only documents and/or records we have examined and the only searches and enquiries we have
carried out for the purposes of this Opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;/ 11</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSUMPTIONS</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">We
have assumed:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            genuineness and authenticity of all signatures and the conformity to the originals of all
                                            copies (whether or not certified) examined by us and the authenticity and completeness of
                                            the originals from which such copies were taken;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            where a document has been examined by us in draft form, it will be or has been executed and/or
                                            filed in the form of that draft, and where a number of drafts of a document have been examined
                                            by us all changes thereto have been marked or otherwise drawn to our attention;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            accuracy and completeness of all factual representations made in the Registration Statement
                                            and the Documents reviewed by us;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            the public records of the Company we have examined are accurate and that the information
                                            disclosed by the Searches is true and complete.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            the Resolutions were signed by all or a majority of the directors, as the case may be, in
                                            the manner prescribed in the Company&rsquo;s articles of association, remain in full force
                                            and effect and have not been rescinded or amended;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(f)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            there is no provision of the law of any jurisdiction, other than the British Virgin Islands,
                                            which would have any implication in relation to the opinions expressed herein;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(g)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            upon issue of any shares to be sold by the Company, the Company will receive consideration
                                            for the full issue price thereof which shall be equal to at least the par value thereof;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(h)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Company&rsquo;s issuance of any Ordinary Shares is or will be in compliance with its Memorandum
                                            and Articles;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            Memorandum and Articles will not be amended in any manner that would affect the opinions
                                            set forth herein;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;/ 11</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(j)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            the Registration Statement has been declared effective by the Commission prior to, or concurrent
                                            with, the sale of the Securities pursuant to the Registration Statement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(k)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Registration Statement and the transactions contemplated thereunder complies with the requirements
                                            of the applicable rules of the Nasdaq Capital Market and the Securities <FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">Act;</FONT></FONT></TD></TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(l)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            capacity, power and authority of each of the parties to the Documents, as the case may be,
                                            other than the Company, to enter into and perform its respective obligations thereunder;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(m)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            due execution and delivery of the Documents by each of the parties thereto, other than the
                                            Company, and the physical delivery thereof by the Company with an intention to be bound thereby;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(n)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            validity and binding effect under the laws of such jurisdiction (the &ldquo;<B>Foreign Laws</B>&rdquo;)
                                            of the Documents in accordance with its terms;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(o)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            validity and binding effect under the Documents of the submission by the Company to the exclusive
                                            jurisdiction of the relevant state and federal courts of the United States of America (the
                                            &ldquo;<B>Foreign Courts</B>&rdquo;);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(p)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
                                            invitation has been or will be made by or on behalf of the Company to the public in the British
                                            Virgin Islands to subscribe for any shares of the Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(q)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            on the date of entering into the Documents the Company is, and after entering into the Documents
                                            the Company is and will be able to, pay its liabilities as they become due; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(r)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">none
                                            of the parties to the Documents is carrying on unauthorised financial services business for
                                            the purposes of the Financial Services Commission Act of the British Virgin Islands, and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(s)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            the contents of the Registered Agent&rsquo;s Certificate are true and correct as of the date
                                            hereof.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;/ 11</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCHEDULE
3 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal">QUALIFICATIONS</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">1.
The obligations under the Documents will not necessarily be legal, valid, binding or enforceable in all circumstances and this Opinion
is not to be taken to imply that each obligation would necessarily be capable of enforcement or be enforced in all circumstances in accordance
with its terms. In particular, but without limitation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            binding effect, validity and enforceability of obligations may be limited by laws relating
                                            to bankruptcy, insolvency, moratorium, liquidation, dissolution, reorganisation and other
                                            laws of general application relating to, or affecting the rights of, creditors;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">enforcement
                                            may be limited by general principles of equity (for example, equitable remedies such as specific
                                            performance or the issuing of an injunction are available only at the discretion of the court
                                            and may not be available where damages are considered to be an adequate alternative and we
                                            therefore express no opinion on whether such remedies will be granted if sought);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">claims
                                            may be or become barred under the laws relating to the prescription and limitation of actions
                                            or may become subject to the general doctrine of estoppel or waiver in relation to representations,
                                            acts or omissions of any relevant party or may become subject to defences of set-off or counterclaim;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                            obligations are to be performed in a jurisdiction outside the British Virgin Islands, they
                                            may not be enforceable in the British Virgin Islands to the extent that performance would
                                            be illegal under the laws of that jurisdiction;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(e)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            courts of the British Virgin Islands have jurisdiction to give judgment in the currency of
                                            the relevant obligation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(f)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obligations
                                            to make payments that may be regarded as penalties will not be enforceable;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(g)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            company cannot, by agreement or in its articles of association, restrict the exercise of
                                            a statutory power;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(h)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
                                            exists doubt as to enforceability of any provision whereby the Company covenants not to exercise
                                            powers specifically given to its Members by the Act;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the enforcement of
                                                                                                                                                                                    contractual obligations may be limited by the provisions of British Virgin Islands law applicable to agreements or contracts held to
                                                                                                                                                                                    have been <FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">frustrated by events happening after the relevant agreement
                                                                                                                                                                                    or contract was entered into;</FONT></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;/ 11</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(j)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            enforcement of obligations may be invalidated or vitiated by reason of fraud, duress, undue
                                            influence, mistake, illegality or misrepresentation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(k)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            courts of the British Virgin Islands may:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">refuse
                                            to enforce a provision that amounts to an indemnity in respect of the costs of enforcement
                                            or of unsuccessful proceedings brought in the British Virgin Islands where such courts have
                                            already made an order to that effect;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">decline
                                            to exercise jurisdiction in relation to substantive proceedings brought under or in relation
                                            to the Documents in matters where they determine that such proceedings may be tried in a
                                            more appropriate forum; and/or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(iii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">find
                                            that a hybrid dispute resolution clause, though generally recognised under British Virgin
                                            Islands law, is unenforceable on the grounds, amongst others, that it confers concurrent
                                            jurisdiction on an arbitral tribunal and the courts of the British Virgin Islands;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(l)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provisions
                                            that purport to require parties to reach agreement in the future may be unenforceable for
                                            lack of certainty;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(m)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            agreement made by a person in the course of carrying on unauthorised financial services business
                                            is unenforceable against the other party to the agreement under section 50F of the Financial
                                            Services Commission Act, 2001;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(n)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                            the courts of the British Virgin Islands determine that a contractual term may be interpreted
                                            in more than one manner the courts may employ the one that is deemed to be most consistent
                                            with business and common sense;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(o)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
                                            is possible that a judgment (in the British Virgin Islands or elsewhere) relating to a particular
                                            agreement or instrument would be held to supersede the terms of such agreement or instrument
                                            with the effect that, notwithstanding any express term to the contrary in such agreement
                                            or instrument, such terms would cease to be binding; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(p)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
                                            is a presumption that the courts of the British Virgin Islands will give effect to an exclusive
                                            jurisdiction clause in an agreement and upon application, may stay proceedings brought in
                                            the British Virgin Islands or grant an anti-suit injunction against a party that commences
                                            proceedings elsewhere where such proceedings are
in breach of the exclusive jurisdiction clause, unless a party can satisfy the courts of the British Virgin Islands that it would be
just and equitable to depart from that presumption (for example, not to do so would deprive one party of access to justice).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: -0.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;/ 11</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            maintain the Company in good standing under the laws of the British Virgin Islands, the Company
                                            must inter alia pay annual filing fees to the Registrar, comply with its economic substance
                                            requirements and obligations under the Virgin Islands Economic Substance (Companies and Limited
                                            Partnerships) Act, 2018 and file a copy of its register of directors with the Registrar.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            make no comment on references to any Foreign Laws or to any representations or warranties
                                            made in any agreement or document.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            express no view as to the commercial terms of the Documents or whether such terms represent
                                            the intentions of the parties and make no comment with regard to the representations that
                                            may be made by the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            offer no opinion as to whether the acceptance of, or the execution or performance of, the
                                            Company&rsquo;s obligations under the Documents will or may result in the breach or infringement
                                            of any other deed, contract or document entered into by, or binding upon, the Company (other
                                            than the Memorandum and Articles).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;/ 11</FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>6
<FILENAME>ea027358601ex5-2_vciglobal.htm
<DESCRIPTION>OPINION OF SICHENZIA ROSS FERENCE CARMEL LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 5.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<IMG SRC="ex5-2_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">January 21, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.05pt">VCI Global Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Suite 33.03 of Level 33, Menara Exchange 106, Lingkaran TRX, Tun Razak
Exchange</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">55188 Kuala Lumpur, Malaysia</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -4.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Re: <U>Securities Registered under Registration Statement on Form
F-3</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To Whom It May Concern,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have acted as counsel to you in connection
with your filing of a Registration Statement on Form F-3 (File No. 333-279521) (as amended or supplemented, the &ldquo;<B>Registration
Statement</B>&rdquo;) filed on May 17, 2024 with the Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) pursuant
to the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), relating to the registration of the offering by VCI
Global Limited, a British Virgin Islands business company (the &ldquo;<B>Company</B>&rdquo;), of up to $200,000,000 of any combination
of securities of the types specified therein. The Registration Statement was declared effective by the Commission on May 28, 2024. We
are delivering this supplemental opinion letter in connection with the prospectus supplement (the &ldquo;<B>Prospectus Supplement</B>&rdquo;)
filed on January 21, 2026 by the Company with the Commission pursuant to Rule 424 under the Securities Act. The Prospectus Supplement
relates to the offering by the Company of (i) 3,179,716 ordinary shares, no par value per share, of the Company (the &ldquo;<B>Ordinary
Shares</B>&rdquo;), (ii) Common A warrants (&ldquo;<B>Common A Warrants</B>&rdquo;) to purchase up to 8,573,388 Ordinary Shares (&ldquo;<B>Common
A Warrant Shares</B>&rdquo;), (iii) Common B warrants (&ldquo;<B>Common B Warrants</B>&rdquo;, and together with Common A Warrants, the
&ldquo;<B>Common Warrants</B>&rdquo;) to purchase up to 8,573,388 Ordinary Shares (&ldquo;<B>Common B Warrant Shares</B>&rdquo;, and together
with Common Warrant A Shares, the &ldquo;<B>Common Warrant Shares</B>&rdquo;) and (iv) Pre-Funded Warrants (&ldquo;<B>Pre-Funded Warrants</B>&rdquo;)
to purchase 5,393,672 Ordinary Shares (&ldquo;<B>Pre-Funded Warrant Shares</B>&rdquo;) (collectively, the &ldquo;<B>Securities</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have reviewed such documents and made such
examination of law as we have deemed appropriate to give the opinions set forth below. We have relied, without independent verification,
on certificates of public officials and, as to matters of fact material to the opinions set forth below, on certificates of officers of
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The opinion set forth below is limited to the
laws of the State of New York and the federal laws of the United States of America.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of the opinions set forth below,
without limiting any other exceptions or qualifications set forth herein, we have assumed that (i) the Common Warrants and Pre-Funded
Warrants will be governed by the internal law of New York and (ii) after the issuance of any Securities offered pursuant to the Registration
Statement, the total number of issued Ordinary Shares together with the total number of shares of such stock issuable upon the exercise,
exchange, conversion or settlement, as the case may be, of any exercisable, exchangeable or convertible security (including without limitation
any Common Warrants or Pre-Funded Warrants), then outstanding, will not exceed the total number of authorized Ordinary Shares available
for issuance under the Company&rsquo;s organizational documents as then in effect (the &ldquo;<B>Charter</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on the foregoing, and subject to the qualifications,
assumptions and limitations stated herein, we are of the opinion that, when the Common Warrants and Pre-Funded Warrants have been duly
authorized and, upon issuance and delivery against payment therefor in accordance with the terms of the securities purchase agreement
with certain institutional investor dated January 20, 2026 (the &ldquo;Securities Purchase Agreement&rdquo;), and the placement agency
agreement with E.F. Hutton &amp; Co. dated January 16, 2026 (the &ldquo;Placement Agency Agreement&rdquo;), the Common Warrants and Pre-Funded
Warrants will constitute valid and legally binding obligations of the Company in accordance with their terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">1185 AVENUE OF THE AMERICAS | 31ST FLOOR | NEW
YORK, NY | 10036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">T (212) 930-9700 | F (212) 930-9725 | WWW.SRFC.LAW</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The opinion set forth above are subject to bankruptcy,
insolvency, fraudulent transfer, reorganization, moratorium and other similar laws of general application affecting the rights and remedies
of creditors and to general principles of equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion letter and the opinion it contains
shall be interpreted in accordance with the Core Opinion Principles as published in 74 Business Lawyer 815 (Summer 2019).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the inclusion of this opinion
as Exhibit 5.2 to the Company&rsquo;s Report on Form 6-K to be filed with the Commission on the date hereof and to the references to our
firm under the caption &ldquo;Legal Matters&rdquo; in the Registration Statement. In giving our consent, we do not admit that we are in
the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 40%">Very truly yours,</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><I>/s/ Sichenzia Ross Ference Carmel LLP</I></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Sichenzia Ross Ference Carmel LLP</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">1185 AVENUE OF THE AMERICAS | 31ST FLOOR | NEW
YORK, NY | 10036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">T (212) 930-9700 | F (212) 930-9725 | WWW.SRFC.LAW</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>7
<FILENAME>ea027358601ex10-1_vciglobal.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 10.1</B></P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><I>Execution Version</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of January 20, 2026, between VCI Global Limited, a company incorporated under the BVI
Business Companies Act, 2004 (as amended) of the British Virgin Islands (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified
on the signature pages hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as defined below),
the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company,
securities of the Company as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company and the
Purchasers are executing and delivering this Agreement with respect to the securities of the Company in reliance upon the Registration
Statement (as defined below) filed by the Company with the United States Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
pursuant to the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder (collectively, the &ldquo;<U>Securities
Act</U>&rdquo;), for the registration of the Securities, as such Registration Statement may be amended and supplemented from time to time
(including pursuant to Rule 462(b) of the Securities Act), including all documents filed as part thereof or incorporated by reference
therein, and including all information deemed to be a part thereof at the time of effectiveness pursuant to Rule 430B of the Securities
Act, and the Prospectus Supplement (as defined below) that is delivered by the Company to the Purchaser in connection with the execution
and delivery of this Agreement, including the documents incorporated by reference therein, and that is filed with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>ARTICLE
1<BR>
<BR>
DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1 <U>Definitions</U>. In
addition to the terms defined elsewhere in this Agreement the following terms have the meanings set forth in this <U>Section 1.1</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 4.6</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(j)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Approved
Stock Plan</U>&rdquo; means any equity incentive plan, employee stock purchase plan or other employee benefit plan which has been approved
by the board of directors of the Company prior to the date hereof, and future increases in the Ordinary Shares authorized to be issued
pursuant to the Company&rsquo;s existing equity incentive plan approved by a majority of the non-employee members of the Board of Directors
or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company,
pursuant to which Ordinary Shares and standard options to purchase Ordinary Shares may be issued to any employee, officer or director
for services provided to the Company in their capacity as such.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall have the meaning ascribed to such term in Section 2.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Block
Trades</U>&rdquo; means any privately negotiated transaction involving the sale or resale of Ordinary Shares, executed outside of the
public exchange (including trades executed through alternative trading systems, dark pools, or direct negotiation), involving at least
10,000 Ordinary Shares, including trades where a broker-dealer attempts to sell the securities as agent but may position and resell a
portion of the block as principal to facilitate the transaction. Such trades may be conducted without substantial marketing efforts prior
to pricing and may include same-day trades, overnight trades or similar transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in the City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in the City of New York are generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 2.1(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Date</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 2.1(a).</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Sale Price</U>&rdquo; shall mean for any security as of any date, the last closing trade price for such security on the principal securities
exchange or trading market where such security is listed or traded, as reported by Bloomberg, L.P., or if the foregoing does not apply,
the average of the bid prices of all of the market makers for such security as reported in the &ldquo;pink sheets&rdquo; by OTC Markets
Group Inc. (formerly Pink Sheets LLC). All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock
combination or other similar transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Statement</U>&rdquo; means the Closing Statement in the form on <U>Annex A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
shall have the meaning ascribed to such term in the preamble.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
A Warrants</U>&rdquo; means the Ordinary Share purchase warrants delivered to the Purchasers at the applicable Closing in accordance with
<U>Section 2.2(a)</U> hereof, which Common Warrants shall be exercisable immediately and have a term of exercise equal to five (5) years,
in the form of <U>Exhibit A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
B Warrants</U>&rdquo; means the Ordinary Share purchase warrants delivered to the Purchasers at the applicable Closing in accordance with
<U>Section 2.2(a)</U> hereof, which Common Warrants shall be exercisable immediately and have a term of exercise equal to one-hundred
eighty (180) days, in the form of <U>Exhibit B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Warrants</U>&rdquo; means, collectively, the Common A Warrants and the Common B Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
BVI Counsel</U>&rdquo; means Carey Olsen (BVI) L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
U.S. Counsel</U>&rdquo; means Sichenzia Ross Ference Carmel LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Convertible
Securities</U>&rdquo; means any share capital or other security of the Company that is at any time and under any circumstances directly
or indirectly convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any share
capital or other security of the Company (including, without limitation, Ordinary Shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">[&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof,
unless otherwise instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Environmental
Laws</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(m)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(s)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt
Issuances</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 4.12(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>First
Tranche Closing</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 2.1(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>First
Tranche Closing Date</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 2.1(a).</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>IFRS</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(h)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in <U>Section 3.1(bb)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Initial
Closing</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 2.1(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Initial
Closing Date</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 2.1(a).</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(p)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up
Agreements</U>&rdquo; means the Lock-Up Agreements, dated as of the date hereof, by and among the Company and Victor Hoo and Karen Liew,
in the form of <U>Exhibit D</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in <U>Section 3.1(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(n)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Ordinary
Share</U>&rdquo; means the ordinary shares of the Company, no par value per share, and any other class of securities into which such securities
may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Ordinary
Share Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Ordinary Shares, including, without limitation, any debt, preferred shares, right, option, warrant or other instrument that
is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share
Purchase Price</U>&rdquo; means a price per Share equal to the product of (i) 80% multiplied by (ii) the Closing Sale Price of the Ordinary
Shares on the Trading Day immediately prior to the applicable Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agent</U>&rdquo; means EF Hutton LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded
Warrants</U>&rdquo; means the Ordinary Share purchase warrants delivered to certain of the Purchasers at the applicable Closing in accordance
with <U>Section 2.2(a)(ix)</U> hereof to the extent any Purchasers elect to receive Pre-Funded Warrants in lieu of Shares, which Pre-Funded
Warrants shall be exercisable into Ordinary Shares and shall be in the form of <U>Exhibit C</U> attached hereto, which Pre-Funded Warrants
shall be exercisable beginning on the Initial Exercise Date (as defined therein) until all of the Pre-Funded Warrants have been exercised,
and shall be exercisable at an exercise price of $0.0001 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the base prospectus filed pursuant to the Registration Statement, including all information, documents and exhibits filed with or
incorporated by reference into such prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act, including all information,
documents and exhibits filed with or incorporated by reference into such prospectus supplement, that is filed with the Commission and
delivered by the Company to each Purchaser at the Initial Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public
Information Failure</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 4.3(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public
Information Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 4.3(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public
Report</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(h)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 4.9</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement on Form F-3 filed with Commission (File No. 333-279521), including all
information, documents and exhibits filed with or incorporated by reference into such registration statement, which registers the issuance
and sale of the Shares, the Warrants and the Warrant Shares to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 3.1(e)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Restricted
Period</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 4.12(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Second
Tranche Closing</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 2.1(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; shall have the meaning ascribed to such term in the preamble.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the Ordinary Shares issued or issuable to each Purchaser pursuant to this Agreement, including any Ordinary Shares underlying the
Pre-Funded Warrants but excluding the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing Ordinary Shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on Schedule 3.1(a) and shall, where applicable, also include any direct or indirect subsidiary
of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Tranche
Closing</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 2.1(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Ordinary Shares are listed or quoted for trading on the
date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York
Stock Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Lock-Up Agreements, the Warrants, all exhibits and schedules thereto and hereto and any
other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means the transfer agent of the Company, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in <U>Section 4.12(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means the volume weighted average price for the Ordinary Shares traded on the Trading Market during normal trading hours for the applicable
time period, excluding Block Trades.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Warrants and the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means the Ordinary Shares issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>ARTICLE
2<BR>
<BR>
PURCHASE AND SALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1 <U>Closing</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) <U>Closing Sequencing</U>.
Subject to the satisfaction (or waiver) of the conditions set forth herein, the Company agrees to issue and sell, and the Purchasers,
severally and not jointly, agree to purchase, up to an aggregate of $15,000,000 (the &ldquo;<B>Purchase Price</B>&rdquo;) of Shares (or
Pre-Funded Warrants in lieu of Shares) and Common Warrants, scheduled as follows: (i) the initial sale and purchase (the &ldquo;<B>Initial
Closing</B>&rdquo; and the date thereof, the &ldquo;<B>Initial Closing Date</B>&rdquo;) of an aggregate of $5,000,000 of Shares (or Pre-Funded
Warrants in lieu of Shares) and Common Warrants shall take place as soon as practicable, but no later than the Business Day following
the satisfaction of all of the closing conditions set forth <U>Section 2.3</U> applicable to the Initial Closing (other than those to
be satisfied at the Initial Closing, but subject to the satisfaction or waiver of such closing conditions); (ii) the additional sale and
purchase (the &ldquo;<B>First Tranche Closing</B>&rdquo; and the date thereof, the &ldquo;<B>First Tranche Closing Date</B>&rdquo;) of
$5,000,000 of Shares (or Pre-Funded Warrants in lieu of Shares) and Common Warrants, subject to the satisfaction or waiver of all of the
closing conditions set forth in Section <U>2.3</U> applicable to the First Tranche Closing, shall take place as soon as practicable after
all of the closing conditions set forth in <U>Section 2.3</U> applicable to the First Tranche Closing are satisfied or waived (other than
those to be satisfied at the First Tranche Closing, but subject to the satisfaction or waiver of such closing conditions); and (iii) the
additional sale and purchase (the &ldquo;<B>Second Tranche Closing</B>&rdquo;) of $5,000,000 of Shares (or Pre-Funded Warrants in lieu
of Shares) and Common Warrants, subject to the satisfaction or waiver of all of the closing conditions set forth in Section 2.3 applicable
to the Second Tranche Closing, shall take place as soon as practicable after all of the closing conditions set forth in <U>Section 2.3</U>
applicable to the Second Tranche Closing are satisfied or waived (other than those to be satisfied at the Second Tranche Closing, but
subject to the satisfaction or waiver of such closing conditions.) Each of the First Tranche Closing and the Second Tranche Closing is
referred to as a &ldquo;<B>Tranche Closing</B>&rdquo;, each of the Tranche Closings and the Initial Closing, a &ldquo;<B>Closing</B>&rdquo;,
and the date of each such Closing, a &ldquo;<B>Closing Date</B>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) <U>Closing Notice</U>.
At least three (3) Business Days before the Closing Date for each Tranche Closing, the Company shall deliver written notice to each Buyer
specifying (i) the anticipated Closing Date for such Tranche Closing and (ii) the wire instructions for delivery of the applicable portion
of the Purchase Price to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c) <U>Beneficial Ownership
Limitation</U>. Notwithstanding anything herein to the contrary, to the extent that a Purchaser determines, in its sole discretion, that
such Purchaser&rsquo;s purchase of Shares at a Closing would cause such Purchaser&rsquo;s beneficial ownership (together with such Purchaser&rsquo;s
Affiliates, and any Person acting as a group together with such Purchaser or any of such Purchaser&rsquo;s Affiliates) of the Ordinary
Shares to exceed the Beneficial Ownership Limitation, or as such Purchaser may otherwise choose, such Purchaser shall receive Pre-Funded
Warrants in lieu of Shares in such manner to result in the same aggregate portion of the Purchase Price being paid by such Purchaser to
the Company. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 9.9% of the number of Ordinary Shares outstanding immediately
after giving effect to the issuance of the Shares on the applicable Closing Date. Each Purchaser shall deliver to the Company, via wire
transfer or a certified check, immediately available funds equal to such Purchaser&rsquo;s Purchase Price as to the applicable Closing,
and the Company shall deliver to each Purchaser its respective Shares (or Pre-Funded Warrants in lieu of Shares) and Common Warrants,
as determined pursuant to <U>Section 2.2(a)</U>, and the Company and each Purchaser shall deliver the other items set forth in <U>Section
2.2</U> deliverable at each Closing. Upon satisfaction of the covenants and conditions set forth in <U>Sections 2.2</U> and <U>2.3</U>,
the Closing shall occur at the offices of Company Counsel or such other location as the parties shall mutually agree.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2 <U>Closing Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) On or prior to the applicable
Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(i) with regard to the Initial
Closing, this Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ii) legal opinions of Company
BVI Counsel and Company U.S. Counsel, directed to the Placement Agent and the Purchasers, in a form reasonably acceptable to the Placement
Agent and Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iii) a copy of the irrevocable
instructions to the Transfer Agent to credit Ordinary Shares to the applicable balance accounts at The Depository Trust Company (&ldquo;DTC&rdquo;),
registered in the name of Purchaser or its respective nominee(s), for the Shares equal to such Purchaser&rsquo;s pro rata portion of the
Purchase Price to be paid at the applicable Closing divided by the Per Share Purchase Price (plus, if applicable, such Purchaser&rsquo;s
aggregate exercise price of the Pre-Funded Warrants, provided that such instructions shall state that the number of Ordinary Shares issuable
upon exercise of such Purchaser&rsquo;s Pre-Funded Warrants shall not be issued until exercise of such Purchaser&rsquo;s Pre-Funded Warrants),
registered in the name of such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iv) duly executed Pre-Funded
Warrants, if any, registered in the name of such Purchaser, as applicable to such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(v) duly executed Common A Warrants
registered in the name of such Purchaser to purchase up to a number of Warrant Shares equal to the total number of Shares and Pre-Funded
Warrants purchased by such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(vi) duly executed Common B
Warrants registered in the name of such Purchaser to purchase up to a number of Warrant Shares equal to the total number of Shares and
Pre-Funded Warrants purchased by such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(vii) the Company&rsquo;s wire
instructions, on Company letterhead and executed by the Executive Chairman, Chief Executive Officer, or Chief Financial Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(viii) with regard to the Initial
Closing, the duly executed Lock-Up Agreements;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ix) with regard to the Initial
Closing, the Prospectus and the Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(x) a duly executed Officer&rsquo;s
Certificate, substantially in the form acceptable to the Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(xi) reimbursement for legal
expenses incurred by the Purchasers for legal counsel in connection with preparation of the Transaction Documents in an amount equal to
$40,000, which the parties acknowledge has already been paid; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(xii) all documents, instruments
and other writings required to be delivered by the Company to the Purchasers on or before the applicable Closing Date pursuant to any
provision of this Agreement or in order to implement and effect the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) On or prior to the applicable
Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(i)with regard to the Initial
Closing, this Agreement duly executed by such Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ii) such Purchaser&rsquo;s
pro rata portion of the Purchase Price to be paid at the applicable Closing (minus, if applicable, a Purchaser&rsquo;s aggregate exercise
price of the Pre-Funded Warrants, which amounts shall be paid as and when such Pre-Funded Warrants are exercised for cash) as set forth
on such Purchaser&rsquo;s signature hereto by wire transfer to the account specified in writing by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3 <U>Closing Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) The obligations of the
Company hereunder in connection with each Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(i) the accuracy in all material
respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) on
such Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which
case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ii) all obligations, covenants
and agreements of each Purchaser required to be performed at or prior to such Closing Date shall have been performed; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iii) the delivery by each Purchaser
of the items set forth in <U>Section 2.2(b)</U> of this Agreement applicable to such Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) The respective obligations
of the Purchasers hereunder in connection with each Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(i) the accuracy in all material
respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when
made and on such Closing Date of the representations and warranties of the Company contained herein (unless as of a specific date therein
in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ii) all obligations, covenants
and agreements of the Company required to be performed at or prior to such Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iii) the delivery by the Company
of the items set forth in <U>Section 2.2(a)</U> of this Agreement applicable to such Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(iv) there shall have been no
Material Adverse Effect with respect to the Company since the date hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(v) the Registration Statement
shall be effective and the Prospectus and Prospectus Supplement shall be available for the issuance and sale of the Securities hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(vi) from the date hereof to
such Closing Date, trading in the Ordinary Shares shall not have been suspended by the Commission or the Company&rsquo;s principal Trading
Market, and, at any time prior to such Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been
suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on
any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall
there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in
its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(v) with
regard to each Tranche Closing, on the Trading Day immediately prior to such Closing Date, the Closing Sale Price for the Ordinary Shares
on the Trading Market is at least $0.50 per share;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(viii) with
regard to each Tranche Closing, the average daily trading volume of the Ordinary Shares on the Trading Market during the ten (10) consecutive
Trading Days immediately prior to such Closing Date is at least $500,000;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(ix) with
regard to the First Tranche Closing, (A) at least ninety (90) calendar days have passed since the Initial Closing Date; or (B) both (x)
the average daily trading volume of the Ordinary Shares on the Trading Market during the ten (10) consecutive Trading Days immediately
prior to the First Tranche Closing Date is at least $750,000 and (y) the VWAP for such ten (10) consecutive Trading Day period is 15%
above the Closing Sale Price of the Ordinary Shares on the Initial Closing Date; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(x) with
regard to the Second Tranche Closing, (A) at least ninety (90) calendar days have passed since the First Tranche Closing Date; or (B)
both (x) the average daily trading volume of the Ordinary Shares on the Trading Market during the ten (10) consecutive Trading Days prior
to the Second Tranche Closing Date is at least $750,000 and (y) the VWAP for such ten (10) consecutive Trading Day period is 15% above
the Closing Sale Price of the Ordinary Shares on the Initial Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>ARTICLE
3<BR>
<BR>
REPRESENTATIONS AND WARRANTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1 <U>Representations and
Warranties of the Company</U>. Except as set forth, or incorporated by reference, in the Registration Statement, which shall be deemed
a part hereof and shall qualify any representation made herein to the extent of the disclosure contained therein, the Company hereby makes
the following representations and warranties as of the date hereof and as of each Closing Date to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) <U>Subsidiaries</U>. All
of the direct and indirect subsidiaries of the Company are set forth on Schedule 3.1(a). The Company owns, directly or indirectly, at
least a majority of the share capital or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued
and outstanding share capital of each Subsidiary owned by the Company are validly issued and are fully paid, non-assessable and free of
preemptive and similar rights to subscribe for or purchase securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) <U>Organization and Qualification</U>.
The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties
and assets and to carry on its business as described in the Registration Statement and the Prospectus Supplement. Neither the Company
nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws
or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in
good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property
owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise)
of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in
any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material
Adverse Effect</U>&rdquo;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking
to revoke, limit or curtail such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c) <U>Authorization; Enforcement</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(i) The Company has the requisite
corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction
Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of
the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been
duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors
or the Company&rsquo;s shareholders in connection herewith or therewith other than in connection with the Required Approvals. The Company
and the Board of Directors believe that they have taken all actions necessary to ensure that the execution and delivery of this Agreement
and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby
believe they will not result in a breach of the fiduciary duties of the members of the Board of Directors. This Agreement and each other
Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered
in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the
Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d) <U>No Conflicts</U>. The
execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the issuance
and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i) conflict
with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of incorporation, bylaws or other
organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or
both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary,
or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation (with or without
notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or
otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or
any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule,
regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a
Subsidiary is subject (including, without limitation, foreign, federal and state securities laws and regulations and the rules and regulations
of the Trading Market and including all applicable foreign, federal and state laws, rules and regulations), or by which any property or
asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not, individually
or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e) <U>Filings, Consents and
Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing
or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the
execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to <U>Sections
4.5</U> and <U>4.7</U> of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) the notice and/or application(s)
to each applicable Trading Market for the issuance and sale of the Securities and the listing of the Shares and Warrant Shares for trading
thereon in the time and manner required thereby, and (iv) such filings as are required to be made under applicable state securities laws
(collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f) <U>Issuance of the Securities;
Registration</U>. The Shares are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents,
will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens. The Warrants are duly authorized and, when
issued in accordance with this Agreement, will be duly and validly issued and constitute the legal, valid and binding obligations of the
Company, enforceable against the Company in accordance with their terms, free and clear of all Liens. The Warrant Shares, when issued
in accordance with the terms of the Transaction Documents, will be validly issued, fully paid and nonassessable, free and clear of all
Liens imposed by the Company. The Company has reserved from its duly authorized share capital and registered under the Securities Act
(pursuant to the Registration Statement, the Prospectus and the Prospectus Supplement) 250% of the maximum number of Ordinary Shares issuable
pursuant to this Agreement and the Warrants. The Company has prepared and filed the Registration Statement in conformity with the requirements
of the Securities Act, which became effective on May 28, 2024, including the Prospectus, and such amendments and supplements thereto as
may have been required to the date of this Agreement. The Registration Statement is effective under the Securities Act and no stop order
preventing or suspending the effectiveness of the Registration Statement or suspending or preventing the use of the Prospectus has been
issued by the Commission and no proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened
by the Commission. The Company, if required by the rules and regulations of the Commission, shall file the Prospectus Supplement with
the Commission pursuant to Rule 424(b). At the time the Registration Statement and any amendments thereto became effective, at the date
of this Agreement and at the applicable Closing Date, the Registration Statement and any amendments thereto conformed and will conform
in all material respects to the requirements of the Securities Act and did not and will not contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading; and
the Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement thereto was issued
and at the applicable Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and
did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading. The Company was at the time of the filing of the
Registration Statement eligible to use Form F-3. The Company is eligible to use Form F-3 under the Securities Act and the sale of the
Securities pursuant to this Agreement meets the transaction requirements set forth in General Instruction I.B.1 of Form F-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(g) <U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as provided in writing to the Purchasers during their due diligence review
of the Company. . No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate
in the transactions contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Securities and as set
forth, or incorporated by reference, in the Registration Statement, there are no outstanding options, warrants, scrip rights to subscribe
to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable
or exchangeable for, or giving any Person any right to subscribe for or acquire, any Ordinary Shares or the share capital of any Subsidiary,
or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional
Ordinary Shares or Ordinary Share Equivalents or share capital of any Subsidiary. The issuance and sale of the Securities will not obligate
the Company or any Subsidiary to issue Ordinary Shares or other securities to any Person (other than the Purchasers). There are no outstanding
securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset
price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding securities
or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments,
understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such
Subsidiary. The Company does not have any share appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar
plan or agreement. All of the outstanding share capital of the Company is duly authorized, validly issued, fully paid and nonassessable,
has been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation
of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any shareholder,
the Board of Directors or others is required for the issuance and sale of the Securities. There are no shareholders&rsquo; agreements,
voting agreements or other similar agreements with respect to the Company&rsquo;s share capital to which the Company is a party or, to
the knowledge of the Company, between or among any of the Company&rsquo;s shareholders. The Company is not a &ldquo;shell&rdquo; company
as defined in Section 405 of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(h) <U>Public Reports; Financial
Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company
under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date
hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including
the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and the Prospectus Supplement, being
collectively referred to herein as the &ldquo;<U>Public Reports</U>&rdquo;) on a timely basis or has received a valid extension of such
time of filing and has filed any such Public Reports prior to the expiration of any such extension. As of their respective dates, the
Public Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and
none of the Public Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the
Company included in the Public Reports comply in all material respects with applicable accounting requirements and the rules and regulations
of the Commission with respect thereto as in effect at the time of filing. The interactive data in eXtensible Business Reporting Language
included or incorporated by reference in the Registration Statement fairly presents the information called for in all material respects
and has been prepared in accordance with the Commission&rsquo;s rules and guidelines applicable thereto. No other financial statements
or supporting schedules are required by United States federal securities laws to be included in the Registration Statement, any Prospectus
Supplement or the Prospectus. Such financial statements have been prepared in accordance with International Financial Reporting Standards,
as issued by the International Accounting Standards Board, applied on a consistent basis during the periods involved (&ldquo;<U>IFRS</U>&rdquo;),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by IFRS, and fairly present in all material respects the financial position of the Company and
its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) <U>Material Changes; Undisclosed
Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within the Public Reports,
except as set forth in the Public Reports, (i) there has been no event, occurrence or development that has had or that could reasonably
be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other
than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities
not required to be reflected in the Company&rsquo;s financial statements pursuant to IFRS or disclosed in filings made with the Commission,
(iii) the Company has not altered its method of accounting, and (iv) the Company has not declared or made any dividend or distribution
of cash or other property to its shareholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its share
capital. The Company does not have pending before the Commission any request for confidential treatment of information. Except for the
issuance of the Securities contemplated by this Agreement no event, liability, fact, circumstance, occurrence or development has occurred
or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses,
prospects, properties, operations, assets or financial condition, that would be required to be disclosed by the Company under applicable
securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one (1) Trading Day
prior to the date that this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(j) <U>Litigation</U>. Except
as set forth in the Public Reports, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to
the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before
or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth in the Public Reports (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director
or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities
laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated,
any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission
has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary
under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(k) <U>Labor Relations</U>.
No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could
reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees is a member
of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company nor any of
its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected
to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement
or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued
employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any
of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and
regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the
failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(l) <U>Compliance</U>. Neither
the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with
notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary
received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other
agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation
has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii)
is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all international, foreign, federal, state and local laws relating to taxes, environmental protection, space, land use, occupational health
and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected
to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(m) <U>Environmental Laws</U>.
The Company and its Subsidiaries (i) have complied with and are in compliance with all federal, state, local and foreign laws relating
to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface
strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or
toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating
to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well
as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have
received and maintained all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their
respective businesses; and (iii) have complied with and are in compliance with all terms and conditions of any such permit, license or
approval, except as could not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(n) <U>Regulatory Permits</U>.
The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local
or foreign regulatory authorities necessary to conduct their respective businesses as described in the Public Reports, except where the
failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material Permits</U>&rdquo;),
and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material
Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(o) <U>Title to Assets</U>.
The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable
title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and
clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the
use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal, state
or other taxes, for which appropriate reserves have been made therefor in accordance with IFRS and, the payment of which is neither delinquent
nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under
valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(p) <U>Intellectual Property</U>.
The Company and its Subsidiaries own, or possess adequate rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, know-how (including trade secrets and other unpatented and/or unpatentable proprietary
or confidential information, systems or procedures), copyrights, licenses and other intellectual property rights and similar rights as
are material for the conduct of their respective businesses as currently conducted or as currently proposed to be conducted, in each case,
as described in the Public Reports (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). To the knowledge of the Company,
neither the Company nor its Subsidiaries is infringing, and upon commercialization of any product or service described in the Public Reports,
will not infringe on, any valid claim of any issued patents, copyrights or trademarks of others. The Company has not conducted a &ldquo;freedom
to operate&rdquo; study. None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of,
the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within
two (2) years from the date of this Agreement, except where such action would not reasonably be expected to have a Material Adverse Effect.
Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the Public
Reports, a written notice of a claim or otherwise has any knowledge that the Company&rsquo;s products or planned products as described
in the Public Reports violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have
a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing
infringement by another Person of any of the Intellectual Property Rights. To the knowledge of the Company, no employee, consultant or
independent contractor of the Company or its Subsidiaries is in or has ever been in violation in any material respect of any term of any
employment contract, patent disclosure agreement, invention assignment agreement, non- competition agreement, non-solicitation agreement,
nondisclosure agreement or any restrictive covenant to or with a former employer or independent contractor where the basis of such violation
relates to such employee&rsquo;s employment or independent contractor&rsquo;s engagement with the Company or its Subsidiaries or actions
undertaken while employed or engaged with the Company or its Subsidiaries. The Company and its Subsidiaries have taken reasonable measures
to protect its confidential information and trade secrets of its business and to maintain and safeguard the Company&rsquo;s Intellectual
Property Rights, including the execution of appropriate nondisclosure and confidentiality agreements, and to the Company&rsquo;s knowledge,
no employee of the Company or its Subsidiaries is in or has been in violation of any term of any employment contract, patent disclosure
agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement, or any restrictive
covenant to or with a former employer where the basis of such violation relates to such employee&rsquo;s employment with the Company or
any of its Subsidiaries. All patents and patent applications owned by or licensed to the Company or its Subsidiaries or under which the
Company or its Subsidiaries have rights, to the knowledge of the Company, been duly and properly filed and maintained; to the knowledge
of the Company, there are no material defects in any of the patents or patent applications disclosed in the Public Reports as being owned
by the Company or its Subsidiaries; to the knowledge of the Company, the parties prosecuting such applications have complied with their
duty of candor and disclosure to the United States Patent and Trademark Office (the &ldquo;<U>USPTO</U>&rdquo;) in connection with such
applications; and the Company is not aware of any facts required to be disclosed to the USPTO that were not disclosed to the USPTO and
which would preclude the grant of a patent in connection with any such application or could form the basis of a finding of invalidity
with respect to any patents that have issued with respect to such applications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(q) <U>Insurance</U>. The
Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited
to, directors and officers insurance coverage at least equal to the aggregate Purchase Price. Neither the Company nor any Subsidiary has
any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(r) <U>Transactions with Affiliates
and Employees</U>. Except as set forth in the Public Reports, none of the officers or directors of the Company or any Subsidiary and,
to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the
Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement
providing for the furnishing of services to or by, providing for rental of real or personal property to or from providing for the borrowing
of money from or lending of money to, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge
of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director,
trustee, shareholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for
services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including equity
award agreements under any equity award plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(s) <U>Sarbanes-Oxley; Internal
Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley
Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder
that are effective as of the date hereof and as of the applicable Closing Date. The Company and the Subsidiaries maintain a system of
internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management&rsquo;s
general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity
with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s general
or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals
and appropriate action is taken with respect to any differences. Except as set forth in the Registration Statement, the Company&rsquo;s
internal accounting controls are effective. The Company and the Subsidiaries maintain disclosure controls and procedures, as such term
is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed
by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time
periods specified in Commission rules and forms, and that such information is accumulated and communicated to the Company&rsquo;s management,
including its Executive Chairman, Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.
Under the supervision and with the participation of the Company&rsquo;s management, the Company&rsquo;s certifying officers have evaluated
the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by
the most recently filed Annual Report on From 20-F (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;), and the disclosure controls
and procedures are effective in all material respects to perform the functions for which they were established. The Company presented
in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of
the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been
no significant deficiencies or material weaknesses in the Company&rsquo;s internal control over financial reporting (whether or not remediated)
and no change in the Company&rsquo;s internal control over financial reporting that has materially affected, or is reasonably likely to
materially affect, the Company&rsquo;s internal control over financial reporting, other than as identified in the Registration Statement.
Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the
Exchange Act) that have materially affected, or are reasonably likely to materially affect, the internal control over financial reporting
of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(t) <U>Certain Fees</U>. Except
as set forth in the Prospectus Supplement, no brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company or
any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect
to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with
respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection
with the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(u) [Reserved.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(v) <U>Investment Company</U>.
The Company is not, and immediately after receipt of payment for the Securities will not be, an &ldquo;investment company&rdquo; or an
Affiliate of an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company shall
conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the Investment
Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(w) <U>Registration Rights</U>.
No Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of
the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(x) <U>Listing and Maintenance
Requirements</U>. The Ordinary Shares are registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken
no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Ordinary Shares
under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Ordinary Shares
are or have been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of
such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance
with all such listing and maintenance requirements. The Ordinary Shares are currently eligible for electronic transfer through the Depository
Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company
(or such other established clearing corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(y) <U>Application of Takeover
Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control
share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover
provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state of incorporation
that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising
their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s issuance of the Securities
and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(z) <U>Disclosure</U>. Except
with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information. The Company understands and confirms that the Purchasers
will rely on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or
on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions
contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue statement
of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances
under which they were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date
of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made and
when made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with
respect to the transactions contemplated hereby other than those specifically set forth in <U>Section 3.2</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(aa) <U>No Integrated Offering</U>.
Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in <U>Section 3.2</U>, neither the Company, nor
any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security
or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with
prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market on which any of the
securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(bb) <U>Solvency</U>. Based
on the consolidated financial condition of the Company as of the applicable Closing Date, after giving effect to the receipt by the Company
of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds the amount
that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known contingent
liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its business as
now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the
business conducted by the Company, consolidated and projected capital requirements and capital availability thereof and (iii) the current
cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into
account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts
are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account
the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances
which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction
within one year from the applicable Closing Date. The Public Reports set forth as of the date hereof all outstanding secured and unsecured
Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement,
&ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade
accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect
of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the
notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary
course of business; and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in
accordance with IFRS. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(cc) <U>Tax Status</U>. Except
for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the
Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and franchise
tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental
assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii)
has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to
which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority
of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(dd) [Reserved.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ee) <U>Foreign Corrupt Practices</U>.
Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf
of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other
unlawful expenses related to foreign or domestic political activity, (ii) made, offered, promised or authorized any unlawful payment to
foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds,
(iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which
the Company is aware) which is in violation of law or (iv) violated in any material respect any provision of FCPA, or any applicable law
or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions,
or committed an offence under the Bribery Act of 2010 of the United Kingdom, or any other anti-bribery or anti- corruption law applicable
to the Company and/or its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ff) <U>Accountants</U>. The
Company&rsquo;s independent registered public accounting firm is set forth in the Public Reports. To the knowledge and belief of the Company,
such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and the rules of the Public Company Accounting
Oversight Board (&ldquo;<U>PCAOB</U>&rdquo;), (ii) has expressed its opinion with respect to the financial statements included in the
Company&rsquo;s Annual Report for the fiscal year ending December 31, 2024, (iii) is in compliance with the applicable requirements relating
to the qualification of accountants under Rule 2-01 of Regulation S-X under the Act and (iv) a registered public accounting firm as defined
by PCAOB whose registration has not been suspended or revoked and who has not requested such registration to be withdrawn.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(gg) <U>No Disagreements with
Accountants and Lawyers</U>. There are no disagreements of any kind presently existing, or reasonably anticipated by the Company to arise,
between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company is current with respect
to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any of its obligations under
any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(hh) <U>Acknowledgment Regarding
Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely in the
capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company
further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with
respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective
representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental
to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s decision
to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions
contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) <U>[Reserved]</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(jj) <U>Regulation M Compliance</U>.
The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause
or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any
of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities, or (iii)
paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than,
in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(kk) <U>Equity Award Plans</U>.
No equity award granted under the Company&rsquo;s equity award plan has been backdated. The Company has not knowingly granted, and there
is no and has been no Company policy or practice to knowingly grant, equity awards prior to, or otherwise knowingly coordinate the grant
of equity awards with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their
financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ll) <U>No Conflicts with
Sanctions Laws</U>. Neither the Company nor any of its Subsidiaries, directors, officers, or employees, nor, to the knowledge of the Company,
any agent, employee, affiliate or other person associated with or acting on behalf of the Company or any of its Subsidiaries is currently
the subject or the target of any sanctions administered or enforced by the U.S. government, including, without limitation, the Office
of Foreign Assets Control of the U.S. Department of the Treasury (&ldquo;<U>OFAC</U>&rdquo;) and the U.S. Department of State and including,
without limitation, the designation as a &ldquo;specially designated national&rdquo; or &ldquo;blocked person&rdquo;), the United Nations
Security Council, the European Union, His Majesty&rsquo;s Treasury or other relevant sanctions authority (collectively, &ldquo;<U>Sanctions</U>&rdquo;),
nor is the Company or any of its Subsidiaries located, organized or resident in a country or territory that is the subject or target of
Sanctions, including, without limitation, Cuba, Iran, North Korea and Syria (each, a &ldquo;<U>Sanctioned Country</U>&rdquo;); and the
Company will not directly or indirectly use the proceeds of the offering of the Securities hereunder, or lend, contribute or otherwise
make available such proceeds to any subsidiary, joint venture partner or other person or entity (i) to fund or facilitate any activities
of or business with any person that, at the time of such funding or facilitation, is the subject or target of Sanctions, (ii) to fund
or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner that will result in a violation by
any person (including any person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions.
For the past five (5) years, the Company and its Subsidiaries have not knowingly engaged in and are not now knowingly engaged in any dealings
or transactions with any person that at the time of the dealing or transaction is or was the subject or the target of Sanctions or with
any Sanctioned Country.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(mm) [Reserved.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(nn) <U>U.S. Real Property
Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section
897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(oo) <U>Bank Holding Company
Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended
(the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal Reserve</U>&rdquo;).
Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the
outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity
that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises
a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal
Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(pp) <U>Money Laundering</U>.
The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping
and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the applicable money laundering
statutes of all jurisdictions where the Company or any Subsidiary conducts business, the applicable rules and regulations thereunder and
any related or similar rules, regulations or guidelines issued, administered or enforced by any governmental agency (collectively, the
&ldquo;<U>Money Laundering Laws</U>&rdquo;), and no Action or Proceeding by or before any court or governmental agency, authority or body
or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of
the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(qq) [Reserved.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(rr) <U>Other Covered Persons</U>.
The Company is not aware of any person that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers
in connection with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ss) <U>Government Audits;
Trade Controls</U>. To the knowledge of the Company, there are no outstanding allegations of improper activities arising from any government
audit or non-audit review, including without limitation, by the Defense Contract Audit Agency, of the Company or any of its Subsidiaries
or work performed by the Company or any of its Subsidiaries that would, individually or in the aggregate, have a Material Adverse Effect.
In the past five (5) years, the Company and each of its Subsidiaries has been and is in compliance in all material respects with any applicable
United States national customs or export control laws and regulations, including the Export Administration Regulations, the Arms Export
Control Act, and the International Traffic in Arms Regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(tt) <U>Privacy and Data Security
Laws and Regulations</U>. The Company and the Subsidiaries have established and maintain appropriate technical, physical and organizational
measures and security systems and technologies in compliance with all material data security requirements under all applicable laws designed
to protect Company data against accidental or unlawful processing in a manner appropriate to the risks represented by the processing of
such data by the Company and its data processors, in all material respects. The Company and the Subsidiaries have operated and currently
operate their respective businesses in a manner compliant with all applicable foreign, federal, state and local laws and regulations,
all contractual obligations and all Company policies (internal and posted) related to privacy and data security applicable to the Company&rsquo;s
and the Subsidiaries&rsquo; collection, use, handling, transfer, transmission, storage, disclosure and/or disposal of the data of their
respective customers, employees and other third parties (the &ldquo;<U>Privacy and Data Security Laws</U>&rdquo;) and there has been no
non-compliance with such Privacy and Data Security Laws that would be reasonably expected to have, individually or in the aggregate, a
Material Adverse Effect. There has been no loss or unauthorized access, use, modification or breach of security of customer, employee,
third party or other confidential information, including data of the Company and its Subsidiaries, maintained by or on behalf of the Company
and the Subsidiaries, and neither the Company nor any of the Subsidiaries has notified, nor has the current intention or obligation to
notify, any customer, governmental entity or the media of any such event with regard to any material data breach.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2 <U>Representations and
Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date
hereof and as of each Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) <U>Organization; Authority</U>.
Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws
of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power
and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its
obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the
transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability
company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly
executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally
binding obligation of such Purchaser, enforceable against it in accordance with its terms, except (i) as limited by general equitable
principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement
of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief
or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) <U>Own Account</U>. Such
Purchaser is acquiring the Securities as principal for its own account and not with a view to or for distributing or reselling such Securities
or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing
any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement
or understandings with any other persons to distribute or regarding the distribution of such Securities in violation of the Securities
Act or any applicable state securities law (this representation and warranty not limiting such Purchaser&rsquo;s right to sell the Securities
pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is
acquiring the Securities hereunder in the ordinary course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c) <U>Purchaser Status</U>.
At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which it exercise
any Warrants, it will be, either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8),
(a)(9), (a)(12), or (a)(13) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo; as defined in Rule 144A(a)
under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d) <U>Experience of Such
Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in
business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(e) [Reserved].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(f) <U>Access to Information</U>.
Such Purchaser acknowledges that it has had the opportunity to review the Public Reports, Transaction Documents and has been afforded
(i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning
the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information
about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable
it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire
without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company acknowledges and agrees that the representations
contained in this <U>Section 3.2</U> shall not modify, amend or affect such Purchaser&rsquo;s right to rely on the Company&rsquo;s representations
and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other
document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated
hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>ARTICLE
4<BR>
<BR>
OTHER AGREEMENTS OF THE PARTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1 [Reserved.]&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2 <U>Acknowledgment of Dilution</U>.
The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding Ordinary Shares, which dilution
may be substantial under certain market conditions. The Company further acknowledges that its obligations under the Transaction Documents,
including, without limitation, its obligation to issue the Securities pursuant to the Transaction Documents, are unconditional and absolute
and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any claim
the Company may have against any Purchaser and regardless of the dilutive effect that such issuance may have on the ownership of the other
shareholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3 <U>Furnishing of Information;
Public Information</U>. Until the earlier of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired, the Company
covenants to maintain the registration of the Ordinary Shares under Section 12(b) or 12(g) of the Exchange Act and to timely file (or
obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after
the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4 <U>Integration</U>. The
Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section
2 of the Securities Act) in a manner that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations
of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction unless shareholder
approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5 <U>Securities Laws Disclosure;
Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated
hereby, and (b) file a Report of Foreign Private Issuer on Form 6-K, including the Transaction Documents as exhibits thereto, with the
Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company represents to
the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company
or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation,
the Placement Agent, in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance
of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement,
whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, employees, Affiliates
or agents, including, without limitation, the Placement Agent, on the one hand, and any of the Purchasers or any of their Affiliates on
the other hand, shall terminate. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in
effecting transactions in securities of the Company. The Company and each Purchaser shall consult with each other in issuing any other
press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press
release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any
Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably
be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other
party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not publicly disclose
the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading
Market, without the prior written consent of such Purchaser, except (a) as required by federal securities law in connection with the filing
of final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations,
in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b) and reasonably
cooperate with such Purchaser regarding such disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6 <U>Shareholder Rights
Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is
an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7 <U>Non-Public Information</U>.
Except with respect to the material pricing terms of the transactions contemplated by the Transaction Documents, which shall be disclosed
pursuant to <U>Section 4.5</U>, the Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide
any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes, material
non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such information and agreed
in writing with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be relying
on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company, any of its Subsidiaries,
or any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public information to a Purchaser
without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality
to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without
limitation, the Placement Agent, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, employees,
Affiliates or agents, including, without limitation, the Placement Agent, not to trade on the basis of, such material, non- public information,
provided that the Purchaser shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction
Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously
file such notice with the Commission pursuant to a Report of Foreign Private Issuer on Form 6-K. The Company understands and confirms
that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8 <U>Use of Proceeds</U>.
The Company shall use the net proceeds from the sale of the Securities hereunder for working capital and other general corporate purposes
and shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s debt (other than payment of trade payables
in the ordinary course of the Company&rsquo;s business and prior practices), (b) for the redemption of any Ordinary Shares or Ordinary
Share Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9 <U>Indemnification of
Purchasers</U>. Subject to the provisions of this <U>Section 4.9</U>, the Company will indemnify and hold each Purchaser and its directors,
officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning
of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners
or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such
title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all losses,
liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court
costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of,
arising out of, in connection with or relating to (a) any breach of any of the representations, warranties, covenants or agreements made
by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any
capacity, or any of them or their respective Affiliates, by any shareholder of the Company who is not an Affiliate of such Purchaser Party,
with respect to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material
breach of such Purchaser Party&rsquo;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings
such Purchaser Party may have with any such shareholder or any violations by such Purchaser Party of state or federal securities laws
or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct).
For the avoidance of doubt, the Company will reimburse each Purchaser Party for all reasonable expenses (including reasonable fees and
expenses of counsel) as they are incurred in connection with investigating, preparing, pursuing or defending any such action whether or
not pending or threatened and whether or not any Purchaser Party is a party, provided that the Company will not be responsible for any
losses, claims, damages or liabilities (or expense relating thereto) that have resulted from the bad faith, gross negligence or intentional
misconduct of any Purchaser Party. If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought
pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to
assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have
the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel
shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized
by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel
or (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position
of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses
of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement
by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed;
or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s breach
of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction
Documents. The Company will not, without the Purchaser Party&rsquo;s prior written consent, settle, compromise, consent to the entry of
any judgment in or otherwise seek to terminate any action, claim, suit or proceeding in respect of which indemnification may be sought
hereunder (whether or not any Purchaser Party is a party thereto) unless such settlement, compromise, consent or termination includes
a release of each Purchaser Party from any liabilities asserted against such Purchaser Party arising out of such action, claim, suit or
proceeding. If the indemnification provided for in this Section is judicially determined to be unavailable to a Purchaser Party in respect
of any losses, claims, damages or liabilities referred to herein, then, in lieu of indemnifying such Purchaser Party hereunder, the Company
shall contribute to the amount paid or payable by such Purchaser Party as a result of such losses, claims, damages or liabilities (and
expense relating thereto): (i) in such proportion as is appropriate to reflect the relative benefits to the applicable Purchaser Party,
on the one hand, and the Company, on the other hand, of the transaction or (ii) if the allocation provided by clause (i) above is not
available, in such proportion as is appropriate to reflect not only the relative benefits referred to in such clause (i) but also the
relative fault of each of the applicable Purchaser Party and the Company, as well as any other relevant equitable considerations; provided,
however, that in no event shall any Purchaser Party&rsquo;s aggregate contribution to the amount paid or payable exceed such Purchaser&rsquo;s
aggregate Purchase Price. Assuming that the Company has fully satisfied or agreed to satisfy the amount of its obligations provided for
herein to the Purchaser Party, and have agreed that the Purchaser Party shall have no further liabilities in connection therewith, then
the Company may take control of any pending action or litigation in order to reduce the expenses in connection therewith. The indemnification
and contribution required by this <U>Section 4.9</U> shall be made by periodic payments of the amount thereof during the course of the
investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition
to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject
to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10 <U>Reservation of Ordinary
Shares</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times,
free of preemptive rights, a number of its duly authorized and unissued Ordinary Shares equal to 250% of the maximum number of (i) Shares
issuable pursuant to this Agreement and (ii) Warrant Shares issuable pursuant to any exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11 <U>Listing of Ordinary
Shares</U>. The Company shall: (i) in the time and manner required by the principal Trading Market, prepare and file with such Trading
Market an additional shares listing application covering a number of Ordinary Shares on the date of such application for the Shares and
Warrant Shares, (ii) take all steps necessary to cause such Ordinary Shares to be approved for listing or quotation on such Trading Market,
(iii) provide to the Purchasers evidence of such listing or quotation and (iv) maintain the listing or quotation of such Ordinary Shares
on such date on such Trading Market or another Trading Market. The Company further agrees, if the Company applies to have the Ordinary
Shares traded on any other Trading Market, it will then include in such application all of the Shares and Warrant Shares, and will take
such other action as is necessary to cause all of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as
promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its Ordinary Shares
on a Trading Market and will comply in all respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws
or rules of the Trading Market. The Company agrees to maintain the eligibility of the Ordinary Shares for electronic transfer through
the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to
the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12 <U>Additional Issuance
of Securities</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) The Company agrees that
for the period commencing on the date hereof and ending on the earlier of the ninetieth (90<SUP>th</SUP>) day after the most recent Closing
Date and the date upon which all Warrants have been exercised (the &ldquo;<U>Restricted Period</U>&rdquo;), the Company shall not (i)
directly or indirectly issue, offer, sell, grant any option, restricted stock unit or right to purchase, or otherwise dispose of (or announce
any issuance, offer, sale, grant of any option or right to purchase or other disposition of) any Ordinary Shares or any Ordinary Share
Equivalents or (ii) file any new registration statement or amendment or supplement thereto, other than the Prospectus Supplement, amendments
or supplements to registration statements filed prior to the date hereof, or registration statements on Form S-8 in connection with any
employee benefit plan. Notwithstanding the foregoing, this <U>Section 4.12(a)</U> shall not apply in respect of the issuance of (collectively,
the &ldquo;<U>Exempt Issuances</U>&rdquo;) (i) Ordinary Shares or standard options to purchase or restricted stock units to acquire Ordinary
Shares to directors, officers or employees of the Company in their capacity as such pursuant to an Approved Stock Plan; (ii) Ordinary
Shares issued upon the conversion or exercise of Convertible Securities (other than standard equity awards to purchase Ordinary Shares
issued pursuant to an Approved Stock Plan that are covered by clause (i) above) issued prior to the date hereof, provided that the conversion,
exercise or other method of issuance (as the case may be) of any such Convertible Security is made solely pursuant to the conversion,
exercise or other method of issuance (as the case may be) provisions of such Convertible Security that were in effect on the date immediately
prior to the date of this Agreement, the conversion, exercise or issuance price of any such Convertible Securities (other than standard
equity awards to purchase Ordinary Shares issued pursuant to an Approved Stock Plan that are covered by clause (i) above) is not lowered,
other than as identified in the Registration Statement, none of such Convertible Securities (other than standard equity awards to purchase
Ordinary Shares issued pursuant to an Approved Stock Plan that are covered by clause (i) above) are amended to increase the number of
shares issuable thereunder and none of the terms or conditions of any such Convertible Securities (other than standard equity awards to
purchase Ordinary Shares issued pursuant to an Approved Stock Plan that are covered by clause (i) above) are otherwise materially changed
in any manner that adversely affects any Purchaser; (iii) the Shares, and (iv) Ordinary Shares or Convertible Securities issued in connection
with acquisitions or strategic transactions or institutional investments or partnerships.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b) From the date hereof until
the earlier of six (6) months from the most recent Closing Date and the date as of which the Purchasers no longer hold Securities, the
Company shall be prohibited from entering into or agreeing to enter into a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo;
means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or
exercisable for, or include the right to receive, additional Ordinary Shares either (A) at a conversion price, exercise price or exchange
rate or other price that is based upon, and/or varies with, the trading prices of or quotations for the Ordinary Shares at any time after
the initial issuance of such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being reset
at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events
directly or indirectly related to the business of the Company or the market for the Ordinary Shares or (ii) enters into, or effects a
transaction under, any agreement, including, but not limited to, an equity line of credit or an &ldquo;at the market offering&rdquo;,
whereby the Company may issue securities at a future determined price, regardless of whether shares pursuant to such agreement have actually
been issued and regardless of whether such agreement is subsequently canceled; provided that Exempt Issuances as provided in <U>Section
4.12(a)</U> above shall not be considered Variable Rate Transactions. Any Purchaser shall be entitled to obtain injunctive relief against
the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13 <U>Equal Treatment of
Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend
or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered to
all of the parties to such Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each
Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class
and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting
of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14 <U>Certain Transactions
and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it, nor any Affiliate
acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales, of any of the
Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in <U>Section 4.5</U>.
Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by
this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in <U>Section 4.5</U>, such Purchaser
will maintain the confidentiality of the existence and terms of this transaction and the information included in the [Disclosure Schedules].
Notwithstanding the foregoing, and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges
and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions
in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant
to the initial press release as described in <U>Section 4.5</U>, (ii) no Purchaser shall be restricted or prohibited from effecting any
transactions in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in <U>Section 4.5</U> and
(iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its
Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agent, including , without limitation, the Placement
Agent after the issuance of the initial press release as described in <U>Section 4.5</U>. Notwithstanding the foregoing, in the case of
a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s
assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio
manager that made the investment decision to purchase the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.15 <U>Exercise Procedures</U>.
The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of the Purchasers in order to
exercise the Warrants. No additional legal opinion, other information or instructions shall be required of the Purchasers to exercise
their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall any medallion
guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to exercise the Warrants. The
Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms, conditions and time periods
set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.16 <U>Lock-Up Agreements</U>.
The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except to extend the term of the
lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If any party to a Lock-Up Agreement
breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek specific performance of the terms
of such Lock-Up Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.17</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a) <U>Maintaining the Registration
Statement</U>. If all or any portion of a Warrant is exercised at a time when there is an effective registration statement to cover the
issuance or resale of the Warrant Shares or if the Warrant is exercised via cashless exercise, the Warrant Shares issued pursuant to any
such exercise shall be issued free of all legends. If at any time following the date hereof the Registration Statement (or any subsequent
registration statement registering the sale of the Warrant Shares) is not effective or is not otherwise available for the sale of the
Warrant Shares, the Company shall immediately notify the holders of the Warrants in writing that such registration statement is not then
effective and thereafter shall promptly notify such holders when the registration statement is effective again and available for the sale
of the Warrant Shares (it being understood and agreed that the foregoing shall not limit the ability of the Company to issue, or any Purchaser
to sell, any of the Warrant Shares in compliance with applicable federal and state securities laws). The Company shall use best efforts
to keep a registration statement registering the issuance of the Warrant Shares effective during the term of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>ARTICLE
5<BR>
<BR>
MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1 <U>Termination</U>. This
Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if a Closing has not been consummated
on or before the fifth (5th) Trading Day following the date hereof, provided, however, that no such termination will affect the right
of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2 <U>Fees and Expenses</U>.
The Company shall deliver to each Purchaser, prior to each Closing, a completed and executed copy of a Closing Statement, attached hereto
as Annex A. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of
its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without
limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any conversion or exercise
notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the
Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3 <U>Entire Agreement</U>.
The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement, contain the
entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings,
oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4 <U>Notices</U>. Any and
all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed
given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email attachment
at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day,
(b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email attachment at the email
address set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time)
on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier
service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications
shall be as set forth on the signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction Document
constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously
with the delivery of such notice file such notice with the Commission pursuant to a Report of Foreign Private Issuer on Form 6-K. The
Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5 <U>Amendments; Waivers</U>.
No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of
an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Securities based on such Purchasers&rsquo;
aggregate Purchase Prices hereunder (or, prior to a Closing, the Company and each Purchaser) or, in the case of a waiver, by the party
against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately
and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers)
shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed
to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.
Any amendment effected in accordance with this <U>Section 5.5</U> shall be binding upon each Purchaser and holder of Securities and the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6 <U>Headings</U>. The headings
herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7 <U>Successors and Assigns</U>.
This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may
not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger).
Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities,
provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction
Documents that apply to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8 <U>No Third Party Beneficiaries</U>.
The Placement Agent shall be the third party beneficiary of the representations and warranties of the Company in <U>Section 3.1</U> and
the representations and warranties of the Purchasers in <U>Section 3.2</U>.This Agreement is intended for the benefit of the parties hereto
and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any
other Person, except as otherwise set forth in <U>Section 4.9</U> and this <U>Section 5.8</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9 <U>Governing Law</U>.
This Agreement and each of the Transaction Documents will be deemed to have been made and delivered in the State of Delaware, and the
binding provisions of this Agreement, the Transaction Documents, and the transactions contemplated hereby, will be governed as to validity,
interpretation, construction, effect and in all other respects by the internal laws of the State of Delaware, without regard to the conflict
of laws principles thereof. Each of the parties hereto: (i) agrees that any legal suit, Action or Proceeding arising out of or relating
to Agreement and/or the transactions contemplated hereby will be instituted exclusively in the courts located in the City of New York,
County of New York, State of New York, (ii) irrevocably waives any objection which it may have or hereafter to the venue of any such suit,
action or proceeding, (iii) irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such action or proceeding is improper or is an inconvenient venue for such Action
or Proceeding, and (iv) irrevocably consents to the exclusive jurisdiction of the state courts located in the City of New York, County
of New York, State of New York, in any such suit, action or proceeding, waiving any, and consenting not to assert any, basis for seeking
transfer or removal of such action to any other court, whether federal or state, unless the New York court in which such action or proceeding
was commenced first declines jurisdiction. Each party hereby irrevocably waives personal service of process and consents to process being
served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence
of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve
process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction
Documents, then, in addition to the obligations of the Company under <U>Section 4.9</U>, the prevailing party in such Action or Proceeding
shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the
investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10 <U>Survival</U>. The
representations and warranties contained herein shall survive each Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.11 <U>Execution</U>. This
Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a &ldquo;.pdf&rdquo;
format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.12 <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.13 <U>Rescission and Withdrawal
Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction
Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not
timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion
from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to
its future actions and rights; provided, however, that, in the case of a rescission of an exercise of a Warrant, the applicable Purchaser
shall be required to return any Ordinary Shares subject to any such rescinded exercise notice concurrently with the return to such Purchaser
of the aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser&rsquo;s right to acquire such
shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.14 <U>Replacement of Securities</U>.
If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to
be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor,
a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction.
The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including
customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.15 <U>Remedies</U>. In addition
to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and
the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not
be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would
be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.16 <U>Payment Set Aside</U>.
To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces
or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are
subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded,
repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any
bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation
or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not
been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.17 <U>Independent Nature
of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and not
joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through
the legal counsel of the Placement Agent. The legal counsel of the Placement Agent does not represent any of the Purchasers and only represents
the Placement Agent. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience
of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that
each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and
not between the Company and the Purchasers collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.18 <U>Liquidated Damages</U>.
The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing
obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding
the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall
have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.19 <U>Saturdays, Sundays,
Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.20 <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and Ordinary Shares in any Transaction Document shall be subject to adjustment for reverse and forward share splits, share
dividends, share combinations and other similar transactions of the Ordinary Shares that occur after the date of this Agreement. For the
avoidance of doubt, the average daily trading volume figures expressed in dollar amounts shall not be adjusted for reverse or forward
share splits or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.21 <U>WAIVER OF JURY TRIAL</U>.
IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY,
TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL
BY JURY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><B>VCI GLOBAL LIMITED</B></TD>
    <TD><U>Address for Notice</U>:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><U>Email</U>: </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">Name:&nbsp;</TD>
    <TD STYLE="width: 31%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy to (which shall not constitute notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[&nbsp;&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK<BR>
SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO VCI GLOBAL LIMITED</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Signature of Authorized Signatory of Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address of Authorized Signatory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Address for Delivery of Securities to Purchaser
(if not same as address for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Purchase Price:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Initial Closing: $5,000,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">First Tranche Closing: $5,000,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Second Tranche Closing: $5,000,000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">EIN Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CLOSING STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the attached Securities Purchase Agreement,
dated as of the date hereto, the purchasers shall purchase Shares from VCI Global Limited, a company incorporated under the BVI Business
Companies Act, 2004 (as amended) of the British Virgin Islands (the &ldquo;<U>Company</U>&rdquo;), at a price per share of <B>$[____]</B>.
All funds will be wired into an account maintained by the Company. All funds will be disbursed in accordance with this Closing Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Disbursement Date:</B> [____], 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>I. <U>PURCHASE PRICE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><B>Gross Proceeds
to be Received $[___]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>WIRE INSTRUCTIONS</U>:<BR>
Please see attached.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Acknowledged and agreed to<BR>
this [___] day of [____], 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF COMMON A WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF COMMON B WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>




<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF PRE-FUNDED WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT D</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF LOCK-UP AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="text-align: center; margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="text-align: center; font-size: 1pt; border-top: black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>8
<FILENAME>ea027358601ex10-2_vciglobal.htm
<DESCRIPTION>FORM OF PLACEMENT AGENCY AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PLACEMENT AGENCY AGREEMENT
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">January 16, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B><U>PERSONAL AND CONFIDENTIAL</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">VCI Global Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">Suite 33.03, of
Level 33, Menara Exchange 106</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">Lingkaran TRX,
Tun Razak Exchange</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">55188 Kuala Lumpur,
Malaysia</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">Attention: Victor
Hoo, Director, Executive Chairman and Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">Dear Mr. Hoo:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">This agreement
(the &ldquo;<B>Agreement</B>&rdquo;) constitutes the agreement between E.F. Hutton &amp; Co. (the &ldquo;<B>Placement Agent</B>&rdquo;)
on one hand, and VCI Global Limited, a company incorporated under the laws of Delaware (the &ldquo;<B>Company</B>&rdquo; and each of the
Company and the Placement Agent, a &ldquo;<B>Party</B>&rdquo; and, together, the &ldquo;<B>Parties</B>&rdquo;) on the other hand, pursuant
to which the Placement Agent shall serve as the exclusive placement agent for the Company, on a &ldquo;reasonable best efforts&rdquo;
basis, in connection with the proposed placement (the &ldquo;<B>Placement</B>&rdquo;) of: 1) the Company&rsquo;s Ordinary Shares, no par
value (&ldquo;<B>Ordinary Share&rdquo;)</B> (or Pre-Funded Warrants in lieu of Ordinary Shares); 2) warrants to purchase 7,381,163 Ordinary
Shares, exercisable for a period 5 years (&ldquo;<B>Warrant A</B>&rdquo;), subject to adjustment as provided in the Warrant A at the Exercise
Price (as defined in Warrant A); and (B) warrants to purchase 7,381,163 Ordinary Shares, exercisable for 180 days, (&ldquo;<B>Warrant
B</B>&rdquo;), at the Exercise Price (as defined in Warrant B) (Warrant A and Warrant each a &ldquo;<B>Warrant</B>&rdquo; and collectively
with the Ordinary Shares, Pre-Funded Warrants and Ordinary Shares exercisable under the Warrants, the &ldquo;<B>Securities</B>&rdquo;).
The terms of the Placement and the Securities shall be mutually agreed upon by the Company and the purchasers (each, a &ldquo;<B>Purchaser</B>&rdquo;
and collectively, the &ldquo;<B>Purchasers</B>&rdquo;) and nothing herein constitutes that the Placement Agent would have the power or
authority to bind the Company or any Purchaser or an obligation for the Company to issue any Securities or complete the Placement. This
Agreement and the documents executed and delivered by the Company and the Purchasers in connection with the Placement, are collectively
referred to as the &ldquo;<B>Transaction Documents</B>.&rdquo; The closing of the Placement shall be referred to herein as the &ldquo;<B>Closing</B>&rdquo;
and the date of the Closing shall be referred to herein as the &ldquo;<B>Closing Date</B>.&rdquo; The Company expressly acknowledges and
agrees that the Placement Agent&rsquo;s obligations hereunder are on a reasonable best efforts basis only and that the execution of this
Agreement does not constitute a commitment by the Placement Agent to purchase the Securities and does not ensure the successful placement
of the Securities or any portion thereof or the success of the Placement Agent with respect to securing any other financing on behalf
of the Company. With the prior written consent of the Company, the Placement Agent may retain other brokers or dealers to act as sub-agents
or selected-dealers on its behalf in connection with the Placement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.5pt; text-align: justify; text-indent: -0.5pt">The Company hereby
confirms its agreement with the Placement Agent as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: -0.5pt"><B>Section 1. Agreement to Act
as Placement Agent</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) On
the basis of the representations, warranties, and agreements of the Company herein contained, and subject to all the terms and conditions
of this Agreement, the Placement Agent shall be the exclusive placement agent in connection with the offering and sale by the Company
of Warrants, with the terms of such offering (the &ldquo;<B>Offering</B>&rdquo;) to be subject to market conditions and negotiations between
the Company, the Placement Agent, and the prospective Purchasers. The Placement Agent will act on a reasonable best efforts basis and
the Company agrees and acknowledges that there is no guarantee of the successful placement of the Securities, or any portion thereof,
in the prospective Offering. Under no circumstances will the Placement Agent or any of its &ldquo;Affiliates&rdquo; (as defined below)
be obligated to underwrite or purchase any of the Securities for its own account or otherwise provide any financing. The Placement Agent
shall act solely as the Company&rsquo;s agent and not as principal. The Placement Agent shall have no authority to bind the Company with
respect to any prospective offer to purchase Securities and the Company shall have the sole right to accept offers to purchase Securities
and may reject any such offer, in whole or in part. Subject to the terms and conditions hereof, payment of the purchase price for, and
delivery of, the Securities shall be made at the Closing of the Offering as provided in the Purchase Agreements. As compensation for services
rendered, on each Closing Date, the Company shall pay to the Placement Agent the fees and expenses set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(i) A cash fee equal to
seven percent (7.0%) of the aggregate gross proceeds raised in the Offering (the &ldquo;<B>Cash Fee</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The foregoing fees
are due and payable to the Placement Agent immediately upon the closing of the Offering and shall be disbursed to the Placement Agent
simultaneously with the delivery of the proceeds of the Offering to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">For the avoidance
of doubt, in the event the Company proceeds with a financing transaction outside of the Placement Agent with an Introduced Party during
the term of this Agreement, the Placement Agent shall be entitled to receive full commissions at the percentage stated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The
term of the Placement Agent&rsquo;s exclusive engagement will begin on date of this Agreement and end upon the earlier of 7 days after
the date of this Agreement or the date of the Closing unless extended or earlier terminated by the Parties in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything to
the contrary contained herein, the provisions concerning the payment of fees, reimbursement of expenses, tail, indemnification and contribution,
confidentiality, conflicts, independent contractor, and waiver of the right to trial by jury will survive any expiration or termination
of this Agreement. Notwithstanding anything to the contrary contained herein, the Company has the right to terminate this Agreement for
cause in compliance with FINRA Rule 5110(g)(5)(B)(i). The exercise of such right of termination for cause eliminates the Company&rsquo;s
obligations with respect to the provisions relating to the tail fees. Notwithstanding anything to the contrary contained in this Agreement,
in the event that the Offering pursuant to this Agreement shall not be carried out for any reason whatsoever during the Term, the Company
shall be obligated to pay to the Placement Agent its actual and accountable out-of-pocket expenses related to the Offering (including
the fees and disbursements of the Placement Agents; legal counsel) as set forth in Section 7 hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nothing in this Agreement
shall be construed to limit the ability of the Placement Agent or its Affiliates to pursue, investigate, analyze, invest in, or engage
in investment banking, financial advisory, or any other business relationship with Persons (as defined below) other than the Company.
As used herein (i) &ldquo;Persons&rdquo; means an individual or corporation, partnership, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof), or other entity of any
kind and (ii) &ldquo;<B>Affiliate</B>&rdquo; means any Person that, directly or indirectly through one or more intermediaries, controls
or is controlled by or is under common control with a Person as such terms are used in and construed under Rule 405 under the Securities
Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;). The Company shall furnish, or cause to be furnished, to the Placement
Agent all information requested by the Placement Agent for the purpose of rendering services hereunder and conducting due diligence (all
such information being the &ldquo;<B>Information</B>&rdquo;). In addition, the Company agrees to make available to the Placement Agent
upon request from time to time the officers, directors, accountants, counsel and other advisors of the Company. The Company recognizes
and confirms that the Placement Agent (a) will use and rely upon the Information, including any documents provided to investors in each
Offering (the &ldquo;<B>Offering Documents</B>&rdquo;) and upon information available from generally recognized public sources in performing
the services contemplated by this Agreement without having independently verified the same; (b) does not assume responsibility for the
accuracy or completeness of the Offering Documents or the Information and such other information; and (c) will not make an appraisal of
any of the assets or liabilities of the Company. Upon reasonable request, the Company will meet with the Placement Agent or its representatives
to discuss all information relevant for disclosure in the Offering Documents and will cooperate in any investigation undertaken by the
Placement Agent thereof, including any document included or incorporated by reference therein. At the request of the Placement Agent,
the Company shall deliver such legal letters, including, without limitation, negative assurance letters), opinions, comfort letters, officers&rsquo;
and secretary certificates, and good standing certificates, all in a form and substance reasonably satisfactory to the Placement Agent
and its counsel as is customary for the Offering. The Placement Agent shall be a third-party beneficiary of any representations, warranties,
covenants, closing conditions and closing deliverables made by the Company in any Offering Documents, including representations, warranties,
covenants, closing conditions and closing deliverables made to any investor in the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) The
Closing of the Offering shall be conducted pursuant to the Purchase Agreement via wire transfer and such Securities shall be registered
in such name or names and shall be in such denominations. The Placement Agent shall not have any independent obligation to verify the
accuracy or completeness of any information contained in Purchase Agreement or other subscription documents for the Offering (the &ldquo;<B>Subscription
Documents</B>&rdquo;) or the authenticity, sufficiency, or validity of any check delivered by any prospective Investor in payment for
the Securities, nor shall the Placement Agent incur any liability with respect to any such verification or failure to verify.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: -0.5pt"><B>Section 2. Representations,
Warranties, and Covenants of the Company</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The
Placement Agent shall be the third-party beneficiary of the representations and warranties of the Company to the Investors in the Purchase
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) Any
certificate signed by an officer of the Company and delivered to the Placement Agent or to counsel for the Placement Agent shall be deemed
to be a representation and warranty by the Company to the Placement Agent as to the matters set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) The Company
acknowledges that the Placement Agent will rely upon the accuracy and truthfulness of the foregoing representations and warranties
and hereby consents to such reliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) In
connection with the Offering of the Securities, the Company has not published, distributed, issued, posted, or otherwise used or employed
and shall not publish, distribute, issue, post, or otherwise use or employ (i) any form of general solicitation or advertising within
the meaning of Rule 502 under the Securities Act (&ldquo;<B>General Solicitation</B>&rdquo;) other than with the prior written consent
of the Placement Agent, or (ii) any General Solicitation that constitutes a written communication within the meaning of Rule 405 under
the Securities Act (&ldquo;<B>Written General Solicitation Material</B>&rdquo;). Each individual Written General Solicitation Material,
if any, does not and will not conflict with the information contained in the SEC Reports (as defined below), and does not and will not,
contain an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light
of the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) The
Company will furnish a copy of any amendment or supplement to a Written General Solicitation Material to the Placement Agent and counsel
for the Placement Agent and obtain the Placement Agent&rsquo;s written consent prior to any publication, distribution, issuance, posting,
or other use or employment of any such amendment or supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) If
at any time after the date hereof and prior to a Closing, any event shall have occurred as a result of which any Written General Solicitation
Material, as then amended or supplemented, would conflict with the information in the Company&rsquo;s reports, schedules, forms, statements,
and other documents required to be filed by the Company under the Securities Act and the Securities Exchange Act of 1934, as amended (the
&ldquo;<B>Exchange Act</B>&rdquo;) (collectively, the &ldquo;<B>SEC Reports</B>&rdquo;), or would include an untrue statement of a material
fact or omit to state any material fact necessary in order to make the statements therein or in the SEC Reports, in light of the circumstances
under which they were made, not misleading, or, if for any other reason it shall become necessary to amend or supplement any Written General
Solicitation Material, the Company shall promptly notify the Placement Agent and upon its request, shall use its best efforts to ensure
that all purchasers or expected purchasers of the Securities receive corrected Written General Solicitation Materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) The
Company represents, warrants, and agrees that all sales of the Securities shall be made only to (i) an &ldquo;accredited investor&rdquo;
as defined in 501(a)(1), (a)(2), (a)(3), (a)(5), (a)(6), (a)(7), (a)(8), (a)(9), (a)(10), (a)(11), (a)(12), or (a)(13) under the Securities
Act, as applicable, or (ii), a Non U.S. Person as defined under Regulation S promulgated under the Securities Act. Notwithstanding the
foregoing, the Placement Agent shall use commercially reasonable efforts to assist its customers to complete the Subscription Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) None
of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating
in the Offering, any beneficial owner of twenty percent (20%) or more of the Company&rsquo;s outstanding voting equity securities, calculated
on the basis of voting power, any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company in
any capacity at the time of sale nor any compensated solicitor or any director, executive officer, or other officer of the compensated
solicitor participating in the Offering (each, an &ldquo;<B>Issuer Covered Person</B>&rdquo; and, together, &ldquo;<B>Issuer Covered Persons</B>&rdquo;)
is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a
&ldquo;<B>Disqualification Event</B>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has
exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied,
to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Placement Agent a copy of any disclosures
provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) The
Company will notify the Placement Agent in writing, prior to the Closing Date of (i) any Disqualification Event relating to any Issuer
Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event relating to any Issuer Covered
Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement, including, without limitation, the issuance of the Securities, and otherwise to carry out its obligations hereunder
and thereunder. The execution and delivery of this Agreement and each of the Securities by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Board of Directors of the Company (&ldquo;<B>Board</B>&rdquo;), or the Company&rsquo;s shareholders
in connection herewith or therewith. This Agreement and any other applicable agreement, has been (or upon delivery will have been) duly
executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation
of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and
applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of general application affecting enforcement of creditors&rsquo;
rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable
remedies, and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) <U>Issuance
of the Securities</U>. The Securities will be duly authorized, validly issued, fully paid, and non- assessable upon payment of the purchase
price therefor to the Company in accordance with the terms of the Purchase Agreement, and will have the applicable rights, preferences,
and priorities set forth in the Company&rsquo;s Memorandum Articles of Association (including the Certificate of Incorporation and any
other charter documents of the Company) (as the same may be amended or restated from time to time, collectively, the &ldquo;Charter&rdquo;).
The holders of the Securities will not be subject to personal liability solely by reason of being such holders. The Securities have been
duly authorized and, when issued in accordance with this Agreement will be duly and validly issued, fully paid and nonassessable, free
and clear of all liens, charges, pledges, security interests, encumbrances, or other restrictions imposed by the Company other than restrictions
provided for in this Agreement and in the Securities Purchase Agreement. The Company has reserved from its duly authorized capital stock
the maximum number of shares of Common Stock exercisable pursuant to the Warrants. The issuance of the Securities are not subject to any
preemptive rights, rights of first refusal, or other similar rights of any securityholder of the Company. No holder of the Securities
will be subject to personal liability solely by reason of being such a holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) Each
of the representations and warranties (together with any related disclosure schedules thereto) made by the Company to the Investors in
the applicable Transaction Documents is hereby incorporated herein by reference, as though fully restated herein, and is hereby made to,
and in favor of, the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt"><B>Section 3.
Delivery and Payment</B>. The Closing shall occur at the offices of Sichenzia Ross Ference Carmel LLP (&ldquo;<B>Company Counsel</B>&rdquo;)
(or at such other place as shall be agreed upon by the Parties, including via remote transmission of Closing documentation and the Transaction
Documents). Subject to the terms and conditions hereof, at the Closing, payment of the purchase price for the Securities sold on the Closing
Date shall be made by federal funds via wire transfer, and such Securities shall be registered in such name or names and shall be in such
denominations, as the Placement Agent may request at least one business day before the time of purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Deliveries of the documents
with respect to the purchase of the Securities, if any, shall be made at the offices of Company Counsel. All actions taken at the Closing
shall be deemed to have occurred simultaneously. The Company and the Placement Agent may agree to conduct one or more Closings of the
Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt"><B>Section 4.
Closing</B>. The obligations of the Placement Agent and the closing of the sale of the Warrants (the &ldquo;Placement Agent Securities&rdquo;)
are subject to the accuracy, when made and on the Closing Date, of the representations and warranties on the part the Company contained
herein and in the Purchase Agreement, to the performance by the Company of its obligations hereunder and under the Purchase Agreement,
and to each of the following additional conditions, any of which may be waived in writing by the Placement Agent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify"><U>Corporate Proceedings and Legal Opinion.</U> All corporate
proceedings and other legal matters incident to the authorization, execution, and delivery of this Agreement, the Purchase Agreement,
(as filed with the Secretary of State of Delaware), and the transactions contemplated hereby shall be completed or resolved in a manner
reasonably satisfactory to the Placement Agent. The Placement Agent shall have received a legal opinion and a negative assurance letter
from Company Counsel, addressed to the Placement Agent and dated as of the Closing Date, in form and substance reasonably satisfactory
to the Placement Agent<B>.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify"><U>No Material Adverse Change.</U> Subsequent to the execution
and delivery of this Agreement and prior to the Closing Date, in the Placement Agent&rsquo;s sole judgment after consultation with the
Company, there shall not have occurred any material adverse change or development involving a prospective material adverse change in
the condition or the business activities, financial or otherwise, of the Company since the filing of its Condensed Consolidated Interim
Financial Statements (Unaudited) of the Company as of June 30, 2025 and for the six-month periods ended June 30, 2025 and 2024, (a &ldquo;<B>Material
Adverse Change</B>&rdquo;)).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: justify"><U>Officer&rsquo;s and Secretary&rsquo;s Certificates.</U> The
Placement Agent has received customary certificates of the Company&rsquo;s Chief Executive Officer (the &ldquo;<B>Officer&rsquo;s Certificate</B>&rdquo;)
as to the accuracy of the representations and warranties contained in the Purchase Agreement, and a certificate of the Company&rsquo;s
Secretary (or other suitable executive officer) (the &ldquo;<B>Secretary&rsquo;s Certificate</B>&rdquo;) certifying (i) that the Company&rsquo;s
organizational documents are true and complete, have not been modified and are in full force and effect; (ii) that the resolutions of
the Company&rsquo;s Board of Directors (or any authorized committee thereof) relating to the Placement are in full force and effect and
have not been modified; and (iii) as to the incumbency of the officers of the Company. Each of the Officer&rsquo;s Certificate and Secretary&rsquo;s
Certificate must be dated as of the Closing Date, and all documents referenced in the Secretary&rsquo;s Certificate must be attached
thereto. The Company shall have taken no action designed to terminate, or likely to have the effect of terminating, the registration
of the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the U.S. national securities
exchange on which it is listed, nor has the Company received any information suggesting that the Commission or the Trading Market or
other U.S. applicable national
exchange is contemplating terminating such registration or listing.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: justify"><U>Certificate of Good Standing. </U>The Company shall deliver
a certificate of good standing of the Company issued by the Secretary of State of the State of Delaware as of a date within five (5)
Business Days of the Closing Date.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(e)</TD><TD STYLE="text-align: justify"><U>Lock-Up Agreements</U>. The Placement Agent shall have received
duly executed Lock-Up Agreements. in form and substance reasonably satisfactory to the Placement Agent, duly executed and delivered by
the Company, each of its officers, directors, and any affiliate of the Company holding securities of the Company, pursuant to which such
persons agree not to, directly or indirectly, offer, sell, contract to sell, grant any option to purchase, or otherwise dispose of any
shares of the Company&rsquo;s securities during the 90 days period following the Closing, subject to customary exceptions.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(f)</TD><TD STYLE="text-align: justify"><U>Purchase Agreement and Other Deliverables</U>. The Company
shall have delivered, or caused to be delivered, all deliverables set forth in the Purchase Agreement, including the Registration Rights
Agreement, in form and substance reasonably satisfactory to the Placement Agent and its counsel, and such agreements shall be in full
force and effect.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(g)</TD><TD STYLE="text-align: justify"><U>No Legal Impediment. </U>No statute, regulation, rule, executive
order, decree, ruling, or injunction shall have been enacted, entered, promulgated, or endorsed by any court or governmental authority
of competent jurisdiction which prohibits or materially adversely affects any of the transactions contemplated by this Agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">If any of the
foregoing conditions shall not have been satisfied on or before the Closing Date, the Placement Agent may terminate this Agreement, without
liability to the Company, by written notice to the Company. Any such termination shall not affect the obligations of the Company to reimburse
the Placement Agent for expenses or its indemnification and contribution obligations as set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt"><B>Section 5.
Covenants and Agreements of the Company and Placement Agent</B>. The Company further covenants and agrees with the Placement Agent as
follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) <U>Blue
Sky Compliance</U>. The Company will cooperate with the Placement Agent and the Investors in endeavoring to qualify the Securities for
sale under the securities laws of such jurisdictions (United States and foreign) as the Placement Agent and the Investors may reasonably
request and will make such applications, file such documents, and furnish such information as may be reasonably required for that purpose,
<I>provided</I> the Company shall not be required to qualify as a foreign corporation or to file a general consent to service of process
in any jurisdiction where it is not now so qualified or required to file such a consent, and <I>provided further</I> that the Company
shall not be required to produce any new disclosure documents. The Company will, from time to time, prepare and file such statements,
reports, and other documents as are or may be required to continue such qualifications in effect for so long a period as the Placement
Agent may reasonably request for distribution of the Securities. The Company will advise the Placement Agent promptly of the suspension
of the qualification or registration of (or any such exemption relating to) the applicable Securities for the offering, sale, or trading
in any jurisdiction or any initiation or threat of any proceeding for any such purpose, and in the event of the issuance of any order
suspending such qualification, registration or exemption, the Company shall use its commercially reasonable efforts to obtain the withdrawal
thereof at the earliest possible moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) <U>Amendments,
Supplements and Other Matters</U>. The Company will comply with the Securities Act and the Exchange Act, and the rules and regulations
of the Commission thereunder, so as to permit the completion of the sale of the Securities as contemplated in this Agreement. If during
the Offering period, any event shall occur as a result of which, in the judgment of the Company or in the opinion of the Placement Agent
or Lucosky Brookman LLP (&ldquo;Placement Agent Counsel&rdquo;) acting as counsel for the Placement Agent, it becomes necessary to amend
or supplement the SEC Reports in order to make the statements therein, in light of the circumstances under which they were made, as the
case may be, not misleading, or if it is necessary at any time to amend or supplement the SEC Reports, the Company will promptly prepare
an appropriate amendment or supplement to the SEC Reports, that is necessary in order to make the statements therein as so amended or
supplemented, in light of the circumstances under which they were made, as the case may be, not misleading, or so that the SEC Reports,
as so amended or supplemented, will comply with law. Before amending the SEC Reports, the Company will furnish the Placement Agent with
a copy of such proposed amendment or supplement and will not distribute any such amendment or supplement to which the Placement Agent
reasonably objects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) <U>Copies
of any Amendments and Supplements to the SEC Reports</U>. The Company will furnish the Placement Agent, without charge, during the period
beginning on the date hereof and ending on the Closing Date, as many copies of the SEC Reports and other documents to be furnished to
the Investors as the Placement Agent may reasonably request; <I>provided </I>that the Company&rsquo;s filing of the SEC Reports on the
Electronic Data Gathering and Analysis Retrieval system of the SEC shall be deemed to satisfy this covenant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) <U>Transfer
Agent</U>. The Company will maintain, at its expense, a transfer agent for the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) <U>Periodic
Reporting Obligations</U>. For as long as the Company remains subject to the reporting requirements of the Exchange Act, the Company will
duly file, on a timely basis, with the Commission and The Nasdaq Stock Market LLC , or any successor U.S. national securities exchange,
all reports and documents required to be filed under the Exchange Act within the time periods and in the manner required by the Exchange
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f) <U>Additional
Documents</U><I>.</I> The Company will enter into any customary Closing documentation as the Placement Agent or the Investors deem necessary
or appropriate to consummate the Offering, all of which will be in form and substance reasonably acceptable to the Placement Agent and
the Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g) <U>No
Manipulation of Price</U><I>.</I> The Company has not taken, directly or indirectly, any action designed to cause or result in, or that
has constituted or might reasonably be expected to constitute, the stabilization or manipulation of the price of any of its securities,
including of its Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h) <U>Acknowledgment</U>.
The Company acknowledges that any advice given by the Placement Agent to the Company is solely for the benefit and use of the Board and
may not be used, reproduced, disseminated, quoted, or referred to, without the Placement Agent&rsquo;s prior written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) <U>Announcement
of Offering</U>. The Company acknowledges and agrees that the Placement Agent may, subsequent to the Closing and at the Placement
Agent&rsquo;s expense, make public its involvement with the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j) <U>Reliance
on Others</U>. The Company confirms that it will rely on its own counsel and accountants for legal and accounting advice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k) <U>Research
Matters</U>. By entering into this Agreement, the Placement Agent does not provide any promise, either explicitly or implicitly, of favorable
or continued research coverage of the Company, and the Company hereby acknowledges and agrees that the Placement Agent&rsquo;s selection
as a placement agent for the Offering was in no way conditioned, explicitly or implicitly, on the Placement Agent providing favorable
or any research coverage of the Company. In accordance with FINRA Rule 2711(e), the parties hereto acknowledge and agree that the Placement
Agent has not directly or indirectly offered favorable research, a specific rating or a specific price target, or threatened to change
research, a rating or a price target, to the Company or inducement for the receipt of business or compensation. The Company hereby waives
and releases, to the fullest extent permitted by law, any claims that the Company may have against the Placement Agent with respect to
any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments
may be different from or inconsistent with the views or advice communicated to the Company by the Placement Agent&rsquo;s investment banking
divisions. The Company acknowledges that the Placement Agent is a full service securities firm and as such from time to time, subject
to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short position
in debt or equity securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt"><B>Section 6.
Conditions of the Obligations of the Placement Agent</B>. The obligations of the Placement Agent hereunder shall be subject to the accuracy
of the representations and warranties on the part of the Company set forth in <U>Section 2</U> and in the Transaction Documents, in each
case as of the date hereof and as of the Closing Date as though then made, to the timely performance by each of the Company of its covenants
and other obligations hereunder on and as of such dates, and to each of the following additional conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) <U>Transaction
Documents</U>. The Transactions Documents between the Company and the Investors shall have been executed and delivered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) <U>Corporate
Proceedings</U>. All corporate proceedings and other legal matters in connection with this Agreement and the sale and delivery of the
Securities, shall have been completed or resolved in a manner reasonably satisfactory to the Placement Agent Counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) <U>No
Material Adverse Change</U>. Subsequent to the execution and delivery of this Agreement and prior to the Closing Date, in the Placement
Agent&rsquo;s sole judgment after consultation with the Company, there shall not have occurred any (i) a material adverse effect on the
legality, validity, or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets,
business, prospects, or condition (financial or otherwise) of the Company and the subsidiaries of the Company (the &ldquo;<B>Subsidiaries</B>&rdquo;),
taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis
its obligations under any Transaction Document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) <U>Placement
Agent Compensation</U>. The Cash Fee calculated in the manner provided in <U>Section 1(a)</U>, and reimbursement of expenses as set forth
in <U>Section 7</U> shall have been paid or delivered to the Placement Agent by wire transfer of immediately available funds to an account
specified by the Placement Agent to the Company prior to the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any condition specified
in this <U>Section 6</U> is not satisfied when and as required to be satisfied, this Agreement may be terminated by the Placement Agent
by notice to the Company at any time on or prior to the Closing Date, which termination shall be without liability on the part of any
party to any other party, except that <U>Section 7</U> (<I>Payment of Expenses</I>), <U>Section 8</U> (<I>Indemnification and Contribution</I>),
<U>Section 9</U> (<I>Representations and Indemnities to Survive Delivery</I>), and <U>Section 15</U> (<I>Tail</I>) shall at all times
be effective and shall survive such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt"><B>Section 7.
Payment of Expenses</B>. Subject to the following, the Company shall reimburse the Placement Agent Promptly upon request for all reasonable
and accountable out-of-pocket expenses incurred in connection with the Offering, whether or not there is a closing of the Offering, including
but not limited to road show and travel expenses (including, if applicable, the costs associated with the use of a third-party electronic
road show service (such as Net Roadshow), due diligence expenses, the costs of background checks on the Company&rsquo;s officers and directors
and any of its shareholders designated by the Placement Agent, the costs associated with the Placement Agent&rsquo;s use of book- building
and compliance software, the fees and expenses of the Placement Agent&rsquo;s legal counsel and any other independent advisors selected
and retained by the Placement Agent, and all fees, expenses and disbursements required under the Bluck Sky securities laws of such states
and other jurisdictions as the Placement Agent may reasonably designate (with the Company&rsquo;s consent, which shall not be unreasonably
withheld), provided that the expenses reimbursable to the Placement Agent under this Section 7 shall not exceed $70,000. In addition,
the Company shall pay Placement Agent a non-refundable cash fee equal to 0.5% of the gross proceeds of the Placement as a nonaccountable
expense allowance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">The Company will
bear all fees, disbursements and expenses in connection with any proposed Offering, including, without limitation, the Company&rsquo;s
legal and accounting fees and disbursements; the costs of preparing, printing, mailing and delivering the Registration Statement, the
preliminary and final prospectus contained therein and amendments thereto, post-effective amendments and supplements thereto, any other
offering materials, the Placement Agent Agreement and related documents (all in such quantities as the Placement Agent may reasonably
require); preparing and printing stock certificates; the costs of any &ldquo;due diligence&rdquo; meetings; filing fees (including SEC
filing fees), costs and expenses (including third party expenses and disbursements) incurred in registering the Offering, FINRA filing
fees; costs and expenses of making any required filings or notices under applicable state securities or &ldquo;blue sky&rdquo; laws as
specified by the Placement Agent, including Form D filings under Regulation D, but excluding those costs and expenses that FINRA regulations
require to be borne by a selling agent, placement agent or underwriter. The Company will also sign the Placement Agent&rsquo;s agreement
with its Counsel acknowledging that the Company is liable to pay the legal fees on the Placement Agent&rsquo;s behalf which should be
paid from the proceeds of the Offering this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: -0.5pt"><B>Section 8. Indemnification
and Contribution</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The
Company agrees to indemnify and hold harmless the Placement Agent, its affiliates, and each person controlling the Placement Agent (within
the meaning of Section 15 of the Securities Act), and the directors, officers, agents, shareholders, and employees of the Placement Agent,
its affiliates and each such controlling person (the Placement Agent, and each such entity or person. an &ldquo;<B>Indemnified Person</B>&rdquo;)
from and against any losses, claims, damages, judgments, assessments, costs, and other liabilities, including reasonable attorneys&rsquo;
fees (collectively, the &ldquo;<B>Liabilities</B>&rdquo;), and shall reimburse each Indemnified Person for all fees and expenses (including
the reasonable fees and expenses of one counsel for all Indemnified Persons, except as otherwise expressly provided herein) (collectively,
the &ldquo;<B>Expenses</B>&rdquo;) as they are incurred by an Indemnified Person in investigating, preparing, pursuing, or defending any
actions, whether or not any Indemnified Person is a party thereto, (i) caused by a breach by the Company of any of its representations,
warranties, or covenants contained in this Agreement or in any certificate delivered by or on behalf of the Company in connection with
this Agreement, (ii) caused by, or arising out of or in connection with, any untrue statement or alleged untrue statement of a material
fact contained in the SEC Reports or by any omission or alleged omission to state therein a material fact necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading (other than untrue statements or alleged untrue statements
in, or omissions or alleged omissions from, information relating to an Indemnified Person furnished in writing by or on behalf of such
Indemnified Person expressly for use in such documents), or (iii) otherwise arising out of or in connection with advice or services rendered
or to be rendered by any Indemnified Person pursuant to this Agreement, the transactions contemplated thereby or any Indemnified Person&rsquo;s
actions or inactions in connection with any such advice, services, or transactions; <I>provided</I>, <I>however</I>, that, in the case
of clause (iii) only, the Company shall not be responsible for any Liabilities or Expenses of any Indemnified Person that have resulted
primarily from such Indemnified Person&rsquo;s (x) gross negligence, bad faith, or willful misconduct in connection with any of the advice,
actions, inactions, or services referred to above or (y) use of any Offering materials or information concerning the Company in connection
with the offer or sale of the Securities in the Offering which were not authorized for such use by the Company and which use constitutes
gross negligence, bad faith, or willful misconduct. The Company also agrees to reimburse each Indemnified Person for all Expenses as they
are incurred in connection with enforcing such Indemnified Person&rsquo;s rights under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In this regard, and without
limitation, the Company acknowledges that the Placement Agent is not responsible for the actions of the Introduced Parties or their agents.
The Company acknowledges that none of the Indemnified Parties is acting as an attorney, accountant, or negotiator, that the Placement
Agent will not make any recommendations about the Transaction, and that the Company will seek its own professional advice with respect
to any transaction. The Placement Agent may or may not act as broker-dealer or financial advisor to the Company in any transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) Upon
receipt by an Indemnified Person of actual notice of an action against such Indemnified Person with respect to which indemnity may be
sought under this Agreement, such Indemnified Person shall promptly notify the Company in writing; <I>provided </I>that failure by any
Indemnified Person so to notify the Company shall not relieve the Company from any liability which the Company may have on account of
this indemnity or otherwise to such Indemnified Person, except to the extent the Company shall have been prejudiced by such failure. The
Company shall, if requested by the Placement Agent, assume the defense of any such action including the employment of counsel reasonably
satisfactory to the Placement Agent, which counsel may also be Company Counsel. Any Indemnified Person shall have the right to employ
separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the
expense of such Indemnified Person unless: (i) the Company has failed promptly to assume the defense and employ counsel or (ii) the named
parties to any such action (including any impeded parties) include such Indemnified Person and the Company, and such Indemnified Person
shall have been advised in the reasonable opinion of counsel that there is an actual conflict of interest that prevents the counsel selected
by the Company from representing both the Company (or another client of such counsel) and any Indemnified Person; <I>provided </I>that
the Company shall not in such event be responsible hereunder for the fees and expenses of more than one firm of separate counsel for all
Indemnified Persons in connection with any Action or related Actions, in addition to any local counsel. The Company shall not be liable
for any settlement of any action effected without its written consent (which shall not be unreasonably withheld). In addition, the Company
shall not, without the prior written consent of the Placement Agent (which shall not be unreasonably withheld), settle, compromise, or
consent to the entry of any judgment in or otherwise seek to terminate any pending or threatened action in respect of which indemnification
or contribution may be sought hereunder (whether or not such Indemnified Person is a party thereto) unless such settlement, compromise,
consent, or termination includes an unconditional release of each Indemnified Person from all Liabilities arising out of such action for
which indemnification or contribution may be sought hereunder. The indemnification required hereby shall be made by periodic payments
of the amount thereof during the course of the investigation or defense, as such expense, loss, damage, or liability is incurred and is
due and payable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) In
the event that the foregoing indemnity is unavailable to an Indemnified Person other than in accordance with this Agreement, the Company
shall contribute to the Liabilities and Expenses paid or payable by such Indemnified Person in such proportion as is appropriate to reflect
(i) the relative benefits to the Company, on the one hand, and to the Placement Agent and any other Indemnified Person, on the other hand,
of the matters contemplated by this Agreement or (ii) if the allocation provided by the immediately preceding clause is not permitted
by applicable law, not only such relative benefits but also the relative fault of the Company, on the one hand, and the Placement Agent
and any other Indemnified Person, on the other hand, in connection with the matters as to which such Liabilities or Expenses relate, as
well as any other relevant equitable considerations; <I>provided</I> that in no event shall the Company contribute less than the amount
necessary to ensure that all Indemnified Persons, in the aggregate, are not liable for any Liabilities and Expenses in excess of the amount
of fees actually received by the Placement Agent pursuant to this Agreement. For purposes of this paragraph, the relative benefits to
the Company, on the one hand, and to the Placement Agent on the other hand, of the matters contemplated by this Agreement shall be deemed
to be in the same proportion as (i) the total value paid or contemplated to be paid to or received or contemplated to be received by the
Company in the transaction or transactions that are within the scope of this Agreement, whether or not any such transaction is consummated,
bears to (ii) the fees paid to the Placement Agent under this Agreement. Notwithstanding the above, no person guilty of fraudulent misrepresentation
within the meaning of Section 11(f) of the Securities Act, shall be entitled to contribution from a party who was not guilty of fraudulent
misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) The
Company also agrees that no Indemnified Person shall have any liability (whether direct or indirect, in contract or tort or otherwise)
to the Company for or in connection with advice or services rendered or to be rendered by any Indemnified Person pursuant to this Agreement,
the transactions contemplated thereby or any Indemnified Person&rsquo;s actions or inactions in connection with any such advice, services,
or transactions except for Liabilities (and related Expenses) of the Company that are finally judicially determined to have resulted primarily
from such Indemnified Person&rsquo;s gross negligence or willful misconduct in connection with any such advice, actions, inactions, or
services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) The
reimbursement, indemnity, and contribution obligations of the Company set forth herein shall apply to any modification of this Agreement
and shall remain in full force and effect regardless of any termination of, or the completion of any Indemnified Person&rsquo;s services
under or in connection with, this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) The
Placement Agent and the Company agree that the obligations of each of the Parties are solely corporate obligations, and that no officer,
director, employee, agent, or shareholder of either Party shall be subjected to any personal liability whatsoever to any person, nor will
any claim for liability or suit be asserted by, or on behalf of, either the Placement Agent or the Company. In no event shall the Placement
Agent be liable to the Company, nor will the Company be liable to the Placement Agent, whether a claim be in tort, contract or otherwise,
for any amount in excess of the total amount paid by the Company to the Placement Agent under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt"><B>Section 9.
Representations and Indemnities to Survive Delivery</B>. The respective indemnities, agreements, representations, warranties, and other
statements of the Company or any person controlling the Company, of its officers, and of the Placement Agent set forth in or made pursuant
to this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of the Placement Agent, the
Company, or any of its or their partners, officers, or directors or any controlling person, as the case may be, and will survive delivery
of and payment for the Securities sold hereunder and any termination of this Agreement. A successor to the Placement Agent, or to the
Company, its directors or officers or any person controlling the Company, shall be entitled to the benefits of the indemnity, contribution,
and reimbursement agreements contained in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt"><B>Section 10.
Notices</B>. All communications hereunder shall be in writing and shall be mailed, hand delivered, telecopied, or e-mailed and confirmed
to the parties hereto as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">If to E.F. Hutton
&amp; Co.:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">E.F. Hutton &amp;
Co.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">745 Fifth Avenue,
34th Floor &amp; PH</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">New York, NY 10151</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">Attn: Joseph T.
Rallo</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">Email: jrallo@efhutton.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: -0.5pt"><I>With a copy (which shall
not constitute notice) to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">Lucosky Brookman
LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">101 Wood Avenue
South, 5<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">Woodbridge, NJ
08830</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">Attn: Joseph Lucosky</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">Email: jlucosky@lucbro.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">VCI Global Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">Suite 33.03 of
Level 33, Menara Exchange 106, Lingkaran TRX, Tun Razak Exchange</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">55188 Kuala Lumpur,
Malaysia</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">Attn: Victor Hoo</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">Email: datovictor@v-capital.co</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: -0.5pt"><I>With a copy (which shall
not constitute notice) to:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">Sichenzia Ross
Ference Carmel LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">1185 Avenue of
the Americas, 31st floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">New York, NY 10036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">Attn: Ross D.
Carmel, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">Email: rcarmel@srfc.law</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Any party hereto
may change the address for receipt of communications by giving written notice to the others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt"><B>Section 11.
Prior Agreement</B>. By entering into this Agreement, the parties hereto agree that that any prior letter of engagement between the parties
relating to the Offering, shall automatically terminate and cease to have any effect whatsoever and shall be superseded in its entirety
by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt"><B>Section 12.
Successors and Assignment</B>. This Agreement will inure to the benefit of and be binding upon the parties hereto, and to the benefit
of the employees, officers, and directors and controlling persons referred to in <U>Section 8</U> hereof, and to their respective successors,
and personal representative, and no other person will have any right or obligation hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt"><B>Section 13.
Partial Unenforceability</B>. The invalidity or unenforceability of any section, paragraph, or provision of this Agreement shall not affect
the validity or enforceability of any other section, paragraph, or provision hereof. If any Section, paragraph, or provision of this Agreement
is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor
changes) as are necessary to make it valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt"><B>Section 14.
Governing Law Provisions</B>. This Agreement and the transactions contemplated hereby shall be governed as to validity, interpretation,
construction, effect, and in all other respects by the internal laws of the State of New York, without regard to the conflict of laws
principles thereof. The Placement Agent and the Company agree that with respect to any controversy or claim relating to, arising under
or involving this Agreement or breach thereof (a &ldquo;<B>Claim</B>&rdquo;), the matter shall first be submitted for mediation through
the Judicial Arbitration and Mediation Service, Inc. (&ldquo;<B>JAMS</B>&rdquo;) and its applicable rules in New York, New York, provided,
however, that in the case of a breach or threatened breach of the non-circumvention covenant stated herein, the Placement Agent may seek
and obtain, in addition to any remedies available under this Agreement or applicable law, an injunction or other equitable relief from
any court of competent jurisdiction and nothing in this Agreement shall in any way limit or condition its right and recourse to seek and
obtain such equitable relief. In the event that the Placement Agent and the Company are not able to agree on a mediator within thirty
(30) days of the first party seeking mediation, the presiding Judge of the Superior Court of the county which the venue would lie for
the filing of a complaint for relief in such Claim shall have jurisdiction to appoint a mediator. The parties covenant that they will
participate in the mediation in good faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">In the event that
the Placement Agent and the Company are unable to resolve any claim after mediation as set forth in the preceding paragraph, then the
parties hereby agree that such Claim shall be submitted to JAMS for final and binding arbitration pursuant to its Comprehensive Arbitration
Rules and Procedures (the &ldquo;<B>Arbitration Rules</B>&rdquo;) in New York, New York. The arbitration shall be conducted before a neutral
arbitrator who shall be an attorney or retired Judge and shall be selected in accordance with the Arbitration Rules. The arbitrator&rsquo;s
award shall be final and binding on all parties. Except to the extent otherwise required pursuant to the applicable JAMS rules and procedures
and applicable law, each party will pay the fees of its respective attorney(s), expert(s), and other fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">Without limiting
the mediation and arbitration provisions set forth above, each party hereby irrevocably agrees and consents to be subject to the jurisdiction
of the state court sitting in New York County, State of New York, or if the state court lacks jurisdiction, the United States District
Court for the Southern District of New York, in any suit, action or proceeding pursuant to this Agreement. Each party hereby irrevocably
consents to the service of any and all process in any such suit, action or proceeding by the delivery of such process in person, by overnight
courier, facsimile or first class mail with a copy to email to such party as set forth in <U>Section 10</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: -0.5pt"><B>Section 15. Tail</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If there is a Closing of the
Offering, or if this Agreement terminates prior to Closing (other than a termination for cause in compliance with FINRA Rule 5110(g)(5)(B)(i)),
the Placement Agent shall be entitled to compensation under Section 1 hereof, calculated in the manner set forth therein, with respect
to any public offering or other equity financing of any kind (&ldquo;Tail Financing&rdquo;) to the extent that such financing or capital
is provided to the Company by investors that the Placement Agent had introduced to the Company during the Term (if such Financing is consummated
at any time within the 1-month period following the expiration or termination of this Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: -0.5pt"><B>Section 16. [Reserved] </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: -0.5pt"><B>Section 17. General Provisions</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) This
Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous
oral agreements, understandings, and negotiations with respect to the subject matter hereof. This Agreement may be executed in two or
more counterparts, each one of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the
same instrument. This Agreement may not be amended or modified unless in writing by all of the parties hereto, and no condition herein
(express or implied) may be waived unless waived in writing by each party whom the condition is meant to benefit. Section headings herein
are for the convenience of the parties only and shall not affect the construction or interpretation of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The
Company acknowledges that in connection with the offering of the Securities: (i) the Placement Agent has acted at arm&rsquo;s length,
are not agents of, and owe no fiduciary duties to the Company or any other person,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">(ii) the Placement
Agent owes the Company only those duties and obligations set forth in this Agreement, and (iii) the Placement Agent may have interests
that differ from those of the Company. The Company waives to the full extent permitted by applicable law any claims it may have against
the Placement Agent arising from an alleged breach of fiduciary duty in connection with the offering of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) The Company shall be responsible
for any and all compliance with the securities laws applicable to it, including without limitation, Regulation D and the Securities Act,
and Rule 506 promulgated thereunder, and all state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) Each Party agrees
not to mention the name of the other Party or its agents in any press release or news announcement without the express written
consent of the other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) This
Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which together shall constitute
one and the same instrument. Delivery of an executed counterpart of this Agreement by facsimile, email (including .pdf) or other electronic
transmission shall be equally as effective as delivery of a manually executed counterpart.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: -0.5pt"><B>Section 18. Confidentiality.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.05pt; text-align: justify; text-indent: -0.5pt">In the event of
the consummation or public announcement of the Offering, the Placement shall have the right to disclose its participation in such offering,
including, without limitation, the Offering at its own cost of &ldquo;tombstone&rdquo; advertisements in financial and other newspapers
and journals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: -0.5pt"><B>Section 19. Limitations on
Engagement; Limitations of Placement Agent Liability </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The
Company acknowledges that the Placement Agent has been retained only by the Company, that the Placement Agent is providing services hereunder
as an independent contractor (and not in any fiduciary or agency capacity) and that the Company&rsquo;s engagement of the Placement Agent
is not deemed to be on behalf of, and is not intended to confer rights upon, any shareholder, owner or partner of the Company or any other
person not a party hereto as against the Placement Agent or any of its affiliates, or any of its or their respective officers, directors,
controlling persons (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act), employees or agents. Unless
otherwise expressly agreed in writing by the Placement Agent, no one other than the Company is authorized to rely upon this Agreement
or any other statements or conduct of the Placement Agent, and no one other than the Company is intended to be a beneficiary of this Agreement.
The Company acknowledges that any recommendation or advice, written or oral, given by the Placement Agent to the Company in connection
with the Placement Agent&rsquo;s engagement is intended solely for the benefit and use of the Company&rsquo;s management and directors
in considering a possible Offering and any such recommendation or advice is not on behalf of, and shall not confer any rights or remedies
upon, any other persons or be used or relied upon for any other purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The
Placement Agent and the Company agree that neither the Placement Agent nor any of its affiliates or any of its or their respective officers,
directors, controlling persons (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act), employees or
agents shall have any liability to the Company, its security holders or creditors, or any person asserting claims on behalf of or in the
right of the Company (whether direct or indirect, in contract, tort, for an act of negligence or otherwise) for any losses, fees, damages,
liabilities, costs, expenses or equitable relief arising out of or relating to this Agreement or the services rendered hereunder, except
for losses, fees, damages, liabilities, costs or expenses that arise out of or are based on any action of or failure to act by the Placement
Agent and that are finally judicially determined to have resulted solely from the gross negligence or willful misconduct of the Placement
Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.4pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">[<I>The remainder of this page
has been intentionally left blank.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">[SIGNATURE PAGE TO THE PLACEMENT
AGENCY AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.85pt; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">If the
foregoing is in accordance with your understanding of our agreement, please sign below whereupon this instrument, along with all
counterparts hereof, shall become a binding agreement in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left; text-indent: 0in">Very truly yours,</TD>
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left; text-indent: 0in"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left; text-indent: 0in"><B>E.F. Hutton &amp; Co. </B></TD>
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; text-indent: 0in; width: 35%">&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in; width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in">Name:&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in">Duncan B. Swanston</TD>
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in">Title:</TD>
    <TD STYLE="text-align: justify; text-indent: 0in">Supervisory Principal</TD>
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing Placement Agency
Agreement is hereby confirmed and accepted as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: left; text-indent: 0in"><B>VCI Global Limited </B></TD>
    <TD STYLE="text-align: left; text-indent: 0in"><B>&nbsp;&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in"><B>&nbsp;</B></TD>
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0in; width: 35%">&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in; width: 60%">&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in">Name:&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">Victor Hoo</TD>
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in">Title:</TD>
    <TD STYLE="text-align: left; text-indent: 0in">Director, Executive Chairman and Chief Executive Officer</TD>
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>9
<FILENAME>ea027358601ex99-1_vciglobal.htm
<DESCRIPTION>PRESS RELEASE ISSUED BY VCI GLOBAL LIMITED ON JANUARY 20, 2026
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-variant: normal"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0; background-color: white"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="text-transform: uppercase"><B>VCI
Global Announces US$5 Million Institutional Registered Direct Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>19 January 2026 | Globe Newswire</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">KUALA LUMPUR, Malaysia, January 20, 2026 &ndash;
VCI Global Limited (<B>NASDAQ: VCIG</B>) (&ldquo;<B>VCI Global</B>&rdquo; or the &ldquo;<B>Company</B>&rdquo;)&nbsp;a cross-sector platform
builder focused on technology, digital infrastructure, and capital market solutions, today announced that it has entered into a definitive
agreement with Esousa Group Holdings, LLC, a New York based family office, for the issuance and sale of its ordinary shares and warrants
in a registered direct offering. The offering is structured in multiple tranches, with the initial tranche expected to result in aggregate
gross proceeds of $5,000,000, before deducting placement agent fees and other offering expenses. Pursuant to the terms of the agreement
between the parties, the initial closing of the offering is expected to occur on or about January 20, 2026, subject to the satisfaction
of customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">E.F. Hutton &amp; Co. is acting as the exclusive
placement agent for the offering. The Company intends to use the net proceeds from this offering for working capital and general corporate
purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities described above are being offered
and sold by the Company in a registered direct offering pursuant to a shelf registration statement on Form F-3 (File No. 333-279521)
that was originally filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on May 17, 2024, and became effective on
May 28, 2024. The offering of the securities is being made only by means of a base prospectus and final prospectus supplement that form
a part of the effective registration statement. A final prospectus supplement and accompanying base prospectus relating to, and describing
the terms of, the registered direct offering will be filed with the SEC and will be available on the SEC&rsquo;s website at www.sec.gov.
Electronic copies of the final prospectus supplement and the accompanying base prospectus relating to the registered direct offering,
when available, may also be obtained by contacting E.F. Hutton &amp; Co., at 745 Fifth Avenue, 34th Floor &amp;amp; PH, New York, NY
10151, by telephone at (212) 970-3700, or by email at info@efhutton.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release shall not constitute an offer
to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in
any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification
under the securities laws of any such state or other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About VCI Global Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">VCI Global Limited is a cross-sector platform
builder at the forefront of technology and financial architecture. The Company focuses on developing and scaling platforms across artificial
intelligence, encrypted data infrastructure, digital treasury systems, and next-generation capital markets solutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">By integrating technology innovation with financial
ecosystems, VCI Global enables enterprises, governments, and institutions to capture opportunities in the evolving digital economy. The
Company&rsquo;s strategy is centered on building scalable platforms that deliver resilience, efficiency, and long-term value across multiple
high-growth sectors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For more information on the Company, please log
on to https://v-capital.co/.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Cautionary Note Regarding Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains forward-looking statements
that are subject to various risks and uncertainties. Such statements include statements regarding the Company&rsquo;s ability to grow
its business and other statements that are not historical facts, including statements which may be accompanied by the words &ldquo;intends,&rdquo;
&ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;plans,&rdquo; &ldquo;expects,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;projects,&rdquo;
&ldquo;predicts,&rdquo; &ldquo;estimates,&rdquo; &ldquo;aims,&rdquo; &ldquo;believes,&rdquo; &ldquo;hopes,&rdquo; &ldquo;potential&rdquo;
or similar words. These forward-looking statements are based only on our current beliefs, expectations, and other future conditions. Because
forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that
are difficult to predict and many of which are outside of our control. Therefore, you should not rely on any of these forward-looking
statements. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including
without limitation, the Company&rsquo;s ability to achieve profitable operations, customer acceptance of new products, the effects of
the spread of coronavirus (COVID-19) and future measures taken by authorities in the countries wherein the Company has supply chain partners,
the demand for the Company&rsquo;s products and the Company&rsquo;s customers&rsquo; economic condition, the impact of competitive products
and pricing, successfully managing and, general economic conditions and other risk factors detailed in the Company&rsquo;s filings with
the United States Securities and Exchange Commission (&ldquo;SEC&rdquo;). The forward-looking statements contained in this press release
are made as of the date of this press release, and the Company does not undertake any responsibility to update the forward-looking statements
in this release, except in accordance with applicable law.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CONTACT INFORMATION:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For media queries, please contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>VCI GLOBAL LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">enquiries@v-capital.co&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex4-3_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex4-3_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  9 "4# 2(  A$! Q$!_\0
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "* JP# 2(  A$! Q$!_\0
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MK&UANX3=^'T6*-A!;SW40\Z3\R_^#CK_ ()]:C\?/V<=#_;3^!\.LZ7^U/\
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M-!^''P]U+6/"OA6[TGQ+9Z-XEN/'?B?7;WQY-#I$N@S-J%AK-X+7._X+'_\
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M_@K/_P $V?VM/BU^T/\ \$<-2M_$7P(^+&NR>*=2^!MKX@\%RG1&U"22[O\
MPAK_ ,//B9>:5X5\3:-H.IW>I'P+XA\-7<OC+1]!NK?1H9=/GBU*^US^WFBM
M<JS;%915Q$J,</7H8NFJ6)PF+HQKX>M33B^6<)==-)+EE%.7+)7,\5@J>*=*
M3G5HU:,G.E6H24*D&[\R3<9>[+[2TO9:G\-?@G_@F)_P6-_X*V?M!?"CQ?\
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MNOV;_$FLVZ>*/%>M^,M56YU>Y^+\4UP'UCQ!?>0OEQI;VJ6\"H#&SR?T:_\
M!-/Q+_P5F\?? ?X[+_P45\)^#OA!\=VU^[T_X&7>F:7X!O- M-(N/"%J;/Q'
MK>D_#?Q=XAMM4ATWQ>97N;2\U/2]0ELHOL\(6%S?+^SU%:YGQ!_:=.:ED^38
M/$5*JK5<;@L+.EBJLW)RG[2=2M6C+VC:4[1C=+S,L%E3P52,H9CF56$*<J<*
M-:O"=.*=[-1=*RM?1)+H?Q)Z5H__  =:_L87WB?P1HNC^#/VV/!>K:MJO]C>
M+_$VL^ _B#;6TFH7UY=&_P!(F\0^*_A?\3-(L[J2Y'V?0/%=O=Z+H<:?8K&Q
MMM+41W'W%_P04_X)B_M;?LM?$_\ :H_;!_;;T7PWX)^-W[3-[;06OPZ\*7'A
M6XAT.RO?%&I>-_&FJZM:_#U[GP#H!\0:])I#:)I'A^]O(M*M=.OHKM+6_P!4
MCMZ_J*HIXGB2O7P&(P-++LIP/URG2IXS$X+"SHXBO"BXN*:>(G0@I.$95%&A
M[\KRT;TFCDU*E7IUIXS'XE47.5*EB:T*D5.I)R<Y35&-6<HN34/WL8QA:/*T
MC^+#_@L%^P-_P5&\:_\ !7'X<_MS_L*_L^1_$:+X2_#WX4W'A3Q3K7B;X66F
M@)XV\*W7BQ[NQU#P[XQ^('AC5[Z*R_M&/S2+>&TG\R)K6]G'FJFVW[0/_!W.
M'B,O[)_P5CC,F'9;/X"@K&RMYARGQZ()5<M&K#YI1%AU*[7_ +-**UI\3S^H
M8; 8K)\EQRPE">&I8K%8:M+%>QE4E4C!U(8F$4J;DU'EA%/5OR3R>U>O7I8_
M&T7B,1'$5(0E2Y.>-.-/1>R5KJ-V_/K9'YW?\%*/A+\5?C__ ,$W/VGO@Y\.
MO"LGB?XP?$WX":UX6\.>$H;_ $?2FU'Q=J>FVO\ Q+%U'5[_ $_1+("[$R&>
M]U*ULE"G-RH*L?SC_P""-?\ P3J\8_#G_@E#X@_8N_;[^!EA;#QM\1/BK<>,
MOA=XEU;P[XBL[_PKXEO=$OM"U(ZKX.U_6;.POH9M.AOM/U/3M<L]7T74K*#5
M=.NM*O;:TNS_ $6T5Y-/-<51RVKE=!QH4*F8X3,U.ES0K4\1@Y\U)4ZBDI1@
MHMTWK?DTONWV/ 4)XJ&+J\U2I&A4P[4G[DX5+7;C:RE=7;2UN]D]/X4_V"_^
M"%/[7O["W_!;?X:?%+0?AS<>+/V+/AQX^^*NI^%?C.OC'P;)=VO@?QC\)O'V
MC^$M.\2>';W7;/QK/XET/4_$&D^%O$D]MX7DMKW58+K5[!WT.>#4#_=1'W_#
M^M245><9SC<\Q%'%8^4)XBCAJ>%52,>5SA2NHN>KO)WNWU=WUTG 9?0RZG5I
MX?FY*M:=:2D[I.;;Y8+:,5?1(****\H[PHHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ^1_B1^TOXF\(_%OQ9\)?!?P!^(_P 6M1\%?#3X?_$_Q-K?
MA/7_ (3Z%IFEZ3\2=>^*'AWP]ID4'Q#^(W@R_P!7UA;GX1^*+R[BL(!9);7&
ME6_VY+JY95Y;1/VTK;X@V=KJ?P)^"7Q:^/&B'POX*\4:SKO@U?AKX7TS06\>
M>#=$^(>@^&IY/BK\2O $VK>+IO!/B;PUK][I/A^'5+'08O$6C6'B+6M*U*\>
MTMZWQ"_9"T#XL_M,?$/XI_$+6?'<?A#Q-\$?@G\+=$T/X>?M _'OX2W,VH?#
M[Q?^T+XI\53^+M ^%/C;P%H&MZ9J%G\6/#-KX?N-6N_$>I&73_$\#V&CZ>J3
M:S4TOX1?&[]G[Q!XVT[]G/P3\#_%GPJ\;ZQIGBG3O#'CKXA^,?A'J'POUJU\
M%^%?!>K:)X<;PG\'OC#:>*_".IV?@K2M?LH=0;P;>:+K5[K%C)?:W9W&DG1>
MB,L.XI<T>=)<W/[L;K1KF6[OZ>>VO)4^LQ;ER5)0<FH^SM*6K?*Y*ZM%+>6M
MM-#TZT_:M^'6K_L[^/OVD]"DU/7O!_PT\+?$KQ!XMT6WTF;1_%^DZI\(X-9E
M\?>!=6\/>(+K39]!\;^'K_0-6\/7^D:S-:QP:O:&1[D6,UO++Q/PA_;2TKXA
M^/O"OPS\8?"KX@?!WQ9X]^#6I?'OP0GC.\^'NM:/X@^&N@7_ (0TKQ#JT^K_
M  ]\=^,HO#%[H]]X\\+&33?%L.B?VC:ZE/-H5YJ_]B:Z-/Y&#]ESQ5X=_9"_
M:9^#+^+])\5_%C]HK2?VB/$7BOQG=V%[X;\('XG_ !\TW7X6ATS1-/MO$6L:
M)X"\-7.IZ=HFCP%O$^OP^&-&@OM3OM=U:2ZO+OXD^'G_  32^)>C:3JWAG1?
M"/[/?[,6E>)/V6?&'P&^)UO\'?B?\1_B]:_'/7M=T'3])\(:MXXT/Q;\*/@M
M9>%_#O@74'\8WSS>'UUWQ7K4'CW5O#MGJOAZS^WO>.G#"SC4C5DHN57DIU$W
M;DC&,K*2ULVI:_*R(]IB8S@HT_:_N^:<4W=7;BDNCZ-WM;7L?K]X6_:&^"/C
MK39M7\$?&'X5^,-+M?$.D>%+K5/"_C_PIXATZW\3>(+U-.T#PW/<Z-K-[%#X
M@UN_FBLM&T>20:CJ]X5M;"TFGG@C;K8_'>E7V@:OXA\/W=GXNM=(DUZSEA\*
MW%KK%Q+J_AFYOM/UK0[<6]ZUM-K5CJUA=:/=Z<]U;O9:G;3VM[-!*IC7\P/B
M;^Q]\;/CO;>.[;Q5X5^ 7P/3Q]\+/"/P*U4?"GQWXQ\87]GX)T;X@IXY3XG:
M9JFL_![X2QV_Q0^$C64]O^SSI TF+2O 7BOQ?KGCC5/%NJ#3[+P?<_7'P ^%
M7CWX)?LYZ3\'8KOP7J/B7P)I'B;P_P" _%EQ)K5W8>-Q!?W]UX/\;_%:%;+3
M=3B\:^,)9+37?C'>:/<7UOK?C*[\2:[H>JQ?VS96EI%2E2IQ_<5H5)\].U.4
MWK"3_>2<DF_=6R2L_)7-(U:TI\E2BZ,90FU-MN2E%?RVM:^SO\C @_;@\."V
M\<Z;K7PE^+OA;XF>"-8^&OA\_!O5+'X=ZM\0?$^K_&&?5K;X=6WAR;P?\3?$
MOP_SK+>'_$-YJ/\ ;GCW1?\ A%-*T+4M7\8?\(]H\(U)JUQ^W7X2L(-*T34_
MA9\7K/XQ:W\4KCX.Z9^SXNE>!;GXI77C:'X?GXMF--3L_B'<?"*+PY'\,&B\
M6/XTN?BG;^%%03Z%<:K9^,+>X\,0?,/@O]BWXI>#=5\;_$OP1X ^ 7P>\27W
MQ4^$GQE\/_!GPU\5?B7XM^%_BCXD^#V\>Z%\2?&7C3Q_X@^#WA'6_!6L?$SP
M%XXM?"5O/X2^%&KVGA_5/ 7ASQ'>6'BMY9=%B[#QM^RS\8/B"/$GQ-\5^#/A
M!<_&W6?C1H/Q*\+Z'X>^/?QB\#Z;\*=%\+_!^#X3V=QX/^/OAOX/Q>+)/&>L
MP7.NWGB%K_X.Q>%O$/A?Q=J?P[U/0M8@TAO$VH[JGA92@G-.\;R<)-J#OL^^
MEWWZ&7M,5[T53G.=[P45=3A;XFWK%WTLE:VM]3Z%\4?MH>&_#/PCM/C@GPR^
M*VO_  ^L[+X@WWQ%OM&TCP9%?_!VV^$^L7OA_P")7_"P;#7O'VAW-S?^#]?T
M?Q!H5[H?@!/'.MZIJ'A[5Y/#5CKEI D\GT=\3/A1\,/C-X>3PC\6/ /@CXF>
M%8K^UUA?#/C[PKX>\:>'QJMFLHT_4SHGB73M5TW[?9":;[%>_9?M$ FF6*14
MEE5_R[\0?L3?$M_V7?"'[-UGX=^#/CY'U[XG>/\ 4?$/Q$^)_P 9-,UGX0?'
M#Q]\1/&_Q1T_XF^ _%5OX-\:>(?BO<?#O5_'>H#0V\8ZA\-=>\37>@V>K:IX
MSL-1\27L.E_KII%A=:?96=O>ZB^J75O8VEK<7\MO%;27EQ!!'%/>/! 1!"UW
M*C7+P1*(HI99%AVQD(,*U.C3Y98>I+G]K6=W[UJ;Y/9R5WIS>]ITLO,WI^TF
MI1KTVHNG3;4HJ/OOFYX:-W4+1L_/8R?"/@OPIX#T'2/"G@GP]H_A+PMH&GPZ
M5H7AKPWI.FZ%X>T73;966VL-)TC2K6TL=/LK9&:.VMK2"*"",^7'&J\5U0&!
MBEHKF49<[J3FYR::NU;1N_=G0DDDEHDDDNR222^22"BBBK **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?J640YRBG.,Y4'."2,\<X))'N2:=117$=@4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M06*]K5C9J#JKDE.H[<CYKN.FEM+6^%:*Y?T+]K./Q?\ &#Q#\)/#^CIH>I^
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MS6J4'!4W*S]JI.%G>RCOS6ORMWT3M?I<B$U*52-FN1Q2;TO?>UTKV\K^9?+
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:;\2?#OABPT[PK9>+X/$4]K>^'M*T6S\2^'_ !#_ &!H;:=ZWX;_ &./V==
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ex5-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  I O8# 2(  A$! Q$!_\0
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M50"2S,   "2220   23V )J"&\M+@,UO=6TX4E6,,\4H5E +!BC, 5!!(."
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M*#<OW<;<E5Z+6=W[NVFC/ZJEOK)IS;+>6K7"DAK=;B$SJ0 2#$',@(#*2"O
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M0%@/^^C3ZX#L"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)SUH,<9&#&A& ,%5Q@=!C'0=O2OQM^#7[>WC?XAWG[0NGZGJMDT.L_!?Q_\
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MO3^%/&$FJ7USI;VG@.ZAU+3C'I4,MA/-/JUY/J<R3W%K:?91O9CR7PY_:O\
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M:E(;*29(H8=9^'/%,*M2C]5PKJT,&L=BH_7\*H87"NOA\)&O7K.;IPH/'8S
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M PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M";77X/"GPQ\)^'X_%MD;#Q(-,TU+=]6L9"7DL+F0,9/L+.[$V<31V_0"( *
MUOV:?@,^I>&=7?X6>$&U'P=I^C:7X:NFTN)GTJP\.JJ:#;PHV8Y5T955=,>Y
M2>2Q48MGC!.?<%Z#Z#^5+2>:YI-RG+,\QE*JI>TD\?C'*:J4%AYJ<OK2<^;#
MI4)<U^:BO9OW+Q>RX3X65"CAGPUP^Z%#V7L:+R3*O8TW1Q*QU.5.E]1]G"4,
M<GC8N$(M8MO$-RK?O#QZU_9_^#%EXP?X@67PW\*VGC-YKBY/B*VTR"#41=W<
M,EO<WJ21!$COIX)I8I;Y$6[>.616F(=@71? +X.P6GAVPA^'_A^*R\)>*[KQ
MSX:MDM2L.C>+KZ:XN+OQ!9('Q'J-Q/=7$LDQW9:5CM'&/7Z*F69YE.RGF./F
MHPITTIXW%S2A2C.%*"4\1-<M*%6I&G&S5.-2<8**E)/6/#/#<%4C#A[(81JU
M:F(JQADV50A4KU:^%Q-6O4A#+X4YUJF(P."KU*LZ<JE2MA,+4G4E/#T73\6U
M+]G;X):QX.L/A]JGPV\,7_@S2KVXU+3/#US8B73].O[NZGO+F[L%9O-M)[BZ
MN;B::2WDC:1YI-V0Q%9^L?LO_L_:_I?AS1-8^$O@N_TGPC%);^&;&;2(O(T:
MVFD6::TLE0KY=G/.BW$]H<VTUSFXDB:9F<^\T5=/-LUHN+I9IF-)PK5,3!TL
M?C*;AB*K;JUX.&*ARUJK;=2K'EG4N^>4UH9U^%.%<5*K+%<,\.XF=>CA\-6G
MB,BR>O.MA\)5E6PE"K.MEE6I.CA:TY5<-2E4<*$Y2E15-R:?D]W\#/A)?7VL
M:E=> O#TU]X@\&?\*[UFX-F%:_\  ^V1/^$6F6-D4:,$FD5;.-4C56(7   W
M-(^&/@/0-2TW6-&\,:9IVIZ/X>7PGI=Y:Q-'+8>&DN8KQ=$MCO(BT\74$,X@
M4!0\:D8Q7>45SSQ>*J0G3J8K$U(5$HSA.O6G&<5%0491E5DI14$H\K]WE5N6
MU^;LIY)DM*I"K2R?*J56G4C5IU*66X"E.%6+<HU(2IX.FXU(R;E&I&TT]5.Z
>3BQ(TCX08XQU)X_$FGT45SGII):+1=D%%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ex5-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !0 +X# 2(  A$! Q$!_\0
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MCWS-^(W[-_\ P5#_ &Y/'G_! G]M?]M'Q1\9IM1_:2^%_P 9?%7ACX=>/O\
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M_90T34]1_80_X*':?I-AX\^&&@:%J^IZ1\*OB[X,UI?'VCZ1::1H( T&*22
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M  44\5>"/^"F7Q=_9X_X)Y?LC_\ !,"[_8C_ &R+OQ?I?Q;MOB#\6_!_PU^
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M-$C+8)3PS+JS^'4=25;R2<A)%)^R%\5^$@<MKVE$]C]JCXQP/XOITSZ?5_\
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MOWQ]_P""??\ P4(\,_M,^-/VK/V _P!ON;P7+\2;/3+'QA^S/^T]HFN?%KX
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M C\'*)6,GF/[4/\ P7VU[P[_ ,$I_@O_ ,%&/V:OA7X1U+7OBC\5=*^$VO\
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M'1K_ %O4_/6PL[/[9=_9P2=N #@!E)[#.>G/H*^??V8?L/\ PB6O_8?(\_\
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MWC;Q)K^C'Q0?*;PZ^M>(/)\-.DR6_APM)<))<DP?H9\;_AQ^R=^TIX6'P_\
MCYX:^!_Q=\-)>&]LO#7CZ+P;XHCL=3"D1ZEI4.NK(VC:ZK,");<17"JH7S0I
MD!Y_]GC]DG]B[]E34]3T+]F3X%_ ?X.:[JEK%_;\/PS\&^$?#_C*_P!-#H^_
MQ!K$4<?B?6]&$BIY37,L\<<@!B!D)*^5FG$&79M0RG&9ME6+AG&1\-PX?M3<
MZ61SITI/V>)DU&E652'/[\&FIU+<U10<H5#ZSA]';WE=6M>+;_)]G]WE_%!^
MS7X+^"/C3_@JQ_P5_G^,/_!17QO_ ,$_H-+^//VS1_$'@;XV^"_A&/B7CQGX
M_.NZ-KI\1D#Q /">-#  S\WB#Q*#M!9Q_7U_P3EUO]G[0OAAKOP<^#'[<UW^
MW3JOA77KWQ)XG\?^)?C!X-^+_CO0X_$F(M#TC6-:\-RLL7A^'^RG3PB9(V!A
M60K(T:JQ[7QE_P $TO\ @GM\2?%.N^/?'_[%G[,OB[QGXJU2_P!>\1>*_%GP
M2\#:QXBUS5M8V+-K.JZMK7AS[5)K4S?>:>1I8V?"E<J!ZC\"?V0_V5/V:+KQ
M#J?[.7[.WP4^!][XS5;;Q+J/PI^''A'P3-KJ:82(!K;>'K>TDU<QR*ZC<))1
M@B38P##7BSBW*L_P/LZ<.)(SC2R.-.+I9(\,IT(1@^:K3A_:_LE9VBVFZ>Z]
MQJ)B<1]9U=[:)[+H]E:[;[WZ+N?3^[K\\O[_ /U'^S\N?7Y?7YNWXU)!]Z7_
M 'A_(U'Y8_?X@QZ\K_I?RYY].XP?Y<4)T_U?F]/W7R?Z/P/DYQU^@X XQBO@
M?3;IZ'GG\]G[ QB'[=GC<K]E\CR?BX+3[+:E!M_X2.(.-PSCY2< 9W'CG-?N
MQX\\1W7@[PEJ_B2" 77]EY<6MP2 V[5 A;<O7*2#&#]T*<\ U^+W[%/PR^)G
MAS]M/Q[K_B/X>^,_#GAR2R^(]Q;>(/$WAC5M,T]+_7=?6=&TC74T!/#6NZU,
MD;;R6'FP>:$63[C?L+\8+"ZO_AYXDTW3M.N-0NKRXTH6=GIVF_;F.S5]$D/[
MC 1F"J[N>,*K,.(\U^M^,&,P./XMRR>!G3J4_P#5GAZ#E"I3J14X1FJD7*$Y
MJ,HMVE%M2CJI*.Q^+^!N%QF#X2S2&-BXR_UHXA=I1:TE*-G9J/75.WFKG@__
M  TWKN?^17T;&?L?VG[9JV/7'W-WOG=N]\<5D>(OVB-;\1:#J&A3>'=/MO[4
MLVLKR[M;YC]@SR>6)[]/3G&.:\G_ .$&\>9GE_X1#QINM[LLMU=^'-8+,O'(
M'_"-Y*\C)Q[>U._X5YX^_P"A&\7?^$WK%?FEL'?Y_P!=3]H6QZ7\ /&MGX=\
M27.E:G.;>Q\3M';"ZNKP?Z%JL<FNR; 6(5?,V;-Q("[MQSMX^W]5TBSUG2K[
M1M3$MQ;:G:_8[WR<J2A!!PP!V$Y'4'IS7YJ#X?>/CT\$>-;?[5_Q^8T?6#].
MF<CK^.,]:]]\"^/OBUX=M8-+UKP%XN\0V%KQ:O<:-JVFZK8A<_(Q=7'B!>23
MCY@1P0,US8B@G9J2?I)/L]U)^77U \?\<_"GQ1X&EN!-97&HZ$!J;6VI6MH-
M2T^/2W+* ZJQ'A[YDT90<E6*-M9@":\[_P!=_KY_LW_+E_Q^?X \^_![]17Z
M8Z-XRL]2BA(T?Q;ILS=+35_"&O:?C'7YCH0]/X0OK5V7PWX/U(?Z3X5T.Y_Z
M^M(T=CU]US^AH6)>U]=EKUZ:7] .:^$A\_X8^$)=]O/]HT6-_P!UDV1^=@!@
M@@H=N.G]X5_*7^WQJ/BG_@H__P %Y_A5_P $O?'WC?QEX3_8]^"OPJ3XK?%3
MP!X*\3ZSX>_X6YXF/@P^-X$UQM'96^4:]H?AD)N3_BDY/%<B%9IBQ_KQB@MK
M:#]W#;6]M!F:VC%J+&.T!# @C 4<$EF")P2&!&"/YP?^"D/_  3J_:YT;]O/
MX+_\%8/^"==OX#\:?M#_  W\-OX(^,/P)^(6M3>'-(^+?A/^PO$&@ Z1KMV!
MX?A\0S>&M:D\,&&5O"\=M+'X?\6?:WF@D#?3\#XS+,'FF:RS&4(9G4X8X@AP
MU5FX1A3XDJ12HSG.HG"G'WG&,Y^["<HMM:2.W#+7SM9?KTW7R>^_7<UC_@B?
M?_LP?M=_LU_M,?\ !++QMH_[,GAOPSXE71?VH/@KXM\:_$_7? 'QH^&+1QOY
M.DZ//_PEH7Q+_P AM3),+2W6ZNH?%*RRWD,BR?//_!6CP1XA_P""J/\ P4/^
M$'_!*WX=>--;\.?#GX!?![QU^U5^TEXC\+:M'']@\>:YH?\ 8/P.\&:X@50A
M)US1YI%.2/!_Q D8$< >QV'@/_@LW^W7^TQ\ O'?QU\'P?\ !./]ES]G?Q-%
M\0_%_P +_AC\;])^)?Q9_:3U0Q0ZPG@K6&T MX1M_"R1I%X;EA\3;%!E\1RB
M)[B]B'A3R_\ 94_X(:>)/CYXJ_:2_:X_X*/ZY\;_ (6_M1_M"_'7QSXGM_"_
M[/?[2&M>#=+\'_!MFT>+P/X*;6_A])$FNK;F$&7=)PF@>'  KQG=]1A<PIY7
MC8YQQ+Q/0K9ODN0J%)4</3XC=*M.IRTXM04:>=>QI2K\\W;V*G!7;21=DF[N
MVFJ=E?J_6^EEZNZ6IZ3_ ,&TO[4'BGQ]^R+X[_8V^+=W./C=^P9\2]7^"^LZ
M7JJ(=33P-'J,S^"VDR-S+X:U:#7_  <68DQGP]#@?=(_G"_X)TWG_!(*[\8_
MMXS_ /!42^\4W7CJU_:Q\?\ _"J1;WO[3&HK_P (/_;6O'6@Q^#@/AGR_P#A
M(]V\^*QNSC:#UK^@7]F__@DC\=O^";W_  5ZT#XX?LA:-XF^)?[$OQQ^$&L>
M"_VC-9^(?Q=T;7OB1X1\8:K++K1UPGQ%O\5^.PWB?0/!?B,R[I)%C\0>*51V
M55!]I_X(=_\ !.CXW?LE0_MY']JKX3>"],D^-G[6'BKXH_"TRZAX4\::C?\
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M+&"/&7CQDF1UDDE3PV4<2AW']6?_  3'_84_:A_X)X?MX_MJ_#+0_"%GK/\
MP3B^._B!_BS\%O$-GXNT0R?"GQG*W]M3>"AX(?/B=('.N:OX8>=0T1C\-^%I
M"64[CX!^S=_P2!^.'B'_ ()9?\%'_P!C#]HGP?I'A+Q]\?\ ]J?X[_''X,,G
MB#1M3TDZE>Z5X!U7X2>,1-H&MR+HF?%?@1?M$/B6XB>% DMTAA>,/T2XGR?#
M9IFT)8^G4R3/*?"^'E4DL/6KU.')QJTL1[=^SO'/*7M(SK248U.=5)**C)&Z
MQ.%]ZZBM%RZ6LG>_1^\^VJMV=[?EO_P< >,]>_;F^)W[:OC+P7XPU0?L]_\
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ECYAW. 6!5N[?Q=J>GW?^7GK_ )Q[?US7@;Z_EM\O+MY6.8__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
